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Abstract
The uptake of influenza viruses into host cells is initiated by binding of their 
haemagglutinins (HA) to terminal sialic acids on receptors. After infection, the immune 
system produces anti-HA antibodies that block receptor-binding activity and thereby 
neutralise virus infectivity. As a consequence, antigenic variation is necessary for a new 
influenza epidemic to occur. Since many epitopes are close to the receptor-binding site 
(RBS) of HA, it was the aim of this thesis to investigate whether changes in antigenicity 
correlated with differences in receptor-binding properties.
A microscale-assay using surface plasmon resonance (SPR) was developed to 
study the interaction of virus particles with receptor analogues. This technique provides 
information on kinetic rate constants and affinities for biomolecular interactions. The 
conditions of the assay were established using bovine fetuin, which contains sialic acid in 
the a(2,3)- and a(2,6)-linkage to terminal galactose of oligosaccharides. Viruses isolated 
from different hosts vary in their ability to recognise sialic acid in these linkages. 
Therefore, the assay was performed using fetuins derivatised to contain sialic acid either in 
the a(2,3)- or the a(2,6)-linkage, in order to determine the linkage-specificity of influenza 
viruses.
Various antigenically distinct HI and H3 subtype viruses, chosen on the basis of 
reactivity with post-infection ferret sera, were tested for their receptor-binding properties. 
It was shown that antigenic evolution of HA for both subtypes was associated with 
changes in affinities for receptor analogues. Sequencing of the gene coding for HA 
revealed that the changes correlated with amino acid substitutions close to or in the RBS. 
The importance of the variant residues for the observed changes in receptor-binding 
properties is discussed using the previously solved X-ray structures of HAs complexed
with receptor analogues.
Finally, the molecular basis for the evolution of avian H3 HAs to recognise sialic 
acid in the a(2,6)-linkage characteristic of human HAs was studied by in vitro selection of 
receptor-binding variant viruses. Although selection of an avian HA with a substitution at 
residue 226 previously reported by Rogers et al. (1985) was not achieved, a variant with a 
substitution at residue 201 was identified.
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Chapter 1 Introduction
1 Introduction
HA plays a major role in influenza virus cell entry and immune response. Studies of 
antigenic variation and receptor-binding properties of HA will therefore help in 
understanding the continued evolution of influenza viruses in the human host.
1.1 Discovery of the Influenza Virus
Based on clinical observation and epidemiology, influenza-like disease outbreaks have
tlibeen reported since the 12 century. However, influenza virus as the causative agent was 
not isolated until 1933. Driven by an influenza wave in the London area, scientists at the 
National Institute for Medical Research (NIMR) decided to make use of their canine 
distemper study facilities to identify and culture the virus. Therefore, ferrets were 
inoculated with filtered throat washings of infected colleagues. The animals developed 
influenza-like illness, transmitted the disease to other ferrets and were rendered immune to 
re-infection (Smith et al., 1933). Finally, the first virus was isolated from one of the 
scientists called Wilson Smith and thus named after him. Serial passage of the virus in 
ferrets resulted in a highly pathogenic strain for mice, and finally Koch’s postulates were 
fulfilled by accident, when a ferret infected with a mouse-adapted influenza virus sneezed 
at a scientist. He developed flu-like symptoms and the virus isolated from his throat 
washings proved to be the same virus as given to the ferret (Smith and Stuart-Harris, 
1936).
1.2 Classification
The name influenza (Italian for “influence”) is based on the old medical belief in 
unfavourable astrological influences as the cause of the disease. Influenza viruses belong
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Chapter 1_______________________________________________________ Introduction
to the Orthomyxoviridae (greek orthos for “standard, correct”, and myxo for “mucus”) 
family of enveloped viruses with a segmented genome of single-stranded RNA of negative 
polarity. They are classified into three genera: Influenza A, B and C, based on differences 
of their nucleocapsid protein (NP) and matrix 1 (Ml) protein antigens (WHO, 1953; 
Schild, 1972). Influenza A viruses infect a variety of mammals and birds, whereas 
Influenza B and C have only been isolated from humans, with the exception of a number 
of type C isolates from pigs (Guo et al., 1983) and a type B isolate from seals (Osterhaus et 
al., 2000). Influenza C contains 7 genome segments, whereas Influenza A and B contain 8 
segments. Influenza A viruses are further divided into subtypes based on the antigenic 
nature of their HA and neuraminidase (NA) glycoproteins. To date 16 HA (HI-HI 6) and 9 
NA (N1-N9) subtypes have been identified (Schild et al., 1980; Fouchier et al., 2005). 
Whereas all 16 HA subtypes circulate in aquatic birds, 3 have evolved in humans (HI, H2, 
H3), at least 2 in pigs (HI, H3) and 2 in horses (H3, H7) (Webster et al., 1992).
1.3 The Influenza Virus Particle
1.3.1 Structure
The Influenza A virus particle contains 8 single-stranded RNA (ssRNA) segments of
negative polarity (McGeoch et al., 1976) coding for 10 viral proteins (see Figure la). Each
of these is independently associated with NP to form a coiled hairpin structure (Pons et al.,
1969; Compans et al., 1972; Jennings et al., 1983), with the polymerase complex proteins
(PB1, PB2 and PA) attached to the 5’ and 3’ ends of the RNA (Hagen et al., 1994). The
complex of viral RNA (vRNA), NP and the polymerase proteins forms the
ribonucleoprotein (RNP) particle. The virion is enveloped by a host-derived lipid bilayer
(Kates et al., 1961) containing the glycoproteins HA and NA. HA is the more abundant of
the two, a virion containing 300-400 HA in contrast to approximately 50 NA molecules
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Figure 1 Structure of the influenza A virus
a) Schematic diagram of the influenza vims particle (adapted from Wright and Webster, 
2001a). The surface of the vims particle contains 3 integral membrane proteins: 
haemagglutinin (HA), neuraminidase (NA) and M2 channel protein. Matrix protein (Ml) 
underlies the lipid membrane. The 8 viral RNA segments are each associated with the 3 
subunits of the polymerase complex (PB1, PB2 and PA) and are encapsidated by 
nucleoprotein (NP), forming the ribonucleoproteins (RNPs). The other virally encoded 
proteins include NS1 and NS2 (NEP). b) Negative-stain electron micrograph of spherical 
vims (X31, H3N2) c) Negative-stain electron micrograph of filamentous virus (Chita/1/03, 
H3N2) Figures b) and c) were taken by L. Calder (NIMR, London).
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(Ruigrok et al., 1984; Ruigrok, 1998). A few copies (~ 14-68) of a third transmembrane 
protein are embedded in the envelope, the membrane-channel matrix 2 (M2) protein 
(Zebedee and Lamb, 1988; Sugrue and Hay, 1991). Underlying the lipid bilayer is a shell 
of Ml, which is the major structural component of the virus (Schulze, 1970; Schulze, 
1972).
1.3.2 Morphology
Electron microscope studies reveal that influenza virions are pleomorphic, ranging from 
small spherical particles with a diameter of 80-120 nm (Taylor et al., 1943) to long 
filaments up to several pm in length (Mosley and Wyckoff, 1946) (see Figure lb and c). 
HA and NA appear as spikes protruding from the virus envelope. Clinical human and 
animal isolates are predominantly filamentous (Chu et al., 1949), and a gradual shift from 
filamentous to spherical morphology has been observed upon serial passages in 
embryonated hens’ eggs (eggs) (Burnet and Lind, 1957; Choppin et al., 1960). Other 
morphologies such as “kidney”-shape and “double-kidney”-shape are artefacts of sample 
preparation for negative-staining electron microscopy and reinforce the impression of 
variability of the virus (Nermut and Frank, 1971; Ruigrok and Hewat, 1991).
1.4 The Influenza Virus Life Cycle
An overview of the virus life cycle is presented in Figure 2.
Influenza viruses bind to cells by interaction of HA with sialylated receptors (reviewed in
Gottschalk, 1959), leading to receptor-mediated endocytosis (Fazekas de St. Groth, 1948b;
Matlin et al., 1981; Sieczkarski and Whittaker, 2002). Acidification of the endosome
triggers a conformational change in the HA structure, resulting in fusion of the viral and
endosomal membranes (White et al., 1981; Skehel et al., 1982; Bullough et al.,
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Figure 2 The virus life cycle (in humans) (Figure adapted from
http://www.chemsoc.Org/exemplarchem/entries/2001/sandersorFimmunologv.htm#work)
Influenza virus enters the respiratory tract (a) and attaches to cells by binding to sialic acid 
on cell surface receptors (b). Virus enters the cell by endocytosis into endosomes (c). 
Acidification of the endosome induces a conformational change in HA, leading to fusion 
of endosomal and viral membranes (d). Genetic material is released into the cytoplasm and 
enters the nucleus of the cell (e). In the nucleus, viral RNA is replicated (f) and transcribed 
into messenger RNA for the production of viral proteins in the cytoplasm (g, h). Viral 
proteins and the viral genome are assembled at the cell surface and progeny virus is 
released by budding (j). Viral neuraminidase removes sialic acid from the viral and cellular 
membranes and this virus can infect a new cell (k).
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1994). Prior to this event, the interior of the virion is acidified by action of the ion-channel 
M2 (Pinto et al., 1992; Bui et al., 1996; Chizhmakov et al., 1996). This leads to 
dissociation of Ml from the RNPs, a prerequisite for entry of the viral genetic material into 
the nucleus (Bukrinskaya et al., 1982; Martin and Helenius, 1991). Once in the nucleus, 
the vRNA is transcribed into messenger RNA (mRNA) and replicated by the polymerase 
complex proteins PA, PB1, PB2 (Hay et al., 1977; Braam et al., 1983; Honda et al., 2002). 
In addition to the polymerase proteins, NP is required for the synthesis of the vRNA 
(Beaton and Krug, 1986; Portela and Digard, 2002). The transmembrane proteins HA, NA 
and M2 are synthesised by endoplasmatic reticulum (ER)-associated ribosomes (Compans, 
1973b; Hay, 1974; Lamb et al., 1985), and inserted into the membrane (McCauley et al., 
1979; Bos et al., 1984; Hull et al., 1988). Folding, assembly into oligomeric structures and 
glycosylation occur in the ER, whereas processing of the glycans and palmitoylation take 
place in the Golgi (Schmidt, 1982; Gething et al., 1986; Sugrue et al., 1990; Gallagher et 
al., 1992; Saito et al., 1995). Upon assembly of the replicated viral genome and proteins at 
the apical side of the polarised cell (Boulan and Sabatini, 1978; Hughey et al., 1992; 
Kundu et al., 1996; Lin et al., 1998), the virus is released from the plasma membrane by 
budding mainly from lipid rafts (Skibbens et al., 1989; Scheiffele et al., 1999; Zhang et al., 
2000). The NA facilitates this process by cleaving sialic acid from the cell surface, 
preventing aggregation of the virus at the cell surface (Palese et al., 1974b).
1.5 Immunity against Influenza
Protective immunity against influenza infection is primarily mediated by the B-cell
response. Although antibodies are directed against any viral structural protein (HA, NA,
Ml, M2 and NP), neutralisation of virus is mediated by anti-HA antibodies (Virelizier et
al., 1976). Serum immunoglobulin (Ig) G is mainly involved in this process (Virelizier,
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1975; Palladino et al., 1995), although IgA and IgM may also contribute. Secretory IgA 
has been suggested to mediate mucosal immunity in the murine nasopharynx (Renegar and 
Small, 1991; Renegar et al., 2004) and has also been detected in nasal washes of influenza- 
immune humans (Clements et al., 1986). Serum antibodies are subtype-specific, and 
infection by one HA subtype confers little or no protective immunity to other subtypes 
(WHO, 1980). It has been shown that neutralisation occurs by blocking the interaction 
with receptors on host cells, thereby preventing internalisation of the virus (Hirst, 1942b; 
Taylor and Dimmock, 1985a; Taylor and Dimmock, 1985b; Knossow et al., 2002), 
although prevention of membrane fusion by some antibodies has also been suggested 
(Kida et al., 1983; Edwards and Dimmock, 2001).
CD4+ T-lymphocytes (T-helper cells) are absolutely required for the production of 
antibodies against HA by signalling to HA-specific populations of B-cells to differentiate 
into antibody-secreting cells (Virelizier et al., 1974; Scherle and Gerhard, 1986). CD8+ T- 
cells (cytotoxic T-cells) are largely cross-reactive (Zweerink et al., 1977) and mainly 
directed against the more conserved internal proteins PB1, PB2, PA and Ml (Bennink et 
al., 1987; Reay et al., 1989), with the major target being NP (Townsend et al., 1984; 
Yewdell et al., 1985). Although they are not protective and may not be absolutely required 
for the control and resolution of an influenza infection (Eichelberger et al., 1991; Scherle 
et al., 1992), they have been observed to enhance virus clearance from the lung 
(Mackenzie et al., 1989).
NA-specific immunity is also antibody-mediated but is unable to prevent infection 
(Webster and Laver, 1967; Kilboume et al., 1968). However, subsequent virus replication 
might be suppressed by blocking release of virus from cells, leading to reduction of virus 
yield and spread (Schulman et al., 1968; Johansson et al., 1989).
Mice have proven to be a good model for the study of influenza immunity in man.
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In the human population, however, the immune response is more complicated. In contrast 
to laboratory mice being naive to individual influenza strains, the human population is 
subject to recurrent infection of antigenically distinct viruses. This results in the production 
of cross-reactive antibodies with reduced affinity (Francis et al., 1953; Fazekas de St. 
Groth and Webster, 1966). Therefore, concomitant immunity to previous infection might 
compromise the antibody repertoire to subsequent infection.
1.6 Influenza Surveillance and Vaccines
Recurrent influenza epidemics cause excess morbidity, particularly in children, and
mortality in the elderly (Glezen, 1982), and result in an estimated 500,000 deaths per year
worldwide (Stohr, 2002). Therefore, high-risk groups are protected against influenza
infection by vaccination. Vaccines against influenza virus primarily stimulate humoral
protective immunity. However, since the surface glycoproteins HA and NA evolve rapidly,
giving rise to new infectious strains (see 1.7.5 Antigenic Variation, p. 52),, the vaccine
formula needs to be updated annually. The World Health Organisation (WHO) coordinates
a global influenza surveillance network since 1952 (WHO; Payne, 1953), which routinely
characterises the antigenic, genetic and epidemiological properties of currently circulating
strains in order to include the prevalent viruses as vaccine components. These include type
B and type A (H1N1 and H3N2) strains (trivalent vaccine). The viruses to be incorporated
in the new vaccine are grown in eggs. Since many clinical isolates do not grow to high
titres in this host cell system, HA and NA from the circulating H1N1 and H3N2 viruses are
currently reassorted with a high yield donor (A/Puerto Rico/8/34) (Kilboume, 1969;
Kilboume et al., 1971; Furminger, 1998). Although eggs are still the main substrate for
vaccine production because of a general high yield of virus, this system presents
drawbacks, e.g. the lack of reliable year-round supplies of high quality eggs, low
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susceptibility of summer eggs to infection with influenza virus, the possible presence of 
pathogens and selection of antigenic variants (see 4.1.3 Host Cell-Mediated Variation, 
p. 134). Therefore, efforts have been made to improve tissue culture systems for large-scale 
virus propagation, with Madin-Darby canine kidney (MDCK) and green monkey kidney 
(VERO) cells being recommended as possible vaccine cell candidates (Bruhl et al., 2000; 
Halperin et al., 2002). Another new approach to vaccination is the use of reverse genetics 
(Neumann et al., 1999; Hoffmann et al., 2000) for possible production of influenza 
vaccines entirely from cloned viral complementary DNA (cDNA) (Subbarao et al., 2003; 
Ozaki et al., 2004).
Vaccines are produced from whole formalin-inactivated virus, from disrupted virus 
particles (“split” vaccines) and from purified surface antigens containing HA and NA 
(“subunit” vaccines). Since the “split” and “subunit” vaccines induce fewer side effects in 
the immunised people than the one prepared from whole virus, they represent the most 
widely used vaccines today. Inactivated vaccines are safe, immunogenic and effective, 
preventing illness in 70-90% of healthy young adults. However, such vaccines are 
considerably less effective (< 50%) in the elderly, infants and patients with certain chronic 
diseases or immunodeficiency, and the duration of protection is relatively short (< 1 year) 
(Wright and Webster, 2001). Therefore, new strategies are being pursued to generate 
longer-lasting vaccines of improved immunogenicity (Kemble and Greenberg, 2003), e.g. 
by the use of adjuvants included in currently available vaccines (e.g. Babai et al., 2001; 
Podda, 2001; Rimmelzwaan et al., 2001) and the development of live attenuated influenza 
virus (LAIV) and DNA vaccines (reviewed by Wareing and Tannock, 2001; Ulmer, 2002). 
Of these, the LAIV vaccine has been extensively used in Russia and is nearing licensure in 
the United States.
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1.7 Haemagglutinin
1.7.1 HA Synthesis and Transport
Haemagglutinin was originally named because of the ability of the virus to agglutinate
erythrocytes (Hirst, 1941). It is encoded by RNA segment 4 and represents a type I integral
membrane protein containing an (N)-terminal signal sequence (McCauley et al., 1979), a
transmembrane domain near the carboxy (C)-terminus and a short cytoplasmic tail. HA is
synthesised as a single polypeptide HAo (molecular weight (MW) ~ 75,000 daltons (Da))
in association with the rough ER (Compans, 1973b). Insertion into the membrane of the
ER, cleavage of the signal peptide and core glycosylation all take place co-translationally
(Compans, 1973a). Glycosylation of HA has been shown to be important for the correct
folding and oligomerisation of HA into trimeric structures (MW ~ 220,000 Da) (Gallagher
et al., 1992; Roberts et al., 1993; Hebert et al., 1995; Molinari and Helenius, 2000), which
is essential for the transition of HA from the ER to the Golgi network (Gething et al.,
1986; Copeland et al., 1988). Another post-translational modification involves the
cleavage of precursor HAo into two disulphide-linked chains H A i (MW ~ 50,000 Da) and
HA2 (MW ~ 30,000 Da) (Lazarowitz et al., 1971; Klenk and Rott, 1973). As discussed
below, proteolytic cleavage is a prerequisite for virus infectivity (Klenk et al., 1975;
Lazarowitz and Choppin, 1975). Nonpathogenic viruses are cleaved extracellularly
(Lazarowitz et al., 1971; Hay, 1974) by host-specific trypsin-like proteases (Lazarowitz et
al., 1973a; Lazarowitz et al., 1973b; Klenk et al., 1977). The enzyme responsible for
cleavage in the human respiratory tract has not been identified but may be similar to serine
tryptase Clara, produced by cells of the rat bronchiolar epithelium, which has been shown
to activate human influenza viruses (Kido et al., 1992). Some highly pathogenic H5 and
H7 viruses are cleaved intracellularly (Klenk et al., 1974) by ubiquitous subtilisin-like
proteases, such as furin (Stieneke-Grober et al., 1992). Accessibility to such proteases
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appears to be due to the insertion of basic amino acids into the cleavage site or deletion of 
a carbohydrate in the vicinity, which, together with the wide tissue distribution of furin­
like enzymes, is thought to be related to the high virulence and systemic infection of these 
viruses (for a review see Steinhauer, 1999).
1.7.2 The Structures of Haemagglutinin
Three different conformations adopted by HA have been defined structurally and are
shown in Figure 3 and 4. The mature HA forms homotrimers of MW ~ 220,000 Da. As
described above, each monomer is synthesised as a single polypeptide precursor HAo,
which is posttranslationally cleaved to generate HA with the C-terminus of HAi and the N-
terminus of HA2 being linked by a single disulphide bond between residue 14 of HAi and
137 of HA2 . This cleaved form of HA is present on the surface of infectious viruses
(discussed below). Cleavage of HA is required for activation of the fusion potential and
virus infectivity (Huang et al., 1980; White et al., 1981). The overall structures of cleaved
and uncleaved HAs are superimposable, with only 19 residues being positioned differently
(Wilson et al., 1981; Chen et al., 1998) (see Figure 3a and b). These form a prominent
surface loop in HAo (shown in yellow) containing the cleavage site. Upon cleavage, the
newly formed HA2 N-terminus is buried in a negatively charged cavity at neutral pH. This
N-terminal sequence contains a stretch of hydrophobic residues, which are highly
conserved among influenza subtypes (Nobusawa et al., 1991). Both cleaved and uncleaved
molecules project approximately 135 A from the viral membrane and consist of two
distinct regions, a globular and a stem domain. The globular domain at the membrane
distal part of the molecule is composed entirely of HAi residues, which primarily form an
eight-stranded anti-parallel p-sheet, corresponding to both the RBS (see 1.7.3.3
Haemagglutinin in Complex with NeuSAc, p. 36) and the principal recognition sites for
29
AC g
J t £ 
^  0 )
as £M o
f l  CDs  arci
3 c 
—  O
W) 3  
6D »
2 ^  S
«  /—s3  o  
- f i  <
'O ffi
«  w
*  ^  3  G
JJ  G
*r .3
3  6 £ >
y - t <D
o 4 3
J-I
CDrH 5
8 C/3
’ h  -»—> 3
o •»—io
B O h
o
3
_g
o
f f i £o
O h
h
3
J-H <DH—<
3
CD
hO
H
3
-4-> £
3 o
_ m 2
<
<D
s C3
v—^
. G g
* 3 O%—» 
3 4 3C/3
’6 b C/3
6 5
3 CD
3 3
<D " G
3 O h
4 3 (D
O h
3
g sS 2ao  g O -3 
■ f i
Vm
O
3
O
«H
Oco
J-H
3O
. . (D
■+•* Vh
«  a
3  t 3
SJ CD
5 «  > >
fe  <D
0 *  r r ?  aj O
■ !o  ^ 3
- D  
- O
2S
m
4 >
L .
3
W D
fct< 'c?
<D
4 3H
' d
CD
J-H
CD
03
C/3
CD
■3
C/5
<D
*-H
( N
<
X
o
3
#G
(D
c3
C/3
CD
3
3
CD
j - i
<
X
l . €3 3  onChX) u-rx30 g* 3 .5
s  12 <D 3
£  J? 
’a  o
(D - 3  
>  O h 
03 (D 
CD O—i D
O  u>
30
M
em
br
an
e 
; 
! 
Fu
si
on
 
an
ch
or
 
j 
; 
pe
pt
id
e
CJe
a  
co• pN
3
<D VO ^  °
GX)
.5  ed
si
<u
0)
6*h «
Wa
C3
Ln
3
QJ
£
31
Chapter 1__________________________  Introduction
neutralising antibodies (see 1.7.5.2.1 Antigenic Sites, p. 54). The stem domain extends 76 A 
from the membrane and consists of residues of both HAi and HA2 . The main structural 
features of this domain are two a-helices connected by a hairpin loop. The HA trimer 
(Figure 3c) is stabilised by independent local contacts in the globular and stem regions. 
The HAi globular domains make pairwise contacts near the upper end of the molecule, 
whereas a triple-stranded coiled-coil of a-helices formed from the top half of the long helix 
from each monomer provides the major contacts in the HA2 region (Wilson et al., 1981).
As described in 1.4 The Influenza Virus Life Cycle, p. 22, internalisation and 
subsequent acidification by the endosome triggers dramatic structural rearrangements in 
HA2 , leading to fusion of the viral and endosomal membranes. The low-pH conformation 
of HA is shown in Figure 4 and reveals the irreversible structural changes as a result of 
acidification (Bullough et al., 1994). The overall effect of these is the extrusion of the 
fusion peptide (the N-terminus of HA2) from its buried position to the tip of the molecule. 
This conformational change leads to the positioning of the fusion peptide and the viral 
membrane anchor at the same end of HA, bringing the membranes into close proximity for 
fusion to occur.
Additionally, HA is co- and post-translationally modified. The molecule is highly
N-glycosylated, the extent differing depending on the HA subtype, (Ha et al., 2002), and
also contains three potential acylation sites at cysteine residues at the C-terminus of HA2
(Kawaoka et al., 1990; Veit et al., 1991). The biological role of the oligosaccharides is
described in 1.7.5.2.2 The Role o f Oligosaccharides in Antigenic Drift, p. 56. All the
structural information described above is derived from HA of A/Aichi/2/68, the prototype
of the H3 subtype viruses responsible for the pandemic in 1968. Since then, the structure
of the cleaved HA has been solved for several HAs of subtypes HI, H3, H5, H7 and H9
(Ha et al., 2002; Ha et al., 2003; Gamblin et al., 2004; Russell et al., 2004). These have
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been shown to be structurally homologous.
1.7.3 Receptor-Binding
1.7.3.1 Discovery of Sialic Acid as Receptor Determinant for HA
As described above, influenza virus initiates infection by binding to cellular receptors,
followed by endocytosis into endosomes. Earliest evidence for a specific cellular receptor
was provided by Hirst, who demonstrated the agglutination of chicken red blood cells
(RBC) by influenza virus at 4°C (Hirst, 1941; Hirst, 1942a). This was supported by the
ability of the virus to adsorb to respiratory cells of ferret and mouse lungs (Hirst, 1943a;
Fazekas de St. Groth, 1948a). Furthermore, interaction of influenza virus with a variety of
mucopolysaccharides and mucoproteins, e.g. sputum mucoprotein (Marmion et al., 1953),
was observed, leading to inhibition of haemagglutination (Burnet, 1951). However, these
studies showed that a rise in incubation temperature to 37°C resulted in spontaneous and
irreversible elution of virus from RBC and respiratory cells and also rendered the
inhibitors inactive. The same effect was observed by incubation with an enzyme obtained
from the culture filtrate of Vibrio cholerae (Burnet et al., 1946; Burnet, 1951). This
enzyme was therefore called receptor-destroying enzyme (RDE) (Burnet and Stone, 1947).
The experiment that pre-treatment of the intact mouse lung with RDE prevented infection
by influenza virus left little doubt on the essential role of cellular receptors for initiation of
virus infection (Stone, 1948). The similarity of effects exhibited by virus and RDE
suggested the existence of an enzyme on the virus envelope, and first chemical evidence
for its activity was provided by incubation of ovomucin with influenza virus (Gottschalk
and Lind, 1949). A product with a low molecular weight was released, which was later
identified as N-acetylneuraminic acid (see below) (Klenk and Lempfrid, 1955). Further
evidence for sialic acid as the cellular receptor determinant was provided by later studies
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showing that binding of virus to RDE (now called neuraminidase)-treated cells could be 
restored by enzymatic reconstitution with sialic acid and by incubation with exogenous 
sialogangliosides (Paulson et al., 1979; Bergelson et al., 1982; Suzuki et al., 1985).
Although HA interacts with both sialic acid-containing glycoproteins and 
glycolipids in receptor-binding studies, the results of a recent studies suggest that 
endocytosis into host cells specifically requires N-linked sialoglycoproteins (Chu and 
Whittaker, 2004).
1.7.3.2 The Structure and Functions of Sialic Acids
Sialic acids represent a family of over forty 9-carbon carboxylated sugars, which are found 
in higher invertebrates, vertebrates and some micro-organisms (reviewed by Schauer, 
1982) (see Figure 5a). The most common is N-acetylneuraminic acid (2-keto-5-acetamido- 
3,5-dideoxy-D-glycero-D-galacto-nonulopyranos-l-onic acid) (Neu5Ac), which is thought 
to be the biosynthetic precursor for all other members (see Figure 5b). Hydroxylation of 
the N-acetyl group gives N-glycolylneuraminic acid (Neu5Gc). Further structural diversity 
is generated by various substitutions at the 4, 5, 7, 8 and 9-carbon positions, most 
commonly by O-acetylation at positions 4, 7, 8 and 9.
Sialic acids are components of a variety of oligosaccharides, polysaccharides,
glycoproteins and glycolipids on cell membranes and secreted molecules and are usually
found at the terminal positions. The linkage involves a-glycosidic bonds between the C-2
anomeric hydroxyl group of sialic acid and most commonly the C-3 or C-6 hydroxyl group
of the penultimate galactose (Gal), N-acetylgalactosamine (GalNAc) or N-
acetylglucosamine (GlcNAc) (a(2,3)- and a(2,6)-linkage, respectively). Where sialic acids
are linked to each other, they usually form a(2,8)-bonds. Sialic acids have been implicated
in various biological processes. By virtue of their negative charge they can mask
34
HO
C O O
CHg
OH
RO
O
Figure 5 Structures of sialic acids
a) Core structure of naturally occurring sialic acids Structural diversity is given by 
differences of the chemical composition of the side-groups (R).
R4 = H, acetyl 
R5 = acetyl, glycolyl 
R7 = H, acetyl
R8 = H, acetyl, methyl, sulphate 
R9 = H, acetyl, L-lactyl, phosphate
b) Struture of neuraminic acid (Neu5Ac) R is the next monosaccharide
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intermolecular and intercellular interactions, such as immune and receptor recognition, and 
hinder the action of proteases and endoglycosidases (Schauer et al., 1984; Schauer, 1985). 
However, sialic acids also act as ligands in recognition phenomena involving lectins, such 
as selectins, I-type lectins, bacterial and viral lectins, and thereby play a regulatory role in 
vascular, immunological, neuronal and infection processes (Varki, 1997).
Many studies have focused on the roles of O- and N-substituted sialic acids in 
biological processes (for a review see Schauer, 1991). O-acetylation at position 4, 7, and 9, 
renders complex carbohydrates more resistant to sialidase action and thus extends the 
lifetime of e.g. serum glycoproteins and RBC. Notably, 9-O-acetylation inhibits binding of 
influenza A viruses (Higa et al., 1985) while mediating binding of influenza C viruses 
(Herrler et al., 1985).
1.7.3.3 Haemagglutinin in Complex with Neu5Ac
When the structure of A/Aichi/2/68 HA was first determined, a shallow depression at the
membrane-distal tip of the molecule was found to be lined with amino acids which had
been conserved since the emergence of the H3 subtype in humans in 1968 (Wilson et al.,
1981). It was therefore suggested that this pocket might form the binding site for the
receptor, which was consequently confirmed by X-ray crystallography of HA in complex
with Neu5Ac (Weis et al., 1988). As seen in Figure 6, the axial carboxylate, the
acetamido-nitrogen and the 8- and 9-hydroxyl groups of the glycerol side-chain of Neu5Ac
orient into the pocket, whereas the 4-hydroxyl points out of the site into solution. The
pocket is defined by three secondary structural elements. The 190-helix (residues 190 to
198) forms the “back” of the site, whereas the “sides” are composed of the 130-loop
(residues 135-138) and the 220-loop (residues 221-228). Conserved residues Tyr98,
Hisl83, Tyrl95 and Trpl53 form the “base” of the site (see Appendix 1 for amino acid
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Figure 6 Schematic diagram of the HA receptor-binding site complexed with 
neuraminic acid (coloured in red) The three main secondary structure elements of the 
receptor-binding pocket are indicated in blue. Conserved residues Tyr98, Hisl53, Tyrl95 
and Trpl53 form the "base" of the site. Potential hydrogen bonds are indicated as dotted 
blue lines.
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three- and one-letter codes, p.254). A number of potential hydrogen bonds are formed 
between conserved residues and between several of these residues and Neu5Ac (shown in 
blue in Figure 6). Additional conserved residues behind the pocket (Cys97, Pro99, Cysl39, 
Phel47, Tyrl95, Arg229) may be important in stabilising the architecture of the RBS 
(Wiley and Skehel, 1987).
A number of studies have assessed the importance of the functional groups of 
Neu5Ac in the interaction with HA and identified the N-acetamido group, the orientation 
of the carboxygroup and the glycerol chain as critical determinants (Sauter et al., 1989; 
Hanson et al., 1992; Kelm et al., 1992; Sauter et al., 1992). The contributions of residues in 
the RBS to the interaction with Neu5Ac has been assessed by mutagenesis studies (Martin 
et al., 1998) and highlighted the importance of the hydrogen network linking residues 
Tyr98, Hisl83, Tyrl95 and Trpl53. The structure of HA in complex with Neu5Ac has 
since been solved for HA of different subtypes, with the receptor determinant being bound 
essentially in the same way (Ha et al., 2001; Gamblin et al., 2004).
1.7.4 Receptor Specificity
1.7.4.1 Host-Range Restriction
Influenza A virus infects a variety of hosts, including humans, pigs, horses, sea mammals,
poultry, wild ducks, and other migrating waterfowl. All 16 HA subtypes are perpetuated in
aquatic birds, which appear to be the reservoir of all influenza viruses for other species (for
a review see Webster et al., 1992). Of these, 3 HA subtypes have evolved in humans (HI,
H2, H3), at least 2 in pigs (HI, H3) and 2 in horses (H3, H7). Despite the common origin
of influenza viruses, their host range appears to be restricted. Experimental infections have
shown poor replication of avian viruses in primates (Murphy et al., 1982; Snyder et al.,
1987; Beare and Webster, 1991), while human isolates do not replicate efficiently in ducks
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(Webster et al., 1978; Kida et al., 1980; Hinshaw et al., 1983). However, restriction is 
considered to be partial due to frequent infection of generally unsusceptible hosts. Such 
interspecies transmission has been observed from birds to humans (Subbarao et al., 1998; 
Peiris et al., 1999; Fouchier et al., 2004), pigs (Brown et al., 1994; Karasin et al., 2000; 
Peiris et al., 2001) and sea mammals (Geraci et al., 1982; Hinshaw et al., 1984; Hinshaw et 
al., 1986), from pigs to humans (Claas et al., 1994; Gregory et al., 2001) and humans to 
pigs (Peiris et al., 2001; Marozin et al., 2002). However, these viruses are not usually 
maintained in the infected species, probably due to inefficient replication as a result of 
poor genetic fit to these hosts.
1.7.4.2 Correlation between Receptor-Linkage Specificity and Host of Origin
Host range restriction appears to be a polygenetic trait and the contribution of each gene
product has not been fully elucidated (Scholtissek et al., 1985; Snyder et al., 1985; Tian et
al., 1985; Snyder et al., 1987; Subbarao et al., 1993). However, HA has been the focus as a
primary determinant due to its role in host cell recognition. Soon after sialic acid was
discovered as the essential component of receptors, it became clear that different influenza
strains varied in their recognition of certain receptor analogues (e.g. Burnet, 1948;
Choppin and Tamm, 1960). In particular, the ability of certain viruses to distinguish
between the a(2,6)- and a(2,3)-linkage of sialic acid to Gal was detected (Paulson et al.,
1979; Carroll et al., 1981). Importantly, a correlation between receptor-binding specificity
and host species, from which the virus was isolated, was reported. Whereas human viruses
preferentially recognised a(2,6)-linked sialic acid, isolates from birds and horses showed
preference for the a(2,3)-linkage (Rogers and Paulson, 1983; Rogers and D'Souza, 1989;
Connor et al., 1994). This observation was confirmed in subsequent studies (Matrosovich
et al., 1993; Gambaryan et al., 1997; Matrosovich et al., 1997; Ito et al., 1998). In contrast,
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porcine viruses are more heterogeneous in their recognition phenotype. The studies 
mentioned above showed that some pig isolates display a clear avian-like, others a more 
human-like receptor recognition, whereas a third group is distinguished by relatively small 
differences in its affinity for the two linkages. In addition, a correlation between amino 
acids at positions 226 and 228 of the H2 and H3 subtype and receptor specificity was 
observed (numbering based on H3 HA, Winter et al. (1981)). Human isolates that 
preferentially bound the a(2,6)-linkage contained Leu226 and Ser228, whereas avian 
viruses recognising the a(2,3)-linkage contained Gln226 and Gly228 (Connor et al., 1994).
The main evidence for the ability of residue 226 to modulate receptor specificity 
has been provided by growth of an H3 human virus in the presence of horse serum, which 
has been shown to be an inhibitor of both H2 and H3 subtype viruses of human origin 
(Cohen and Belyavin, 1959; Rogers et al., 1983b). The inhibitory effect of horse serum has 
been attributed to a2-macroglobulin, a glycoprotein containing mainly a(2,6)-linked sialic 
acid (Hanaoka et al., 1989). A resistant mutant was selected that changed its linkage 
preference from a(2,6) to a(2,3) and contained the single amino acid change Leu226Gln 
(Rogers et al., 1983a; Rogers et al., 1983b). H2 variants isolated by the same method 
(Choppin and Tamm, 1959; Choppin and Tamm, 1960) revealed the same changes in 
specificity and sequence, with an additional change Ser228Gly (Connor et al., 1994). 
Selection in the reverse direction has also been accomplished with an avian H3 virus that 
acquired a(2,6)-linkage recognition and a Leu226, typical for human isolates (Rogers et 
al., 1985). However, other residues in addition to 226 and 228 have been shown to 
modulate receptor specificity, e.g. 218, 193 and 205 (Daniels et al., 1987; Suzuki et al., 
1989) (see 1.7.6 Interrelationship between Antigenic Variation and Receptor-Binding 
Properties, p. 58).
In contrast to the H2 and H3 subtypes, amino acids 226 and 228 appear not to be
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directly implicated in receptor specificity for the HI subtype viruses, since they generally 
contain Gln226 and Gly228, irrespective of their linkage preference. Other amino acids 
have been proposed to be involved in determining specificity, namely 138, 186, 190, 194 
and 225 (Rogers and D'Souza, 1989; Matrosovich et al., 1997; Gambaryan et al., 1999; 
Mochalova et al., 2003). As for the H2 HA, the HI HA amino acid numbering is based on 
the H3 subtype (Winter et al., 1981).
A recent study has shown the ability of an influenza virus to recognise sialic acid in 
the a(2,8)-linkage, in addition to the a(2,3)- and a(2,6)-linkages described above (Wu and 
Air, 2004). The biological significance of the interaction with a(2,8)-linked sialic acid and 
possible differences in its recognition for viruses of different subtypes and host origin 
remains to be shown.
1.7.4.3 Molecular Mechanism for Receptor Specificity
1.7.4.3.1 H3, H5 and H9 Subtype
The molecular mechanism involved in linkage recognition has been addressed with X-ray
studies of HA in complex with receptor analogues containing Neu5Ac either in the a(2,3)-
or the a(2,6)-linkage (Eisen et al., 1997; Ha et al., 2001; Ha et al., 2003). The role of
amino acids at position 226 and 228 has been assessed by these receptor analogues bound
to a human H3 (Leu226, Ser228), an avian H3 (Gln226, Gly228), an avian H5 (Gln226,
Gly228) and a swine H9 subtype (Leu226, Gly228). As can be seen in Figures 7-10, the
orientation of Neu5Ac in the site is essentially identical. However, the preferred receptor
analogues are bound in different conformations. The a(2,3)-linkage is bound in a trans and
the a(2,6)-linkage in a cis conformation around the glycosidic bond of Neu5Ac to the
penultimate Gal, respectively. These enable different atomic contacts between the
glycosidic linkage and residues in the binding site. Whereas the a(2,6)-motif appears to be
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Trp-222
Gly-225
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Figure 7 Structures of human H3 HAs (X31) complexed with receptor analogues
Potential hydrogen bonds are shown in grey broken lines. Residues making interactions via 
main-chain nitrogens are shown as blue spheres and those interacting via main-chain 
carbonyl-groups as red spheres. The receptor analogues are coloured in yellow for carbon, 
red for oxygen and blue for nitrogen atoms a) The a(2,6)-linked receptor analogue (LSTc) 
is bound in cis (indicated by the almost horizontal arrow) enabling the non-polar Leu226 
to make van der Waals contacts with Gal-2, as indicated by semicircles b) The a(2,3)- 
linked receptor analogue (LSTa) is also bound in cis.
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Figure 8 Structures of avian H3 HAs (Dk/Ukraine/1/63) complexed with receptor 
analogues Potential hydrogen bonds are shown in grey broken lines. Residues making 
interactions via main-chain nitrogens are shown as blue spheres and those interacting via 
main-chain carbonyl-groups as red spheres. The receptor analogues are coloured in yellow 
for carbon, red for oxygen and blue for nitrogen atoms a) The a(2,3)-linked receptor 
analogue (LSTa) is bound in trans (indicated by the almost vertical arrow) enabling the 
polar Gln226 to form a hydrogen bond to Gal-2 b) The a(2,6)-linked receptor analogue 
(LSTc) is bound in cis (indicated by the almost horizontal arrow). Only two saccharides 
are ordered.
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Figure 9 Structures of avian H5 HAs (Dk/Singapore/3/97) complexed with receptor 
analogues Potential hydrogen bonds are shown in grey broken lines. Residues making 
interactions via main-chain nitrogens are shown as blue spheres and those interacting via 
main-chain carbonyl-groups as red spheres. The receptor analogues are coloured in yellow 
for carbon, red for oxygen and blue for nitrogen atoms a) The a(2,3)-linked receptor 
analogue (LSTa) is bound in trans (indicated by the almost vertical arrow) enabling the 
polar Gln226 to form a hydrogen bond to Gal-2 b) Only sialic acid is visible for the bound 
a(2,6)-linked receptor analogue (LSTc).
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137
Figure 10 Structures of swine H9 HAs (Sw/Hong Kong/9/98) complexed with receptor 
analogues Potential hydrogen bonds are shown in grey broken lines. Residues making 
interactions via main-chain nitrogens are shown as blue spheres and those interacting via 
main-chain carbonyl-groups as red spheres. The receptor analogues are coloured in yellow 
for carbon, red for oxygen and blue for nitrogen atoms a) The a(2,6)-linked receptor 
analogue (LSTc) is bound in cis (indicated by the almost horizontal arrow) enabling the 
non-polar Leu226 to make van der Waals contacts with Gal-2 (indicated by semicircles) b) 
The a(2,3)-linked receptor analogue (LSTa) is also bound in cis. Only two saccharides are 
ordered.
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stabilised by van der Waals interactions involving Leu226, Gln226 mediates hydrogen 
bonds with the a(2,3)-motif. In contrast, the non-preferred combinations of Leu226 in the 
a(2,3)- and Gln226 in the a(2,6)-complex result in unfavourable interactions of these 
residues with the glycosidic linkage. Comparison of the HA structures also revealed that 
the width of the avian binding site is narrower than the human site, probably dictated by 
the amino acid combinations at positions 226 and 228. The binding site of a swine H9 
containing a human-specific Leu226 and an avian-specific Gly228 has been shown to be of 
intermediate size. The size of the binding site may therefore optimise the interaction with 
the respective linkage, with the Leu226/Gly228 representing an evolutionary intermediate 
between an avian and a human RBS.
1.7.4.3.2 HI Subtype
HA crystal structures of the HI subtype human 1918 pandemic virus and the earliest
human (A/Puerto Rico/8/34) and swine (A/Sw/Iowa/15/30) viruses have recently become
available (Gamblin et al., 2004; Stevens et al., 2004). The structures of the human-1934
and swine HA bound to receptor analogues have also been solved and the residues
involved in receptor-recognition identified, as shown in Figures 11 and 12 (Gamblin et al.,
2004). The human-1934 HA is found in complex with both the a(2,3)- and a(2,6)-linked
receptor analogues, in agreement with earlier studies showing “dual” receptor specificity
for early HI isolates (Rogers and Paulson, 1983; Rogers and D’Souza, 1989). In the swine
HA-a(2,6)-complex, all five sugars are detected, whereas only Neu5Ac is visible for the
a(2,3)-linked receptor analogue. The main interactions involve hydrogen bonds between
residues 222, 225 and Gal-2. This is a result of a lower positioning of Gal into the site as
compared to the H3/H5/H9 subtypes and appears to be due to slightly different
conformations of the 130 and 220 loops. In the swine HA, additional contacts of Asp 190 to
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Figure 11 Structures of human HI HAs (Puerto Rico/8/34) complexed with receptor 
analogues Potential hydrogen bonds are shown in grey broken lines. Residues making 
interactions via main-chain nitrogens are shown as blue spheres and those interacting via 
main-chain carbonyl-groups as red spheres. Water molecules are indicated by green 
spheres. The receptor analogues are coloured in yellow for carbon, red for oxygen and blue 
for nitrogen atoms a) The a(2,6)-linked receptor analogue (LSTc) is bound in cis 
(indicated by the almost horizontal arrow) b) The a(2,3)-linked receptor analogue (LSTa) 
is bound in trans, (indicated by the almost vertical arrow).
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Figure 12 Structures of swine HI HAs (Sw/Iowa/15/30) complexed with receptor 
analogues Potential hydrogen bonds are shown in grey broken lines. Residues making 
interactions via main-chain nitrogens are shown as blue spheres and those interacting via 
main-chain carbonyl-groups as red spheres. Water molecules are indicated by green 
spheres. The receptor analogues are coloured in yellow for carbon, red for oxygen and blue 
for nitrogen atoms a) The a(2,6)-linked receptor analogue (LSTc) is bound in cis 
(indicated by the almost horizontal arrow) b) Only sialic acid is visible for the bound 
a(2,3)-linked receptor analogue (LSTa).
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the N-acetyl of GlcNAc and the Seri 93 to Gal-4 are observed in the a(2,6)-linked 
complex. This finding would explain the preferential binding of 6’-sialyllactosamine 
(6’SLN, Neu5Aca(2,6)Galp(l,4)GlcNAc) over 6’sialyllactose (6’SL, 
Neu5Aca(2,6)Galp(l,4)Glc) by human HI viruses (Matrosovich et al., 1993), which 
generally contain Asp 190 (Matrosovich et al., 1997). In contrast to the H3/H5/H9 
subtypes, Gln226 plays a passive role in recognition of the a(2,6)-linkage by being 
positioned lower in the binding site, thereby preventing unfavourable interactions. 
However, Gln226 appears to be involved in stabilising the a(2,3)- complex by formation 
of hydrogen bonds with Gal-2. The requirement of Glul90 in this process has been 
suggested and the presence of Asp 190 might explain the unfavourable interaction of the 
swine HA with this linkage.
In addition, the structures of the HI and H3 subtype HAs complexed with receptor 
analogues reveal that, whereas the a(2,3)-linkage is always bound in a similar way, the 
conformation of the a(2,6)-linked receptor analogue varies (Figure 13) (Gamblin et al., 
2004).
1.7.4.4 Host Cell Factors Involved in Selection of Linkage Specificity
Evolution of receptor specificity may be the result of selective pressure exerted by the
linkage of sialic acids on host cells. This theory is based on studies with linkage-specific
lectins showing a correlation of host tropism of influenza viruses with the predominance of
a specific linkage in host tissues. In humans, influenza viruses replicate in the ciliated
epithelium of conducting airways (Hers, 1966), although neither initial targets of viral
infection nor specific cell types essential for viral replication have been defined. Initially, it
was shown that human tracheal epithelia cells are abundant in a(2,6)-linked sialic acid
(Baum and Paulson, 1990; Couceiro et al., 1993). However, recent studies have
49
Human receptors
a)
220-Loop
b)
220-Loop
Gln-226
190-Helix
A vian
130-Loop
recep to rs
Figure 13 Overlay of receptor-binding sites of three different HAs with bound a(2,6)- 
linked receptors (a) and a(2,3)-linked receptors (b) Human HI HA (Puerto Rico/8/34) 
is coloured in green, human H3 HA (X31) coloured in red and swine HI HA 
(Sw/Iowa/15/30) coloured in blue. The receptor analogues are coloured according to the 
HA to which they are bound.
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determined two different cell types in human tracheobronchial epithelium cultures, 
correlating with preferential infection by human and avian viruses. Ciliated cells contain 
mainly the a(2,3)-linkage and are infected by avian viruses, whereas non-ciliated cells 
predominant in the a(2,6)-linkage are infected by human viruses (Matrosovich et al., 
2004). In contrast, intestinal cells of ducks, where infection is enteric (Kida et al., 1980), 
and tracheal cells of horses have been reported to be abundant in a(2,3)-linked sialic acid 
(Ito et al., 1998; Suzuki et al., 2000). Furthermore, swine respiratory tract cells contain 
both linkages, in agreement with the observation that viruses with either or “dual” linkage 
specificity have been isolated from pigs (Rogers and D’Souza, 1989; Gambaryan et al., 
1997; Ito etal., 1998).
In addition to the linkage, the type of sialic acid recognised may also affect host 
restriction. The high amount of Neu5Gc in swine (50%) and horse (90%) tracheal 
epithelium compared to Neu5Ac has been shown to correlate with the ability of viruses 
isolated from these hosts to interact with this sialic acid species (Suzuki et al., 1997; 
Suzuki et al., 2000). The recognition of a minor fraction of Neu5Gc in duck intestine may 
also be important for replication in the duck intestine (Ito et al., 2000). By contrast, 
Neu5Gc has not been detected in normal adult human tissues (Schauer, 1982; Schauer, 
1991).
Soluble sialylglycoconjugate inhibitors present in host serum or other body fluids 
might also contribute to the maintenance of virus receptor specificity. However, no formal 
proof is available for this hypothesis, which is based on the above described selection of 
linkage-specific variants by horse serum (Rogers et al., 1983b; Matrosovich et al., 1998), 
and the observation that mucins from the human lung contain sialic acid mainly in the 
a(2,3)-linkage (Breg et al., 1987; Baum and Paulson, 1990; Couceiro et al., 1993).
It should be noted that the HA-receptor interaction can also be influenced by the
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length and composition of glycoproteins and glycolipids (Rogers and Paulson, 1983; 
Suzuki et al., 1986; Suzuki et al., 1992; Matrosovich et al., 1997; Ryan-Poirier et al., 1998; 
Gambaryan et al., 2005). This finding indicates that, in addition to sialic acid and its 
linkage to Gal, receptor-binding properties can be modulated by more distant parts of 
cellular receptors.
1.7.5 Antigenic Variation
In order to remain infectious and persist in the population, influenza virus needs to evade 
immune recognition. This is accomplished by antigenic variation in HA, which alters its 
antigenicity such that it is undetected by previously induced host defence systems. 
Antigenic variation is the main mechanism for the rapid evolution of influenza viruses and 
can be a result of two different processes, antigenic drift and shift.
1.7.5.1 Antigenic Shift
Antigenic shift is defined by the introduction of an HA to which the population contains
little or no immunity. One mechanism through which antigenic shift can occur is
reassortment of RNA segments between different viruses. Upon infection of a cell with
two or more different viruses, hybrid progeny viruses can be packaged due to the
segmented nature of their genome. First evidence for reassortment was provided by Burnet
and Lind, who observed recombination of characters between viruses in mixed infections
(Burnet and Lind, 1949). Reassortment between segments of different species origin, e.g.
avian with human/equine/porcine, has been observed in tissue culture and laboratory
animals, including turkeys and pigs (Tumova and Pereira, 1965; Webster et al., 1971).
However, reassortment also occurs in nature (e.g. Castrucci et al., 1993; Gregory et al.,
2002), and the introduction of novel HA subtypes into an immunologically naive human
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population can result in rapid global spread with widespread morbidity and mortality 
(pandemic). The Asian (1957) and Hong Kong (1968) pandemic have been caused by 
reassortant viruses containing an HA of avian origin (see 1.8 Emergence and Evolution o f 
Human Influenza Viruses, p. 61).
In addition to reassortment, antigenic shift can occur by direct cross-species 
transmission of a virus containing a novel HA, e.g. sporadic infections of humans by avian 
viruses have been reported (Peiris et al., 1999; Fouchier et al., 2004). In particular, the 
avian H5N1 virus (bird flu), which is highly pathogenic for poultry, was first transmitted 
from chickens to humans in 1997 in Hong Kong (de Jong et al., 1997), resulting in 6 
deaths of 18 identified cases (Bender et al., 1999). Although the source of infection was 
removed by slaughtering all the chickens and the virus has not been successfully spread 
from human to human, new cases of human infections are being reported since 2003, 
especially in Vietnam and Thailand. Due to its high mortality rate (57%) this virus poses a 
pandemic threat if it gains the ability to easily infect and transmit among people (WHO, 
2005a).
The 1918 pandemic might also have been caused by direct transmission of an avian 
H1N1 virus (see 1.8 Emergence and Evolution o f Human Influenza Viruses, p. 61).
1.7.5.2 Antigenic Drift
Antigenic drift is a consequence of accumulation of minor amino acid changes in HA,
usually due to single point mutations. The rate at which these mutations occur is much
higher for RNA viruses than for DNA viruses and eukaryotic organisms, since their RNA
polymerase lacks proofreading activity and introduces errors in the range of lO^-lO"4 per
nucleotide, in contrast to 10‘8-10‘n for DNA polymerases (Holland et al., 1982). As a
result of the fast mutation rate, the virus progeny consists of complex and dynamic mutant
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distributions, also known as mutant swarms or mutant clouds, rather than of defined 
genomic sequences. RNA viruses have therefore been described as “quasispecies” 
(Domingo et al., 2001; Domingo, 2003). The influenza virus polymerase error-rate has 
been calculated to be approximately 1.5 x 10‘5 per nucleotide per virus generation for the 
NS gene (Parvin et al., 1986). However, phylogenetic analysis has shown that HA of the 
H3 subtype human influenza viruses evolves 3 times faster than the non-structural proteins 
(Fitch et al., 1991). Furthermore, amino acid substitutions were observed to occur more 
frequently at antigenic than non-antigenic sites, suggesting positive Darwinian selection 
through immune surveillance. Subsequent studies are in support of this mechanism of 
evolution for both the H3 and HI HA in the human population (Ina and Gojobori, 1994; 
Fitch et al., 1997; Bush et al., 1999b). Variants that escape neutralisation by antibodies 
exhibit a growth advantage and therefore have the potential to cause epidemics in the 
human population.
1.7.5.2.1 Antigenic Sites
Antigenic drift changes in influenza viruses have been monitored ever since their first
isolation to ensure efficient vaccine production. These were initially detected by
comparison of reactivity with convalescent ferret sera and later accompanied by nucleotide
sequence analysis of the HA gene. After the first H3 HA was crystallised in 1981 (Wilson
et al., 1981), these changes could be mapped on the structure and 5 distinct antigenic sites
were proposed, designated A-E (Wiley et al., 1981; Daniels et al., 1983). However, it has
now become clear that the majority of the HAi surface is antigenic. Between 1968 and
1997 more than 50% of the solvent-accessible amino acids in the membrane distal domain
have been substituted (Fleury et al., 1998) (see Figure 14). Similar antigenic sites have
been identified in the human HI and H2, the avian H5 and the swine H9 subtypes and have
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been mapped on their solved structures (H5 and H9) or on the H3 structure (HI and H2) 
(Caton et al., 1982; Tsuchiya et al., 2001; Kaverin et al., 2002; Kaverin et al., 2004).
The involvement of these sites in antibody recognition is strongly supported by the 
observation that amino acid substitutions of monoclonal antibody (mAb)-selected 
antigenic variants are located in these sites and often coincide with substitutions found in 
natural variants (Wiley et al., 1981). It was also suggested that substitutions in these sites 
would only cause local structural changes in HA without affecting the main framework of 
the molecule or receptor-binding activity. X-ray studies of mAb-selected mutant HAs have 
confirmed that escape from neutralisation is accompanied by only small structural changes 
in the immediate vicinity of the amino acid substitution, suggesting binding of the 
antibodies to that area (Knossow et al., 1984; Sauter et al., 1992; Bizebard et al., 1995; 
Fleury et al., 1998). Direct evidence for the interaction of antibodies with these sites was 
provided by electron microscopy studies of HA complexed with mAbs recognising 
different epitopes (Wrigley et al., 1983) and subsequently confirmed by X-ray studies of 
complexes of monoclonal Fabs with HA. These studies also showed that selected 
mutations, which allow the virus to escape neutralisation, are located in the epitopes 
(Bizebard et al., 1995; Fleury et al., 1998; Fleury et al., 1999).
Protruding loops as antibody-binding site motifs have also been determined for 
influenza NA (Colman et al., 1983), picomaviruses (Hogle et al., 1985; Rossmann et al., 
1985) and have also been suggested for HIV-1 gpl20 (Wyatt et al., 1998).
1.7.5.2.2 The Role of Oligosaccharides in Antigenic Drift
Immune-evasion can also be mediated by oligosaccharides protruding from the HA
surface. These have the potential to mask the HA surface as antigenically “self5 because of
their host cell origin and can inhibit antibody binding by steric hindrance. Shielding of
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functional epitopes has been directly shown by studies with viruses containing additional 
carbohydrates (Skehel et al., 1984; Gallagher et al., 1988; Munk et al., 1992; Abe et al., 
2004). Support for the involvement of oligosaccharides in immune-evasion is provided by 
antigenic drift mutations that create new oligosaccharide attachment sites (e.g. Seidel et 
al., 1991). The 1968 influenza H3 viruses contained six attachment sites at HAi residues 8, 
22, 38, 81, 165 and 285, with the last three located at the membrane-distal part of the 
molecule (Wilson et al., 1981). Since then, additional oligosaccharide attachment sites 
were accumulated and the one at residue 81 was lost. The majority of viruses isolated since 
1999 contain a total number of 11 carbohydrate sites (at residues 8, 22, 38, 63, 122, 126, 
133 144, 165, 246 and 285), eight of which are located in antigenically important regions. 
A similar increase of oligosaccharide attachment sites has been shown for the HI subtype 
from 1918-2002. The 1918 pandemic HI virus contained 4 attachment sites (at residues 
21, 33, 94a and 289) (Gamblin et al., 2004), whereas further attachment sites were 
accumulated in subsequent years. Therefore, viruses since 1999 usually contain additional 
glycosylation sequons at residues 63,129 and 163 (WHO, 2002a).
Implication of oligosaccharides in immune-evasion has also been suggested for 
HIV-1 and SIV-1 virus surface glycoproteins (Schonning et al., 1996; Reitter et al., 1998).
1.7.5.2.3 Antibody-Binding and Mechanism of Neutralisation of Infectivity
Structural studies have also addressed the molecular mechanisms involved in antibody 
escape and virus neutralisation. Fleury et al. have shown that a Fab bound to an epitope in 
the immediate vicinity of the RBS abrogates virus-cell binding, because it contacts three 
conserved residues that interact with sialic acid (Fleury et al., 1999). Neutralisation was 
also observed when the antibody was bound to epitopes located further from the RBS, in 
this case mediated by steric hindrance with the bulk of either the Fab or immunoglobulin
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molecule. However, efficiency of neutralisation correlates with avidity of the antibody for 
HA, and it has been shown that the most potent inhibitors are antibodies that directly block 
the RBS (Fleury et al., 1999).
Escape from neutralisation is associated with a significant decrease in affinity of 
the selecting antibody for mutant HAs by a factor of 102-104 compared to a Kd of ~ 10'9 M 
for wild-type HA (Fleury et al., 1998). The reduced affinity appears to be mediated by 
steric hindrance in the antigen-antibody interface as a result of the local structural changes 
in the site (Knossow et al., 1984; Bizebard et al., 1995). Another mechanism, antigen 
distortion, has been implicated in inhibition of binding to antibodies. It has been shown 
that the Thrl31Ile HA mutant contacts the antibody in a contorted wild-type-like 
conformation, leading to the break of a hydrogen bond in the interaction interface (Fleury 
et al., 1998). Therefore, escape from neutralisation can be mediated by both steric 
hindrance and/or the loss of one or more interactions (hydrogen bond, salt bridge) between 
HA and antibody.
1.7.6 Interrelationship between Antigenic Variation and Receptor-Binding Properties
The variable antigenic sites in HA are all clustered around the highly conserved RBS. In
order to maintain infectivity of the virus, there is a constraint under which the mechanism
for escape from neutralising antibodies operates: Antigenic variation must occur while
conserving residues involved in receptor-binding activity. This criterion is fulfilled due to
a greater surface area of the “antibody-footprint” compared to the area of the receptor-
binding pocket (600-1,000 A2 versus 315 A2). This ensures that all HA-antibody interfaces
include HA residues not required for receptor-binding function (Bizebard et al., 1995).
Changes in these functionally non-important residues is therefore considered sufficient to
block binding to antibody. The same observation has been made for influenza NA
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(Colman, 1997) and rhinovirus (Smith et al., 1996). However, it has been shown that 
changes in antigenicity can be accompanied by differences in receptor-binding or growth 
properties and vice versa. Direct evidence for a concomitant change in these properties has 
been reported for changes at residues located in the RBS (Rogers et al., 1983a; Daniels et 
al., 1984; Naeve et al., 1984; Martin et al., 1998), in antigenic sites in the vicinity of the 
RBS (Both et al., 1983a; Underwood et al., 1987; Smith et al., 1991) or in combination 
(Laeeq et al., 1997). Furthermore, substitutions at residues in antigenic sites distant from 
the RBS have also been shown to influence both antigenicity and interaction with cellular 
receptors. This finding was observed for amino acids located in the HA trimer interface 
(Daniels et al., 1987; Suzuki et al., 1989) or for residues involved in creating or abolishing 
glycosylation sites (e.g. Skehel et al., 1984; Robertson et al., 1985). In addition to their 
implication in resistance to antibody-recognition (see above), the number and position of 
oligosaccharides at the membrane-distal part of HA have been shown to influence 
receptor-binding properties by providing steric hindrance with receptors (Deom et al., 
1986; Gunther et al., 1993; Matrosovich et al., 1997; Ohuchi et al., 1997; Abe et al., 2004). 
Furthermore, the glycosylation pattern, which is determined by the host cell, can also 
influence receptor-binding properties (Crecelius et al., 1984; Deom et al., 1986; Aytay and 
Schulze, 1991; Mir-Shekari et al., 1997; Gambaryan et al., 1998; Romanova et al., 2003).
Importantly, viruses with altered receptor-binding properties have been selected in
vitro with monoclonal or polyclonal antibodies. Many of these, containing substitutions at
residues close to or in the RBS, are not antigenic variants, since they still interact with the
selecting antibody in enzyme-linked immunosorbent assays (ELISA). They therefore
qualify as adsorptive mutants. These have been reported to display a general increase in
affinity for cellular receptors as judged by binding to periodate- or NA-treated RBC
(Fazekas de St. Groth, 1977; Yewdell et al., 1986; Underwood et al., 1987). In contrast to
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NA, which cleaves off the entire molecule, periodate destroys the glycerol chain of sialic 
acid. In more detailed studies differences in affinity of such variants for receptor analogues 
containing either a(2,3)- or a(2,6)-linked sialic acid were observed. These included 
increased affinity for the a(2,3)-linkage with or without decrease in affinity for the a(2,6)- 
linkage (e.g. Gly218Glu, Serl93Arg, Serl93Asn/Leu226Pro, 224-230 deletion) (Daniels et 
al., 1987), decreased affinity for the a(2,3)-linkage (Seri93lie, Ser205Tyr) (Daniels et al., 
1987; Suzuki et al., 1989), decrease in affinity for the a(2,6)-linkage 
(Glul90Asp/Leu226Gln) (Temoltzin-Palacios and Thomas, 1994) and decrease in affinity 
for both linkages (e.g. Gly218Arg, Glyl35Arg/Gly225Asp, Serl45Asn/Leu226Gln) 
(Daniels et al., 1987; Laeeq et al., 1997). The implications of the selection of receptor- 
binding variants by antibodies for immune-evasion are discussed in 4.1.2 Molecular 
Mechanism for Antigenic Drift, p. 132.
In summary, all the studies described above show that antigenic and receptor- 
binding properties can be interrelated. This observation is most likely due to the close 
proximity of antigenic sites to the RBS. Residues located in an epitope have the potential 
to affect receptor-binding properties if they directly contact an amino acid involved in 
receptor-recognition by affecting its position. Likewise, a change at a RBS residue could 
influence the position of a neighbouring amino acid making part of an epitope and 
therefore affect antigenicity. Substitutions in antigenic sites located further away from the 
RBS can influence the interaction with cellular receptors if they create or abolish a 
glycosylation site (see above). Furthermore, it has been shown that changes at residues in 
the HA interface also have the potential to affect receptor-binding properties, probably by 
altering the quaternary structure of HA (Daniels et al., 1987; Suzuki et al., 1989).
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1.8 Emergence and Evolution of Human Influenza Viruses
1.8.1 Origin of Pandemic Influenza Viruses
Only 3 of the 16 HA subtypes circulating in waterfowl have evolved in the human 
population. The emergence of each of these has caused a major pandemic in the last 
century: HI in 1918 (Spanish flu), H2 in 1957 (Asian pandemic), H3 in 1968 (Hong Kong 
pandemic). The appearance of every new subtype has led to the replacement of the 
previous one, with the exception of the re-introduction of the HI subtype in 1977 (Russian 
flu). Since then, HI and H3 subtypes co-circulate in the human population and cause 
recurrent epidemics due to antigenic drift in HA. Including reports of the sequential 
emergence of H2 viruses in 1889 and H3 viruses in 1900, these 3 subtypes appear to 
recycle through the human population in a cyclical pattern (Masurel and Marine, 1973).
The H1N1 subtype introduced into the human population in 1918 appears to be 
avian-like, based on phylogenetic analysis (Gorman et al., 1990a; Gorman et al., 1991) and 
direct sequencing of the HA isolated from 5 people who died in the 1918 pandemic 
(Taubenberger et al., 1997; Reid et al., 1999; Reid et al., 2003). However, due to the 
limited number of available samples, little is known about the identity of the H1N1 viruses 
circulating before and around 1918. Furthermore, the human H1N1 subtype appears to 
share its common avian ancestor with the classic swine virus, which was introduced into 
pigs around the same time (Gorman et al., 1991). Therefore, it remains elusive whether the 
pandemic 1918 virus was transmitted directly from birds, or whether the virus circulated in 
a pre-pandemic period in humans, pigs or other species with the potential to mutate and/or 
reassort.
The 1957 pandemic strain resulted from reassortment of a human virus with a co-
circulating avian virus, leading to the introduction of avian HA, NA and PB1. In 1968, the
H2 HA and PB1 were again replaced by avian-derived segments, generating the new
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H3N2 subtype (Webster and Laver, 1972; Scholtissek et al., 1978; Kawaoka et al., 1989). 
The identity of avian strains with which the human viruses reassorted has not been 
identified. However, sequence, antigenic and phylogenetic analysis of HA of the 1957 and 
1968 pandemic strains suggests the avian progenitor viruses to be Eurasian-like and 
Dk/Ukraine/l/63-like, respectively (Laver and Webster, 1973; Fang et al., 1981; Bean et 
al., 1992; Schafer et al., 1993). The host for the generation of the 1957 and 1968 
reassortants has not been identified. The pig has been suggested to be a likely candidate to 
serve as a “mixing vessel” for human and avian viruses (Scholtissek et al., 1985). It has 
been shown that a variety of human and avian viruses can replicate in pigs upon 
experimental infection (Hinshaw et al., 1981; Kida et al., 1994). Transmission from birds 
and humans to pigs has also been observed in a natural environment. Notably, the swine- 
endemic HI and H3 subtypes are either of avian (classic and avian-like H1N1 viruses) or 
of human (human-like H3N2 viruses) origin (Ottis et al., 1982; Gorman et al., 1991; 
Schultz et al., 1991). However, although avian and human viruses have reassorted in pigs 
(Castrucci et al., 1993; Brown et al., 1998), transmission of such a virus to humans has 
only been reported once (Claas et al., 1994). Alternatively, chickens have been proposed as 
intermediate hosts for the generation of pandemic viruses (Matrosovich et al., 2001; 
Gambaryan et al., 2002; Gambaryan et al., 2003), and the possibility of reassortment of 
human and avian viruses in the human lung has also been suggested (Matrosovich et al., 
2004).
1.8.2 Early Changes in Haemagglutinin in Adaptation to the Human Host
The molecular mechanism by which avian viruses adapt to growth in humans is poorly
understood. However, interaction with human receptors is believed to be an initial
requirement for introduction of avian-like HA into humans (Ito et al., 1998; Matrosovich et
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al., 2000). Indeed, viruses isolated at the beginning of the 1957 and 1968 pandemics have 
acquired the ability to bind to a(2,6)-linked receptors (Matrosovich et al., 2000). This early 
change in receptor-binding properties was attributed mainly to the Gln226Leu substitution 
compared to avian isolates. In contrast, since no crystal structures of avian HI HAs are 
available, it is not clear whether structural changes in the RBS were required for the initial 
transfer of H1N1 viruses from birds to humans. However, receptor-binding studies with a 
reassortant virus containing the HA of a human 1918 isolate indicate that the earliest 
human HI viruses exhibited clear a(2,6)-linkage preference typical of human isolates 
(Kobasa et al., 2004). In addition, the HA structure of the 1918 HA is very similar to that 
of another early human HI (A/Puerto Rico/8/34) and a closely related swine 
(Sw/Iowa/15/30) strain, both of which were found in complex with a(2,6)-linked receptor 
analogues (Gamblin et al., 2004). This finding supports the ability of the 1918 virus to 
bind to the a(2,6)-linkage.
Upon transfer to the human population, a shift in linkage recognition from a(2,3) to
a(2,6) might represent adaptation to the new host. It was observed that HI viruses from the
first period 1918-1957 often recognised both avian and human receptors, whereas viruses
appear to be more human receptor-specific upon re-emergence in 1977 (Rogers and
D'Souza, 1989). Substitutions Glul90Asp and Gly225Asp in early HI human isolates have
been suggested to play a role in an increase of affinity for a(2,6)-linked receptors
(Matrosovich et al., 2000), whereas loss of ability to bind to a(2,3)-linked receptors was
proposed to be due to Alal38Ser in later strains (Rogers and D'Souza, 1989). Similarly,
whereas early H3 viruses were able to bind to short a(2,3)-linked gangliosides, this
property was gradually lost upon circulation in humans and correlated with the acquisition
of a new glycosylation site at position 126 (Matrosovich et al., 1997). The substitution
Gly228Ser has also been shown to reduce affinity towards a(2,3)-linked receptors
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(Matrosovich et al., 2000), which might be advantageous in providing increased resistance 
to a(2,3)-linkage-containing inhibitors in the human lung. The positions at which these 
early substitutions occurred are highly conserved in the avian RBS of HA subtypes H I-15 
(Alai 3 8, Glul90, Leul94, Gly225, Gln226 and Gly228), providing further evidence for 
their implication in interspecies transmission (Matrosovich et al., 1997).
In conclusion, all the introduced avian HAs share the common feature of 
recognition of the a(2,6)-linkage. The failure of the 1997 avian H5N1 virus to spread 
among the human population might have been a result of the inability of these viruses to 
recognise the human receptors (Matrosovich et al., 1999).
Since their introduction into the human population, HA and NA have been and are 
still evolving, because they are subject to strong selection pressure by antibodies (see
1.7.4.4 Host Cell Factors Involved in Selection o f Linkage Specificity, p.49). Evolution of 
these proteins is also observed in pigs (Brown, 2000). In contrast, the evolutionary rate of 
influenza proteins in birds is very slow and they therefore appear to be in evolutionary 
stasis (Kida et al., 1987; Gorman et al., 1990a; Gorman et al., 1990b; Bean et al., 1992). 
This might be due to poor immune pressure, since influenza viruses do not cause disease in 
aquatic birds (Kida et al., 1980). The avirulent nature of avian influenza may therefore 
reflect an optimal adaptation to this host. Alternatively, the slow evolution of influenza 
virus might be due to the relatively short life-span of birds compared to humans. These 
animals might simply not live long enough to become re-infected by the same virus strain, 
accounting for the lack of selection pressure (Kida et al., 1987). Perpetuation of all 16 HA 
subtypes in aquatic birds provides a reservoir for the potential introduction of novel HA 
subtypes into other species.
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1.9 Structure and Function of Neuraminidase
NA plays important roles in the virus life cycle. It cleaves the receptor sialic acid from the 
host cell surface upon virus assembly at the plasma membrane, facilitating virus release 
and therefore spread of infection (see 1.4 The Influenza Virus Life Cycle, p. 22). In addition 
the enzyme removes sialic acid from oligosaccharides on HA and NA (Basak et al., 1985), 
preventing-self aggregation of virus and promoting haemagglutination activity (Ohuchi et 
al., 1995). Evidence for these functions has been provided by studies using anti-NA 
antibodies (Compans et al., 1969), NA inhibitors (Palese et al., 1974a; Gubareva et al., 
1996) and viruses containing impaired or no NA activity (Palese et al., 1974b; Liu and Air, 
1993). All these studies observed the formation of large clusters of aggregated virus at the 
cell surface due to NA impairment. Furthermore, NA has the ability to inactivate certain 
sialic acid-containing HA-inhibitors (Francis, 1947). Therefore, activity of this enzyme 
might facilitate access to epithelial cells by degradation of inhibitory sialic acid-containing 
mucins in the respiratory tract (Burnet, 1951).
Like HA, NA is an antigenic determinant and is subject to antigenic variation, 
although antibodies do not have neutralising activity (Kilboume et al., 1968). Nine 
different non-cross reactive subtypes are found in nature (N1-N9), of which N1 and N2 
circulate in humans (Schild et al., 1980).
The three-dimensional structure of NA has been solved and revealed the catalytic
and antigenic sites (Colman et al., 1983). NA is a glycosylated tetramer of ~ 240,000 Da,
consisting of a box-shaped globular head attached to a thin stalk spanning the virus
membrane. Neu5Ac binds into a large pocket on the distal surface surrounded by
conserved amino acids, which is, as in HA, flanked by antibody binding sites. Knowledge
of the structure served as a basis for the development of potent, highly specific inhibitors
of NA activity. Two of these, oseltamivir (GS4104, Tamiflu) (Kim et al., 1997) and
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zanamivir (GG167, Relenza) (von Itzstein et al., 1993) are now approved for therapeutic 
use in humans, and no resistance to these drugs has been reported in circulating viruses so 
far. However, resistant variants have been selected upon repeated passaging of virus in cell 
culture in the presence of these inhibitors and have been identified clinically (Gubareva et 
al., 2000).
Similarly to HA, NA shows distinct recognition of different sialic acid species and 
their linkage to Gal, which is dependent on the viral isolate examined. Since its 
introduction from an avian virus, the human N2 has changed its specificity over the years. 
Earliest isolates showed activity only for the a(2,3)-linkage typical for avian isolates 
(Carroll et al., 1981; Corfield et al., 1982; Corfield et al., 1983), followed by a gradual drift 
towards equal recognition of the a(2,3) and a(2,6)-linkage (Baum and Paulson, 1991). This 
finding indicates the development towards the same specificities of HA and NA as a result 
of evolution in hosts. Likewise, in correlation with their ability to bind to Neu5Gc (Suzuki 
et al., 1997), NA from swine viruses has also shown activity towards the N-glycolyl 
species of sialic acid (Xu et al., 1995).
1.10 Functional Balance between HA and NA Activity
Due to the antagonistic nature of HA and NA, the receptor-binding and receptor-
destroying activities and specificities need to be carefully balanced for optimal virus
replication. Evidence for a functional interplay between HA and NA has been provided by
a number of studies. As described above, the specificity of NA and HA towards the species
of sialic acid and its linkage in the receptor have been shown to correlate. Studies with
NA-deficient viruses have shown that a lack of NA activity can be partially compensated
for by a decrease of HA affinity towards cellular receptors (Hughes et al., 2000). Sequence
analysis of HA revealed substitutions around the receptor-binding pocket (e.g. Serl93Arg,
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Val205Met; Glyl35Ala, Serl45Asn, Arg220Lys). A decrease in HA affinity was also
determined by studies with reassortant viruses displaying an HA-NA mismatch caused by
the inability of NA to completely desialylate HA. Accompanying substitutions in the
proximity of the RBS were often of negative charge (e.g. Asn248Asp). Therefore, a
mechanism by which electrostatic repulsion between negative charges of HA and sialic
acid causes a decrease of affinity was postulated (Kaverin et al., 1998; Kaverin et al.,
2000). The importance of functional interplay between HA and NA was also highlighted in
studies on genetically engineered viruses. Viruses generated by reverse genetics containing
a shortened stalk or no stalk showed a markedly decreased efficiency of virus replication
in eggs, in correlation with a reduced ability of these viruses to elute from RBC. Steric
hindrance due to the location of the catalytic site too close to the viral envelope was
suggested to impair NA function (Castrucci and Kawaoka, 1993). Adaptation of these
mutants to growth in eggs led to compensating mutations in HA with a decreased affinity
towards sialylglycoconjugates (Mitnaul et al., 2000). In contrast, deletions of N-glycan
attachment sites at the tip of HA increased the affinity towards cellular receptors (Ohuchi
et al., 1997). Growth of viruses carrying the HA glycosylation mutations was greatly
impaired when combined with a low activity-reduced stalk N1 NA (Wagner et al., 2000).
This interdependence of HA glycosylation and NA stalk length was confirmed in a later
study (Baigent and McCauley, 2001). In particular, combinations of either an HA
glycosylated at residue 158 with a short-stalk NA or HA lacking this glycosylation site
with a full-length stalk NA led to optimal virus replication. Similar concerted changes in
HA and NA stalk length have also been observed under natural conditions, e.g.
transmission of viruses from wild aquatic birds to domestic land-based poultry was
accompanied by deletions in the NA stalk and introduction of an additional N-linked
glycan in HAi (Matrosovich et al., 1999; Banks et al., 2001). Thus, concomitant changes
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might be implicated in adaptation of influenza virus to a new host. Finally, compensating 
mutations in HA have also been observed in NA-inhibitor resistant viruses and present an 
alternative mechanism of drug resistance to mutations in the NA catalytic site (McKimm- 
Breschkin et al., 1996; Bantia et al., 1998; Blick et al., 1998). Due to their decreased 
affinity for cellular receptors, elution of these variants is less dependent on NA activity and 
can therefore occur in the presence of inhibitor.
1.11 Objectives
The aim of this investigation was to elucidate further the interrelationship between 
antigenic variation and receptor-binding properties of HA. Antigenic variants of the H3 
and HI subtypes were identified by probing with convalescent ferret sera and sequence 
comparison from the time of the first appearance of these viruses in humans until the 
present. A sensitive microscale SPR assay using the BIAcore biosensor system was 
established to identify differences in receptor-binding properties of these viruses. 
Monitoring changes in affinity and/or specificity for receptor analogues would 
complement surveillance studies and provide additional information on the evolution of 
influenza virus in the human host.
In addition, it has previously been possible to select for an avian virus 
preferentially recognising the sialic acid linkage typical for human viruses (Rogers et al., 
1985). This alteration in receptor-binding specificity was accompanied by a mutation 
Gln226Leu, which, however, reverted upon growth of the variant in eggs. These selection 
experiments were repeated with an additional avian virus with the aim to identify the 
substitutions involved in the switch from preferential receptor recognition from avian-to 
human-like.
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2 Materials and Methods
All reagents were obtained from BDH Laboratory Supplies (Merck, UK), except where 
specified.
2.1 Standard Buffers and Solutions
2.1.1 Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
2.1.1.1 SDS-Polyacrylamide Gel (non-reducing)
Resolving Gel (12%)
0.4 M Tris-Hydroxymethylaminoethane (Tris) /HC1 pH 8.9 
12% (w/v) acrylamide/Bis 37.5:1 solution (BioRad)
0.1% (w/v) SDS (BioRad)
0.01% (v/v) N,N,N',N'-Tetramethylethylenediamine (TEMED) (Sigma)
0.1% ammonium persulphate (APS) (w/v) (BioRad)
Stacking Gel (6%)
60 mM Tris/HCl pH 6.7
6% (w/v) acrylamide/Bis 37.5:1 solution (BioRad)
0.1% (w/v) SDS (BioRad)
0.01% (v/v) TEMED (Sigma)
0.1% (w/v) APS (BioRad)
2.1.1.2 SDS-Gel Loading Buffer 5 x (non-reducing)
62.5 mM Tris/HCl pH 6.8 
10% (v/v) glycerol
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2% (w/v) SDS (BioRad)
Bromophenol Blue (Sigma)
2.1.13 SDS-Gel Running Buffer 10 x
0.248 M Tris 
1.92 M glycine 
1% (w/v) SDS (BioRad) 
pH 8.3
2.1.1.4 Coomassie Stain Solution for SDS-Gels
40% (v/v) methanol
10% (v/v) acetic acid
0.25% (w/v) Coomassie Blue (BioRad)
2.1.1.5 Destaining Solution for SDS-Gels
40% (v/v) methanol 
10% (v/v) acetic acid
2.1.2 Agarose Gels
2.1.2.110 x Tris Borate/EDTA (TBE)
(prepared by NIMR media services)
0.9 M Tris 
0.9 M boric acid
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20 mM ethylenediaminetetraacetic acid (EDTA) 
pH adjusted to 8.4
2.1.2.2 Agarose DNA Gel Loading Buffer
30% (w/v) sucrose 
Bromophenol Blue (Sigma)
a
2.1.3 Sequencing
2.1.3.1 Loading Buffer for Sequencing
95% formamide (Sigma)
10 mg/ml Blue Dextran (Pharmacia)
5 mM EDTA 
pH adjusted to 8.0
2.1.4 Primers
Oligonucleotide primers for reverse transcription, PCR and sequencing were supplied by 
Oswel:
Reverse Transcription:
Unil2 5’ -AGCAAAAGCAGG- 3’
H3N2 viruses:
H3HAF6 5’ -AAG CAG GGG ATA ATT CTA TTA ACC- 3
H3A1R1 5’ -GTC TAT CAT TCC CTC CCA ACC ATT- 3’
H3HAF567 5’ -CTG AAC GTG ACT ATG CCA AAC AAT- 3
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H3HAR650 5’ -TTG GTC ACT GTC CGT ACT CGG GTG- 3s
H1N1 viruses:
H1A1F1 5’ -CAA CCA AAA TGA AAG CAA AAC TAC- 3’
H1A1R1/2 5’ -ATA CCA CCC ATC CAT CAT TCC A- 3’
H1F594 5’ -GAA GTC CTT GTA CTA TGG GGT GTT- 3’
H1R623 5’ -GAT GAA CAC CCC ATA GTA CAA GGA- 3’
H1R1036 5’ -CTT AGT CCT GTA ACC ATC CT- 3’
H1R1087 5’ -AAA CCG GCA ATG GCT CCA AA- 3’
SPHAF1 5s -AGC AAA AGC AGG GGA AAA TA- 3’
SPHAR13 5’ -TAC CAT CCA TCT ATC ATT CCA GTC CA- 3’
2.1.5 Cell Culture
2.1.5.1 Complete Medium for Cell Culture
Dulbecco's modified eagle's medium containing pyridoxine (DMEM, Gibco)
5% (v/v) heat-inactivated (56°C, 2 hours) fetal calf serum (FCS, PAA Laboratories, 
GMbH)
100 U/ml penicillin, 0.1 mg/ml streptomycin (Sigma)
2.1.5.2 Trypsin Versene
(Supplied by NIMR media services)
0.8% (w/v) NaCl 
0.02% (w/v) KC1 
0.12% (w/v) Na2HP04
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0.02% (w/v) KH2PO4 
0.01% (w/v) EDTA 
0.13% (w/v) trypsin 
0.001% (w/v) phenol red 
pH adjusted to 7.8
2.1.5.3 Plaque Assay
Overlay Medium
45 ml 2x DMEM (Gibco)
2 ml 8 mg/ml Diethylaminoethyl-Dextran (Pharmacia)
1 ml lOOx non-essential amino acids (Gibco)
1 ml penicillin (10,000 U/ml)/streptomycin (10 mg/ml) (Sigma)
1 ml 0.2 M glutamine (Gibco)
0.1 ml 2.5 mg/ml L-(tosylamido-2-phenyl) ethyl chloromethyl ketone 
(TPCK)-treated trypsin (Sigma)
50 ml 1.5% noble agar (prepared by NIMR media services), melted in boiling water bath 
The mixture was cooled down to 37°C before use.
2.1.6 Reagents for Neuraminidase Assay
2.1.6.1 Periodate Solution
0.2 M sodium periodate (meta)
9 M orthophosphoric acid
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2.1.6.2 Arsenite Solution
0.77 M sodium m-arsenite (Sigma)
0.5 M sodium sulphate (anhydrous)
0.05 M sulfuric acid
2.1.6.3 Thiobarbituric Acid 
0.04 M thiobarbituric acid (Sigma)
0.5 M sodium sulphate (anhydrous)
2.1.6.4 Complete Fetuin Substrate
Fetuin substrate was prepared by ammonium sulphate precipitation: 1 L 5.75 M 
ammonium sulphate was added to 1 L fetal calf serum (PAA Laboratories) at 4°C. After 
centrifugation at 2,000 g (1 hour, 4°C) in a Beckman J6-MC centrifuge, the precipitate was 
dialysed in Visking dialysis tubing (Medicell International Ltd.) against distilled water 
with buffer changes until no more precipitate was visible.
2.1.7 Other Buffers
2.1.7.1 Phosphate-Buffered Saline (PBS)
(prepared by NIMR media services)
1% (w/v) NaCl 
0.025% (w/v) KC1 
0.14% (w/v) Na2HP04 
0.025% (w/v) KH2P04
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2.1.7.2 Desialylation Buffer
10 mM 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid (HEPES) (Sigma)
150 mMNaCl 
10 mM CaCl2 
0.5 mM MgCl2 
pH adjusted to 6.0
2.1.7.3 Resialylation Buffer (HEPES buffer)
10 mM HEPES (Sigma)
150 mMNaCl 
10 mM CaCl2 
0.5 mM MgCl2 
1 mg/ml D (+) glucose 
5 mg/ml BSA (Sigma) 
pH adjusted to 7.4
2.1.7.4HBS-EP Buffer
(supplied by BIAcore)
0.01 M HEPES pH 7.4 
0.15 MNaCl 
3 mM EDTA
0.005% (v/v) Surfactant P20
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2.2 Methods
2.2.1 Molecular Biology Techniques
2.2.1.1 Viral RNA extraction
Viral RNA extraction was performed using the QIAamp Viral RNA mini spin kit 
(QIAgen) according to manufacturer's instructions. Virus grown in cell culture, eggs 
(allantoic fluid or purified virus) or resuspended from picked plaques were used to isolate 
RNA.
2.2.1.2 Reverse Transcriptase PCR (RT-PCR)
cDNA was synthesised from vRNA using AMV reverse transcriptase (Roche) using a 
PTC-100 Programmable Thermal Controller (MJ Research, Inc.). The reaction mixture 
consisted of 5 pi viral RNA, 1 x incubation buffer, 1 mM deoxynucleotidetrisphosphates 
(dNTP) (Amersham Pharmacia), 100 ng primer (Oswel) and 12.5 U reverse transcriptase 
made up to 10 pi with double distilled water. The reaction was incubated at 42°C for 1 
hour, 95°C for 10 minutes (min) and then cooled down to 4°C.
2.2.1.3 Polymerase Chain Reaction (PCR)
cDNA was amplified on a PTC-100 Programmable Thermal Controller (MJ Research, 
Inc.). A reaction mixture was prepared containing 5 pi of the RT-PCR product, 1 x 
incubation buffer, 0.2 mM dNTP (Amersham Pharmacia), 100 ng of forward and reverse 
primer, 2.5 U Cloned Pfu DNA polymerase (Stratagene) made up to 50 pi with double 
distilled water. The DNA amplification program consisted of 35 cycles of a denaturation 
step for 15 seconds (sec) at 95°C, an annealing step for 15 sec at 50°C followed by an 
elongation step for 2 min at 72°C. An additional elongation step was performed for 10 min
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at 72°C to complete any partly synthesised DNA strands and then the reaction mixture was 
kept at 4°C.
2.2.1.4 Purification of PCR Products
Gel-extracted DNA fragments were purified using the QIAquick Gel Extraction kit 
(QIAgen) according to manufacturer's instructions.
2.2.1.5 DNA Sequencing
DNA was labelled with dye-terminators using the BigDye Terminator v l.l Cycle
Sequencing Kit (Applied Biosystems). Approximately 50 ng of PCR product as
determined by agarose gel electrophoresis using 50 ng of pGEM (Applied Biosystems) as
a marker were added to the reaction mix (4 pi Big Dye reagent, 4 pi Half term diluent, 3.2
pmoles sequencing primer) and diluted to 20 pi with double distilled water. Following the
sequencing programme (25 cycles of 96°C for 30 sec, 50°C for 15 sec, 60°C for 4 min,
then cooling down the reaction mixture to 4°C) the DNA was precipitated. The reactions
were mixed with 50 pi 96% ethanol and 2 pi 3 M sodium acetate pH 5.2, and incubated on
ice for 10 min. The DNA was pelleted at 10,000 g for 15 min in an Eppendorf 5415 C
centrifuge. The pellet was washed in 500 pi 70% ethanol, respun at 10,000 g for 5 min and
dried on a heating block at 90°C for 1 min. The DNA was resuspended in 4 pi loading
buffer and run on the ABI PRISM 377 DNA sequencer (Applied Biosystems) according to
the manufacturer’s instructions. Sequence data were assembled and edited using the
Staden Package Version 1.5.3 (2004.1). Sequence data were analysed using the Wisconsin
Sequence Analysis Package Version 10 (GCG) and phylogenetic trees were constructed
using PAUP (Phylogenetic Analysis Using Parsimony, Version 4.0, D. Swofford, Illinois
Natural History Survey, Champaign, IL, USA) (Swofford and Olsen, 1990).
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2.2.1.6 Agarose Gel Electrophoresis
Samples were mixed with 10 x loading buffer and separated on 1% agarose (BioRad) gels 
in 1 x TBE containing 0.5 pg/ml ethidium bromide (Sigma). Electrophoresis was carried 
out at 80 V, limiting to 150 mA. DNA bands were visualized by trans UV illumination and 
digital images were captured with a Kodak Image station 440 CF and Digital Science ID 
software (Perkin Elmer). A 1 kb DNA ladder (12216-298 bp, Gibco) was used as DNA 
size marker.
2.2.2 Biochemical and Cell Biology Techniques
2.2.2.1 SDS-PAGE
SDS-PAGE gels containing a 6% stacking and a 12% resolving gel were run using a 
EC 120-4 Mini-Vertical Gel System (Thermo Electron Corporation). Samples were mixed 
with 5 x loading buffer and denatured on a heating block at 90°C for 5 min. The proteins 
were separated by electrophoresis in SDS gel running buffer at 200 V, limiting to 50 mA 
per gel. The gels were stained in Commassie Blue stain for 20 min and destained overnight 
in destain solution. Kaleidoscope Prestained Standards (210,000-7,200 Da, BioRad) were 
used as protein size markers.
2.2.2.2 Western Blotting
Proteins resolved by SDS-PAGE were transferred to Immobilon-P membranes (Millipore)
in a Trans-blot SD semi-dry transfer cell (BioRad) for 1 hour at 300 mA per gel, limiting
to 20 V, in SDS running buffer. The membrane was blocked with 5% Marvel milk powder
(Premier Brands) in PBS for 1 hour and incubated with primary antibody diluted in
PBS/5% milk powder. After 4 washes with PBS/0.1% Tween 20 (Sigma) the membrane
was incubated with Protein-A-HRP (BioRad) diluted 1:1,000 in PBS/5% milk powder for
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one hour. Following 4 washes with PBS/0.1% Tween 20 the reactive protein bands were 
visualized using the ECL chemiluminescence kit (Amersham Pharmacia), with blots being 
exposed to Kodak MXB X-ray film. The following dilutions of primary antibodies were 
used for western blotting
Rabbit 1064 <x-X31 BHA 1:5,000
(provided by the World Influenza Centre (WIC), NIMR, London)
Mouse a-influenza Ml monoclonal antibody (Serotec) 1:5,000
Mouse a-NP 1:1,000
(kindly provided by R. Webster, St. Jude Children’s Research Hospital, Memphis, USA)
2.2.2.3 Passaging of Cells
MDCK cells were cultured in 80 CM2 flasks or 35 mm dishes (Nunc) in complete media at 
37°C and 5% CO2 . All cells were adherent and were detached from the flasks with trypsin 
versene for passaging when confluent.
2.2.2.4 Freezing and Thawing of Cells
Confluent cells in a 175 CM2 flask (Nunc) were trypsinised, diluted to 10 ml with DMEM 
and spun for 5 min at 500 g in a Beckman GS-6R centrifuge. The pellet was resuspended 
in 5 ml freezing medium consisting of 58.5% DMEM, 7.5% DMSO (Sigma) and 33% 
FCS. Aliquots of 0.5 ml were frozen at - 80°C in a polystyrene rack before transfer to 
liquid nitrogen. Cells were thawed quickly in a waterbath at 37°C, washed in 10 ml 
DMEM and resuspended in 1 ml complete medium. The cells were then transferred to a 80 
CM2 flask containing 30 ml complete medium and incubated at 37°C, 5% CO2 .
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2.2.3 Virological Techniques
All continuous sucrose gradients for purification of virus or HA were prepared using a 
two-chamber gradient maker (prepared by NIMR engineering services) and a Minipulse 2 
peristaltic pump (Gilson). Upon centrifugation fractions were taken using the Minipulse 2 
peristaltic pump.
2.2.3.1 Source of Viruses
All virus seed stocks were provided by WIC (NIMR, London) either as allantoic fluid or as 
freeze-dried virus, except for Dk/Hokkaido/33/80, which was kindly provided by H. Kida 
(Hokkaido University, Japan).
2.2.3.2 Virus Growth in Eggs
Influenza viruses were grown in the allantoic cavity of 10-day-old embryonated hen’s
eggs. One hundred pi of virus (in dilutions ranging from 10’1 to 10'5) were injected into
each egg and the site of inoculation was sealed with paraffin wax. The eggs were incubated
at 33°C for 48-72 hours and then at 4°C for 8-24 hours. The allantoic fluid was harvested,
filtered through 0.45 pm filters (Sartorius) and kept at -80°C. Alternatively, virus was
purified by sucrose gradient centrifugation as a modification of Skehel and Schild (1971):
the allantoic fluid was clarified by centrifugation in a Beckman J6-MC centrifuge (900 g,
20 min, 4°C), followed by pelleting the virus in a Beckman Avanti J-25 Centrifuge (7,000
g, 12-15 hours, 4°C). Then the virus was resuspended in 10 mM Tris/150 mM NaCl pH 8
using a homogeniser (Kontes Glass Co.) with a loose pestle and subsequently purified by
centrifugation through a 15-40% (w/v) continuous sucrose gradient in 10 mM Tris/150mM
NaCl pH 8 in a BeckmanXL-90 Ultracentrifuge (85,000 g, 45 min 4°C). The visible white
virus-containing band was removed, diluted to 30 ml with 10 mM Tris/150 mM NaCl pH 8
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and pelleted by spinning in a Beckman XL-90 Ultracentrifuge (85,000 g, 90 min, 4°C). 
The pellet was resuspended in 1-3 ml HBS-EP buffer and stored at 4 °C. Virus titres were 
determined by haemagglutination or plaque assays.
2.2.3.3 Virus Growth in MDCK Cells
MDCK cells in 80 CM2 flasks or 35 mm dishes were washed twice with warm DMEM 
medium. Then, 0.5 ml of virus (in dilutions ranging from 10'1 to 10"5) was added and the 
virus left to adsorb for 30-45 min at room temperature. After removal of unbound virus by 
aspiration, complete medium supplemented with 2.5 pg/ml TPCK-treated trypsin (Sigma) 
was added (20 ml and 2 ml for flasks and dishes, respectively). Upon incubation at 37°C, 
5% CO2 for 48-72 hours, the cell supernatant was centrifuged at 500 g in a Beckman GS- 
6R centrifuge to remove cell debris and kept at - 80°C. Virus titre was determined by 
haemagglutination or plaque assays.
2.2.3.4 Plaque Assay
MDCK cells were seeded in 35 mm dishes and incubated at 37°C, 5% CO2 until they were 
tightly packed. The cells were washed twice with warm DMEM and incubated with 500 pi 
10-fold virus dilutions for 30 min at room temperature. Any unbound virus was removed 
by aspiration and 2 ml of overlay medium were added to each dish. After the overlay had 
set, the dishes were incubated at 37°C, 5% CO2 until plaques became visible (2-4 days). 
Then the cells were fixed in 0.25% glutaraldehyde in PBS for 30 min at room temperature. 
The agar overlay was removed under running water and the cells were stained with 1% 
crystal violet (Sigma) in 20% ethanol. The cells were then washed with water to remove 
any excess dye to visualise the plaques. Alternatively, the plaques were picked with a glass
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pasteur pipette (Volac) and resuspended in 500 pi DMEM for direct sequencing or growth 
in MDCK cells.
2.2.3.5 Haemagglutination Assay
Viral titres were determined in V-bottom microtitre plates (Greiner Labortechnik). Two­
fold serial dilutions of 50 pi virus suspension in PBS were done and 50 pi of 1% (v/v) 
turkey RBC suspension in PBS were added to each well. The plates were read after 
incubation for 1 hour at room temperature and the virus titre (HAUs) expressed as the 
reciprocal of the maximum virus dilution that caused complete agglutination of RBC.
2.2.3.6 Haemagglutination Inhibition (HI) Test
Two-fold serial dilutions of antibody in 50 pi PBS were done in V-bottom microtitre 
plates. Then 8 HAUs of virus in 50 pi of PBS were added to each well and the plate was 
incubated for 30 min at room temperature. Fifty pi of a 1% (v/v) turkey RBC suspension in 
PBS were added to each well and the plate incubated at room temperature for a further 60 
min to allow agglutination. The efficacy of inhibition by antibody or horse serum was 
determined as the reciprocal of the maximum dilution that inhibited agglutination of RBC.
2.2.4 Preparation of Bromelain-Released HA (BHA)
The preparation of BHA is based on the Method described by Compans et al.(1970). Virus
at a final total protein concentration of 2-5 mg/ml was incubated with bromelain in a ratio
of 2:1 (w/w) in 10 mM Tris/150 mM NaCl/50 mM mercaptoethanol/0.1% (w/v) sodium
azide pH 8 at 37°C for 90 min. Then the viral cores were pelleted in a Beckman Optima
Ultracentrifuge (150,000 g, 20 min, 4°C), and the supernatant was spun through a
continuous 5-25% (w/v) sucrose gradient in 10 mM Tris pH 8 in a Beckman XL-90
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Ultracentrifuge (180,000 g, 16 hours, 4°C). The remaining virus pellet was resuspended in 
10 mM Tris/150 mM NaCl pH 8 and the bromelain digestion procedure was repeated for 4 
hours and subsequently overnight. One ml fractions of the sucrose gradients were taken 
and BHA and NA detected by spectrophotometry and by SDS-PAGE. The majority of NA 
was usually removed in the 90 min digest, whereas HA was cleaved off the virus in 
subsequent digests. The gradient fractions containing BHA were pooled and the sucrose 
depleted by buffer exchange in 10,000 MWCO (molecular weight cut-off) Vivaspin 20 
(Sartorius) into 10 mM Tris pH 8 (3 times 1:10 dilution, 1,200 g in a Beckman GS-6R 
Centrifuge). Further purification was achieved by ion-exchange using a Q15 (cation)- 
syringe filter (Sartorius). After equilibration with 10 ml 10 mM Tris pH 8, the sample was 
bound to the filter. Bound proteins were eluted with 2.5 ml 10 mM Tris pH 8 with 
increasing NaCl concentrations (0, 50,100,150, 200, 400 and 1,000 mM). Elution of BHA 
usually occurred at 150-400 mM NaCl, whereas any remaining NA was eluted at 50-100 
mM NaCl, as determined by SDS-PAGE. The fractions containing BHA were pooled and 
any remaining NA was removed from the sample by affinity chromatography using a a- 
NA immunoaffinity column.
2.2.5 Preparation of a-NA Immunoaffinity Column
A 1 ml Hi-Trap rProtein A FF column (Amersham Pharmacia) was connected to a 
Minipulse 2 peristaltic pump and equilibrated with 20 ml PBS. X31 monoclonal a-NA 
antibody solution prepared by the method of Koehler and Milstein (1975) was diluted 1:3 
with PBS and 20 ml pumped through the column for 10 min. Any unbound antibodies 
were washed off with PBS (detected by spectrophotometry). Upon equilibration with 10 
ml 0.2 M triethanolamine pH 8.3, the antibody was crosslinked to the column with 20 ml
0.2 M triethanolamine/30 mM dimethyl pimalidate (Perbio) pH 8.3 for 45 min.
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Subsequently, the reaction was stopped with 20 ml 0.3 M glycine pH 8.3 and any non­
crosslinked antibody was removed with 5 ml 0.15 M citrate buffer pH 3. The column was 
washed with 20 ml PBS/0.1% (w/v) sodium azide and stored at 4°C.
2.2.6 Preparation of low-pH-induced BHA Rosettes
BHA at 1 mg/ml was adjusted to pH 5 with citrate buffer pH 3.5. At this pH, the BHA 
trimers undergo a conformational change associated with membrane fusion and form 
soluble aggregates called rosettes. Each particle contains about 6 to 10 trimers as estimated 
by electron microscopy and display multivalent binding characteristics of a virus, e.g. 
agglutination of RBC (Skehel et al., 1982). Upon incubation at room temperature for 10 
min, the pH was adjusted to 7-8 with 1 M Tris pH 8. The rosettes were then separated from 
non-aggregated trimers by centrifugation through a continuous 5-25% (w/v) sucrose 
gradient with a 60% (w/v) sucrose cushion in 10 mM Tris pH 8 in a Beckman XL-90 
Ultracentrifuge (180,000 g, 16 hours, 4°C). The rosette-containing fractions as determined 
by spectrophotometry and SDS-PAGE were pooled and then dialysed in 10,000 MWCO 
Slide-A-Lyzer cassettes (Perbio) against 4 L PBS for 48 hours at 4°C with one buffer 
change to deplete sucrose. For analysis using the BIAcore, PBS was exchanged for HBS- 
EP in 10,000 MWCO Vivaspin 20 (3 times 1:10 dilution, 1200 g in a Beckman GS-6R 
Centrifuge).
2.2.7 Neuraminidase Activity Assay
This assay is a modification of Warren (1959). Two-fold serial dilutions of virus or sample
to be tested for NA activity were done in 50 pi HBS-EP buffer in 50 x 10 mm test tubes
(SAMCO). A negative control containing only buffer was included. Fifty pi of complete
fetuin substrate (diluted 1:3 in buffer) was added to each tube and the reaction was
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incubated at 37°C for 15 hours. Then 50 jxl periodate reagent was added to the reaction 
mixture and the tubes incubated at room temperature for 20 min. Arsenite solution (250 pi) 
was added and mixed until a yellow-brown colour disappeared. Then 500 pi thiobarbituric 
acid was added and the tubes incubated in a boiling water bath for 10 min. NA activity was 
detected by formation of a red colour and expressed as the reciprocal of the maximum 
virus or sample dilution yielding the colour formation.
2.2.8 Neuraminidase Activity Inhibition (NAI) Test
Two-fold serial dilutions of NA inhibitor were done in 50 pi HBS-EP buffer in 50 x 10 
mm test tubes (SAMCO). Then 50 pi of virus sample was added and the reaction incubated 
for 30 min at room temperature. Upon addition of 50 pi complete fetuin substrate (diluted 
1:3 in buffer) and incubation at 37°C for 15 hours, the NA activity was detected as 
described above and the minimal inhibitory concentration determined as the reciprocal of 
the maximum inhibitor dilution preventing the colour formation. The NA activity of the 
virus sample in absence of inhibitor was determined in parallel as a positive control.
2.2.9 Biotinylation of Fetuin and Asialofetuin
Fetuin and asialofetuin (Sigma) were biotinylated using the Immunoprobe biotinylation kit
(Sigma). Biotinamidohexanoic acid-Sulfo-N-hydroxysuccinimide was mixed with fetuin
or asialofetuin at a molar ratio of 5:1 in sodium phosphate buffer pH 7.2, and the reaction
was incubated at room temperature for 30 min with gentle stirring. Any unincorporated
biotin was removed by buffer exchange in 10,000 MWCO Vivaspin 20 (3 times 1:10
dilution, 1,200 g in a Beckman GS-6R Centrifuge) into PBS or 25 mM 2-
morpholinoethanesulfonic acid (MES) (Sigma)/150 mM NaCl/2.5 mM MgCl2 pH 6. The
biotin/protein ratio was determined using the supplied avidin-2-hydroxyazobenzen-4'-
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carboxylic acid assay using the extinction coefficient as described by the manufacturer.
2.2.10 Treatment of Turkey RBC with Viral Neuraminidases
Turkey RBC were treated with viral NA (X31 or Japan/305/57 (JAP)), prepared by 
bromelain digest and purification as described for production of BHA) in order to remove 
sialic mainly in the a(2,3)-linkage. One ml 10% (v/v) turkey RBC in PBS was spun down 
at 1,500 g in an Eppendorf 5415 C centrifuge and washed twice to yield a 10% (v/v) 
suspension in desialylation buffer. Indicated amounts (see Chapter 5) of sialidases were 
incubated with the blood at 37°C for 15-45 min. Then the blood was washed four times by 
pelleting the cells at 1,500 g in an Eppendorf 5415 C centrifuge and resuspension in 1 ml 
HEPES buffer. Removal of a(2,3)-linked sialic acid was assessed by haemagglutination 
assays with X31, Leu226Gln and Dk/Hokkaido/33/80 viruses or by binding of these 
viruses labelled with 125Iodine to the treated turkey RBC.
2.2.11 De- and Resialylation of Turkey RBC
This assay is a modification of Carroll et al. (1981). One ml 10% (v/v) turkey RBC in PBS
was spun down at 1,500 g in an Eppendorf 5415 C centrifuge and washed twice to yield a
10% (v/v) suspension in desialylation buffer. Then the blood cells were desialylated by
incubation with 100 mU Vibrio cholerae NA (Sigma) at 37°C for 2 hours, followed by 5
washes with 1 ml HEPES buffer. The red cells were then reconstituted with sialic acid
either in the a(2,6)- or the a(2,3)-linkage to galactose by use of linkage-specific
sialyltransferases (a(2,3)-(N)-sialyltransferase, a(2,6)-(N)-sialyltransferase, Calbiochem):
200 pi 10% (v/v) desialylated red cells were incubated with 50 pi 15.3 mM cytidine-5’-
monophospho-N-acetylneuraminic acid (CMP-Neu5Ac) (Sigma) and varying
concentrations of transferases in a total of 1 ml resialylation buffer at 37°C for 4 hours.
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The blood was then washed 3 times in 1 ml resialylation buffer and stored at 4°C. The 
binding capacity of X31, Leu226Gln and Dk/Hokkaido/33/80 viruses for the de- and 
resialylated blood was tested as described below and expressed as percentage compared to 
binding of untreated blood.
2.2.12 Selection Experiments
Two hundred and fifty pi of Dk/Ukraine/1/63 and Dk/Hokkaido/33/80 viruses at titres of 
64-256 HAUs were added to 250 pi of resialylated turkey RBC at 1-0.001% (v/v) final 
concentrations. Viruses were allowed to bind to the cells for 10 min at room temperature. 
Unbound virus was removed by washing the blood 6 times in 500 pi HEPES buffer in an 
Eppendorf 5415 C centrifuge (1,500 g, 1 min). After every wash step, the resuspended 
blood was transferred to a new Eppendorf tube. Then the blood was resuspended in 1 ml 
desialylation buffer pH 6.5 and the virus was eluted from the cells by incubation with 15 
mU Vibrio cholerae NA (Sigma) at 37°C for 1 hour. The RBC were then pelleted, the 
supernatant filtered through 0.45 pm filters and used for infection of MDCK cells in 6-well 
plates. Virus grown after selection with the lowest red cell concentration and with the 1% 
(v/v) red cell suspension was used for further selection assays. In parallel, 
Dk/Ukraine/1/63 and Dk/Hokkaido/33/80 viruses were passaged in MDCK cells to assess 
any mutations due to adaptation to growth in tissue culture cells.
2.2.13 Labelling of Virus with 125Iodine (Bolton-Hunter Reagent)
X31, Leu226Gln and Dk/Hokkaido/33/80 viruses were labelled with 125Iodine using the
Bolton Hunter Reagent (Amersham Pharmacia). Four point six MBq of Bolton-Hunter
reagent were transferred to an Eppendorf tube and dried in a stream of nitrogen gas. Then
300 pi of egg-grown-purified virus (equivalent to 768,000 HAUs) in 0.1 M sodium borate
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pH 8.5 were added to the dry Bolton-Hunter reagent, mixed gently and incubated on ice 
for 15 min. The reaction was stopped by adding 0.5 ml 0.2 M glycine/0.1 M sodium borate 
pH 8.5 and incubation on ice for 5 min. Virus was separated from unincorporated Bolton- 
Hunter label by gel filtration using a BioRad column (30 x 0.7 cm) packed with Sephadex 
G25 (Sigma) and equilibrated with PBS/0.25% gelatine (Sigma)/0.05% (w/v) sodium 
azide. Half ml fractions were collected and 5 pi of each fraction transferred to 3.5 ml 55 x 
12 mm tubes (Sarstedt) containing 0.25 ml 1 M NaOH. Radioactivity was measured for 5 
min using a LKB 1277 Automatic Gamma Counter (Wallac) and expressed as counts per 
minute (cpm). The samples containing at least 10% of the total radioactivity within the 
first 10 fractions were pooled and the virus titre determined by the haemagglutination 
assay.
2.2.14 Binding Experiments of 125Iodine-labelled Virus to Turkey RBC
Labelled virus was diluted 1:1,000 in HEPES buffer, generating a stock solution of 7,GOO- 
12,000 cpm and a haemagglutination titre of 256 HAUs. Then, 250 pi were added to 250 
pi of a 2% (v/v) turkey RBC solution. Virus was allowed to adsorb to the cells for 30 min 
on ice. Unbound virus was removed by washing the cells twice in 0.5 ml HEPES buffer. 
Subsequently the cells were lysed in 500 pi 1 M NaOH for 30 min at 37°C, transferred to
3.5 ml Sarstedt tubes and the radioactivity counted for 5 min in a LKB 1277 Automatic 
Gamma Counter. The amount of bound virus was calculated as percentage of cpm 
compared to the original virus stock solution. All experiments were done three times and 
in duplicates.
2.2.15 Quantitation of Virus Particles for SPR Experiments
Virus concentration of X31 was determined based on the amount of NP protein present in
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the virus preparation. Viral proteins were separated by SDS-PAGE in non-reducing 
loading buffer and stained with Commassie Blue. The net intensity of the NP band was 
then measured on a Kodak Image station 440 CF with the Digital Science ID software 
(Perkin Elmer), and the concentration calculated against a standard curve of BSA. The 
virus concentration was determined assuming a constant number of 590 copies of NP (MW 
= 56,000 Da) per influenza A virion. This number was calculated based on the influenza 
virus genome consisting of 13588 nucleotides and the binding of 23 nucleotides per NP 
monomer (Ruigrok, 1998). The relative amount of other viruses was calculated against a 
standard curve generated by X31 virus. Bovine serum albumin (BSA) or X31 virus was 
run at 5 different concentrations generating equally spaced datapoints for the generation of 
standard curves, whereas virus preparations for which the NP concentration was 
determined were run at two different dilutions on the same SDS-Gel. All the samples were 
run in duplicates.
2.2.16 Preparation of a(2,3)- and a(2,6)-Fetuin as Substrates for Binding Experiments
Fetuin containing Neu5Ac either in the a(2,6)- or a(2,3)-linkage to galactose was prepared
by sialylation of biotinylated asialofetuin with CMP~Neu5Ac (Sigma) and linkage-specific
transferase, a(2,6)-(N)-sialyltransferase and a(2,3)-(N)-sialyltransferase (Calbiochem),
respectively. One hundred pi asialofetuin (at 0.95 mg/ml) in 25 mM MES (Sigma)/150
mM NaCl/2.5 mM MgCk pH 6 were mixed with 1.8 mU a(2,3)-(N)-sialyltransferase or
0.6 mU a(2,6)-(N)-sialyltransferase and 50 pi CMP-Neu5Ac at concentrations described in
Chapter 3, and sialylation was performed for 4 hours at 37°C. Unincorporated Neu5Ac
was removed by buffer exchange in 10,000 MWCO Vivaspin 20 into PBS (4 times 1:10
dilution, 1,200 g in a Beckman GS-6R Centrifuge). In order to monitor incorporation of
unlabeled CMP-Neu5Ac, a trace amount of CMP-[14C]-Neu5Ac (325.2 mCi/mmol; Perkin
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Elmer) was added to give a final specific activity of 93-373 cpm/nmol. After buffer 
exchange, the concentration of sialylated fetuin in 1 ml PBS was determined by 
spectrophotometry. Then 650 pi were transferred into 20 ml scintillation vials (Packard) 
containing 9 ml Ready Safe liquid scintillation cocktail (Beckman) and the radioactivity as 
cpm measured by counting for 1 min in a LS 6000IC Scintillation Counter (Beckman) with 
colour quench correction set with limits o f4.567 to 309.63.
2.2.17 Surface Plasmon Resonance Binding Experiments
Interactions between HA-rosettes or virus (analyte) and fetuin (ligand) were measured on a 
BIAcore 2000 biosensor system (BIAcore AB, Uppsala, Sweden) at 25°C. Fetuin and 
asialofetuin (Sigma) were biotinylated as described above, diluted to 50 pg/ml in PBS, 
filtered through 0.22 pm filters (Sartorius) and stored at -20°C. Alternatively, biotinylated 
asialofetuin was restored with Neu5Ac in the a(2,3)- or a(2,6)-linkage as described and 
stored like fetuin at 50 pg/ml. Then they were immobilized onto streptavidin sensor chips 
by injection over the sensor surface of different flow channels at a constant flow rate of 5 
pl/min for 7 min. Non-specifically bound protein was removed by 3 consecutive injections 
of 5 pi 10 mM glycine/0.5% Tween 20/NaOH pH 11.5 (regeneration solution). Analyte- 
ligand interaction was analysed using HBS-EP (BIAcore AB) as running buffer. Analyte 
was injected over the sensor surface at a flow rate of 10 pl/min using the Kinject 
command. After every binding experiment, regeneration solution was injected 
consecutively for 1 min over the sensor surface until all bound analyte was removed from 
fetuin. The results were analysed using standard non-linear least square fit methods and the 
kinetic parameters calculated as described in Chapter 3.
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3 Development of a Receptor-Binding Assay for Influenza Virus 
and Receptor Analogues Based on Surface Plasmon Resonance
3.1 Introduction
3.1.1 Available Receptor-Binding Assays
A number of different assays have been developed for the study of influenza virus 
receptor-binding activity. The earliest available methods were virus-induced 
haemagglutination assays using RBC from different animal species (e.g. human, chicken, 
guinea pig, horse) (Hoyle, 1968a; Ito et al., 1997a) or enzymatically modified erythrocytes. 
These modifications include potassium periodate oxidation, leading to removal of the 
sialic acid glycerol chain (Underwood, 1985), and reconstitution of sialic acid-depleted 
RBC either with sialic acid species in different linkages (Paulson et al., 1979; Higa et al., 
1985; Paulson and Rogers, 1987) or with incorporated gangliosides (Suzuki et al., 1985; 
Suzuki et al., 1986). While these assays have proven to be useful in detecting relative 
differences in recognition of these erythrocytes, the complex nature of the agglutination 
reaction and the lack of detailed information on the structure, composition and density of 
red cell glycoproteins and glycolipids do not allow a quantitative analysis of the interaction 
being studied. Although adsorption of virus to RBC can be measured in order to overcome 
the complexity of the agglutination reaction (Rogers and Paulson, 1983), the limitations 
mentioned above regarding the substrates used still apply. Furthermore, reproducibility of 
results is limited by the instability of RBC. Other assays providing relative information on 
receptor-binding properties involve binding of virus to gangliosides on thin layer 
chromatography (TLC) plates (Suzuki et al., 1992) and the interaction of HA-expressing 
cells with erythrocytes loaded with horseradish peroxidase (HRP) (Martin et al., 1998).
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In contrast to the qualitative nature of the described assays, quantitative receptor- 
binding information can be obtained by nuclear magnetic resonance (NMR) studies. The 
affinity of the interaction between HA trimers or virus and soluble monovalent receptor 
analogues is expressed by the equilibrium dissociation constant ( K d ) ,  which has been 
determined to be approximately 10' M (Sauter et al., 1989; Hanson et al., 1992). 
Millimolar dissociation constants have also been determined for other viruses recognising 
sialic acid, e.g. polyomavirus and rhesus rotavirus (Stehle and Harrison, 1996; Dormitzer 
et al., 2002). Studies with lectins have confirmed this extremely weak carbohydrate- 
protein interaction (Weis and Drickamer, 1996), which is in contrast to typical high- 
affinity protein-protein interactions of virus and receptor (K d  = 10'6-10'9 M) (Lasky et al., 
1987; McDermott et al., 2000). However, clustering of lectins and the abundance of HA 
trimers on the virus particle leads to the simultaneous binding of multiple receptors. This 
phenomenon is referred to as multivalency, which results in very tight binding of cell 
surface receptors. Although real equilibrium constants are obtained by NMR studies, the 
major drawbacks of this technique are the requirement for milligram quantities of protein 
and the extensive use of a high-field NMR spectrometer.
Competition with a substrate of known affinity for the receptor-binding site
provides an alternative method of determining the binding strength of a ligand for HA or
virus. The affinity can be expressed either as the substrate concentration needed to inhibit
binding of another ligand by 50% (relative potency) or can be calculated directly. This
approach has been used in fluorescence polarisation studies (Weinhold and Knowles,
1992) and adsorption of virus to RBC (Pritchett et al., 1987). Similarly, the relative
potency for inhibition of haemagglutination can be determined (Toogood et al., 1991). A
routinely used assay is the interaction of virions attached to a solid phase with soluble
HRP-labelled sialylglycoproteins or competition of these with unlabelled ligands,
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analogous to a sandwich ELISA (Gambaryan and Matrosovich, 1992). However, 
quantitative analysis by competition assays requires well-characterised ligands and is often 
complicated by differences in their valency.
3.1.2 Studies of Biomolecular Interactions by Surface Plasmon Resonance
All the quantitative assays described above determine the binding strength of an 
interaction by measuring the concentration of free and bound substrates at equilibrium, 
where no net change in complex concentration is observed. However, this approach is 
often limited by the length of time required for many biological reactions to reach 
equilibrium at reasonable substrate concentration and does not yield kinetic constants for 
the rates of association (ka) and dissociation (kd).
Biosensors permitting the study of interactions based on SPR were first introduced 
in 1990 and have developed rapidly since then (Fagerstam et al., 1992; Biacore, 1998). 
These permit real-time analysis of receptor-ligand binding specificity, affinity and kinetic 
constants, and can also provide information on the stoichiometry, cooperativity and 
thermodynamics of a reaction. This method enables the use of substrates with molecular 
weights from hundreds of daltons (Davis and Wilson, 2000) to whole-cell dimensions 
(Quinn et al., 2000), and the measurement of effective affinities from sub-picomolar to 
greater than millimolar (Myszka et al., 1998) can be measured over a wide range of 
chemical conditions. SPR is therefore considered a powerful tool for large-scale screening 
of binding events.
In BIAcore instruments (BIAcore AB, Uppsala, Sweden), molecular interaction is
detected on a sensor chip, consisting of a dextran-coated gold surface (sensor surface)
mounted on a glass side. One of the components of the interaction (ligand) is immobilised
onto the sensor surface, forming one wall of a flow cell, through which the other
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interactant (analyte) is injected (see Figure 15a). Binding of analyte to ligand is detected 
by SPR, an optical phenomenon arising from the interaction of light with a metal surface 
(Kretschmann and Raether, 1968). In binding experiments monochromatic polarised light 
is directed at the sensor surface at various incident angles under conditions of total internal 
reflection. However, since the glass is covered by gold, this reflection is not total but a 
fraction of the light is absorbed by mobile electrons in the metal film. At a particular 
incident angle of the light, a wave of excited electrons (the plasmon resonance) is 
produced at the gold layer, which leads to almost complete absorption of the light. This is 
detected as a marked reduction of intensity of reflected light. Since an evanescent wave 
associated with the electron oscillation travels a short distance from the gold film, the SPR 
angle is dependent on and proportional to the refractive index of the medium near the 
sensor surface. The interaction of analyte and ligand leads to an increase of mass, which is 
proportional to an increase in refractive index. Therefore, a change of the SPR angle 
reflects differences in mass at the sensor surface. The angle of the reduced-intensity 
reflected light is continuously recorded by a detector and expressed in resonance units 
(RUs). A SPR angle change of 0.1° corresponds to 1,000 RUs, which requires the binding 
of ~ 1 ng/mm2 to the sensor surface for the majority of proteins (Stenberg et al., 1991). 
Plotting the changes of the resonance signal as a function of time before, during and after 
injection of substrate generates a sensorgram, which is depicted in Figure 15b. A liquid 
handling system ensures constant flow of buffer and controlled transport of samples to the 
sensor surface.
In virology, SPR is a widely used method to study receptor-ligand interactions with
either soluble viral proteins or whole virus particles (e.g. Casasnovas and Springer, 1995;
McDermott et al., 2000). For influenza virus, an SPR-based assay has been established to
measure the affinity of HA for a receptor analogue (Takemoto et al., 1996). Since the
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Figure 15 Principle of detection of molecular interactions by SPR
a) Components of a typical biosensor (adapted from Biacore, 2003a). A glass slide 
containing a thin gold film is mounted on a prism. Light at different incident angles is 
directed against the sensor surface onto which one interactant (ligand) is captured, reflects 
off the gold film and passes back through the prism to a detector. Samples containing the 
other interactant (analyte) are injected over the sensor surface. Interaction of analyte with 
ligand is detected as changes in the light angle at which SPR creates a large reduction in 
the intensity of reflected light. This change is proportional to the mass of bound analyte 
close to the sensor surface and is expressed in resonance units (RUs).
b) Monitoring changes in SPR angles as a function of time creates a sensorgram. Analyte 
binds to ligand during sample injection, resulting in an increase of signal. At steady-state, 
no more net complex formation is observed. At the end of the injection, the sample is 
replaced by continuous flow of buffer and the decrease in signal reflects dissociation of 
analyte from ligand.
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interaction of HA with monovalent receptor analogues is of low affinity, as determined by 
NMR, the binding of low-pH rosettes (aggregates of BHA produced by treatment with 
low-pH) to fetuin, a sialylated glycoprotein from foetal calf plasma, was studied. The 
presence of multiple Neu5Ac moieties per fetuin molecule and BHA per rosette ensured 
multivalency, which enhanced the otherwise low affinity. Fetuin was immobilised on the 
sensor chip and the rosettes were injected over it.
The aim of the following experiments was to investigate the possibility of using 
virus particles in affinity and specificity studies using SPR.
3.2 Virus-Receptor analogue Interaction Studies by SPR (BIAcore 
biosensor system)
3.2.1 Quantitation of Virus Particles
In order to gain quantitative information on kinetic and equilibrium constants, the
concentrations of the reactants injected over the sensor surface need to be determined.
Since binding of whole virus to fetuin was studied, quantitation of either HA or virus
particles was required. However, the amount of HA in a virus preparation proved difficult
to determine. Quantitation using extinction coefficients or colorimetric assays requires
pure samples of HA produced by either bromelain digestion or disruption of virus with
detergent followed by purification by sucrose gradient, and therefore does not provide
accurate concentration values for the virus preparation. Therefore, viral proteins were
separated by SDS-PAGE, stained with Coomassie Blue and their intensity compared to
BSA standards (Perbio) ranging from 25-125 pg/ml (see Figure 16a). NP is difficult to
separate from HAi, as is Ml from HA2 , by SDS-PAGE due to their similarity in molecular
weights. Therefore, the virus samples were run non-reduced, where HA runs as a single
band. However, HA was partially retained in the stacking gel, as determined by Western
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Figure 16 Quantitation of virus particles (1)
a) SDS-PAGE gel stained with Coomassie Blue showing the separation of viral proteins 
and BSA standards. Vims sample (X31) was mn at two different concentrations compared 
to stock solution in duplicates. BSA standards were mn at five different concentrations in 
duplicates in order to generate a standard curve (see Figure 17). All samples were run non­
reduced for ease of separation of viral proteins. M = protein size marker b) Western blot of 
viral proteins showing that HA but not NP or Ml is partially retained in the stacking gel. 
Viral proteins were probed with a-(HA), a-(NP) and a-(Ml)-antibodies. As a control for 
the specificities of the antibodies, full-length HA (prepared as described by Wharton et al. 
(1986)) was included in the experiment.
97
Chapter 3 Development ofSPR Receptor-Binding Assay
blotting (see Figure 16b), and this approach was therefore not considered to be appropriate 
for concentration determination. Furthermore, HA generated multiple bands of different 
sizes due to the presence of a mixture of monomers, dimers and trimers, complicating the 
analysis. Therefore, the concentration of virus particles was determined instead. Since the 
concentration of NP per virus particle is expected to vary the least due to coating of a 
constant number of 8 genome segments, this protein was quantitated by SDS-PAGE as 
described in 2.2.15 Quantitation o f Virus Particles for SPR Experiments, p. 88. Unlike HA, 
this protein runs as a single band and is not retained in the stacking gel, as shown in Figure 
16b. The BSA standard curve and the results of the quantitation are shown in Figure 17a 
and b. Virus particle concentration was determined by this method for X31 virus, which 
was in turn used to generate standard curves for the other viruses used in SPR studies. It is 
estimated that virus concentrations can be determined to within 5-15% using this approach. 
Errors of this magnitude would not affect the conclusions of the studies reported here. The 
total protein concentration of a 0.26 nM virus sample is estimated to be ~ 15 jxg/ml, based 
on protein determination assays.
3.2.2 Bovine Fetuin as Receptor Analogue
The interaction of virus with Neu5Ac acid was initially studied using bovine fetuin as
receptor analogue. This glycoprotein contains Neu5Ac in both the a(2,3)- and a(2,6)-
linkage and was the first foetal protein to be described (Pederson, 1944). It contains six
carbohydrate moieties/molecule, three N-linked to Asn (Spiro, 1962; Spiro, 1964) and
three O-linked to Ser/Thr (Spiro and Bhoyroo, 1974). These account for 80% and 20% of
total carbohydrate, respectively, and their structures have been extensively studied. Three
distinct structures have been identified for the O-linked oligosaccharides, which are shown
in Figure 18a (Spiro and Bhoyroo, 1974; Edge and Spiro, 1987). In contrast, many
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Figure 17 Quantitation of virus particles (2)
a) BSA standard curve derived from SDS-PAGE gel shown in Figure 16. The net intensity 
of the BSA standards stained by Coomassie Blue was determined on a Kodak Image 
station 440 CF and plotted against BSA concentration, b) Quantitation of NP 
concentration. The BSA standard curve was used to calculate the NP concentration of the 
virus sample run on the same SDS-PAGE gel as the BSA standards. The determined 
concentration was then used for the quantitation of virus particles as described in 2.2.15 
Quantitation o f Virus Particles for SPR Experiments, p. 88.
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Figure 18 Structures of the major oligosaccharides of bovine fetuin
a) Composition of the three oligosaccharides linked to Ser or Thr (O-linked), which make 
up 20% of total carbohydrate of fetuin b) Composition of the three major oligosaccharides 
linked to Asn (N-linked), which make up 80% of total carbohydrate of fetuin.
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different structures have been identified for the N-linked carbohydrates, displaying 
heterogeneity in the number of peripheral branches, the extent of sialylation and the 
location and linkage of Neu5Ac (Green et al., 1988; Bendiak et al., 1989; Cumming et al., 
1989). The major N-linked carbohydrate structures as determined by high-pH anion- 
exchange chromatography are shown in Figure 18b (Townsend et al., 1989). The molar 
ratio of a(2,6) to a(2,3) has been shown to be 31:19 for N-linked and 7:32 for O-linked 
oligosaccharides in fetuin (Edge and Spiro, 1987; Cointe et al., 1998). Taking into account 
the predominance of N-linked (80%) over O-linked (20%) oligosaccharides, fetuin appears 
to contain more a(2,6)- than a(2,3)-linked Neu5Ac. However, since the relative 
proportions of the major N-linked oligosaccharides vary significantly in bovine fetuin from 
different sources (Townsend et al., 1989), it is difficult to calculate the exact ratio of the 
two linkages.
3.2.3 Immobilisation of Fetuin onto Streptavidin-Coated (SA) Sensor Surface
Different methods are available for covalent immobilisation or capturing of proteins on the
sensor surface. Of these, coupling to streptavidin (SA)-coated sensor chips by biotin was
chosen. Therefore, fetuin and asialofetuin were biotinylated to a molar biotin to protein
ratio of 1 to 1.5 as described in 2.2.9 Biotinylation o f Fetuin and Asialofetuin, p. 85. The
biotin supplied by the kit contained a 6-carbon linker, allowing for improvement of
interaction between streptavidin and biotinylated macromolecules (Green et al., 1971).
Biotinylated fetuin was then injected over the sensor surface of the SA chip as described in
2.2.17 Surface Plasmon Resonance Binding Experiments, p. 90, producing a stable signal
of ~ 1,000 RUs, serving as the baseline for binding experiments (see Figure 19a). This
signal of ~ 1,000 RUs corresponds to a fetuin density on the sensor surface of ~ 1 ng/mm
(Stenberg et al., 1991). Asialofetuin was immobilised on a different flow channel. Then
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Figure 19 Interaction of X31 virus with fetuin and asialofetuin measured by SPR
a) Overlay of sensorgrams for binding of fetuin (red) and asialofetuin (blue) to the sensor 
surface of different flow channels. Upon sample injection, non-specifically bound protein 
was removed from the sensor surface by consecutive injections of regeneration solution, b) 
Association and dissociation curves for the interaction of X31 virus with fetuin (red) and 
asialofetuin (blue). Virus was injected at a concentration of 0.26 nM over the sensor 
surface for 25 min, followed by buffer flow for 45 min. The baseline was regenerated by 
injection of regeneration solution. No binding to asialofetuin was detected.
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X31 virus was injected over the sensor surfaces containing either fetuin or asialofetuin. 
This laboratory-derived reassortant virus contains the HA and NA of the first H3 subtype 
virus isolated in 1968 (A/Aichi/2/68) and the remainder of the gene segments of an HI 
subtype (Kilboume, 1969). As can be seen in Figure 19b, the virus-fetuin interaction is 
 solely mediated by Neu5Ac, since no binding to asialofetuin could be detected.
3.2.4 Virus-Fetum Interaction Studies by SPR
The interaction of virus particles with immobilised fetuin was studied using X31 virus and
its single-site mutant Gly225Asp. The HA of this virus has previously been shown to bind
approximately 2-fold more weakly to RBC compared to X31 in a receptor-binding assay
using HA-expressing cells (Martin et al., 1998). The Gly225Asp virus was therefore used
to test the sensitivity of the SPR assay. The viruses were grown in eggs, purified (see
2.23.2 Virus Growth in Eggs, p. 80) and quantitated as described above. In order to prevent
removal of Neu5Ac from immobilised fetuin, the virus sample and running buffer were
supplemented with the NA inhibitor oseltamivir carboxylate, the active metabolite of
oseltamivir (kindly provided by Roche). This inhibitor has been shown to be active across
all nine influenza A NA subtypes, including the highly pathogenic H5N1 and H9N2
influenza viruses isolated from humans (Gubareva et al., 2000; Leneva et al., 2000). The
final concentration of 10 pM is in large excess over an estimated requirement of 25 nM
necessary for complete inhibition of the NA activity of X31 virus particles in the binding
studies. This was determined by NAI studies as described in 2.2.8 Neuraminidase Activity
Inhibition (NAI) Test, p.85, with the virus control displaying NA activity of 1,280 units. In
order to obtain reliable kinetic data, the viruses were injected over the sensor surface at
different concentrations for 25 min. The highest concentration of virus particles used for
SPR experiments was 0.26 nM, which corresponds to ~ 4 x 1010 virus particles in a volume
103
Chapter 3 Development o f SPR Receptor-Binding Assay
of 250 pi injected over the sensor surface. After every binding experiment, virus was 
removed from fetuin by consecutive injections of regeneration solution, resulting in 
restoration of the baseline. An overlay of the sensorgrams for X31 and Gly225Asp virus
as described below. Derivations of these equations are described in more detail in 
Appendix 2, p.255.
3.2.5 Calculation of Association Kinetics
In the simplest case, the signal in a sensorgram, at any given time during complex 
formation R(t), is described by the equation:
Rmax = the maximal response that would be obtained if all available binding sites were 
occupied, [V] = virus concentration, ka= association rate constant, kd = dissociation rate 
constant and kobs = observed rate constant. A is the amplitude of the reaction curve and is 
also referred to as Req. This equation corresponds to a single exponential decay in which 
kobs is equal to:
binding experiments is shown in Figure 20a and b. The kinetic constants were calculated
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Figure 20 Calculation of association rate constants (ka) for the interaction of X31 and 
Gly225Asp with fetuin X31 (a) and Gly225Asp (b) were injected over the sensor surface 
at four different concentrations for 25 min. The observed rate constant (k0bS) was 
determined for each of the association curves as described in 3.2.5 Calculation of 
Association Kinetics, p. 104. A plot of k0bS against virus concentration gives a straight line 
with slope ka (c).
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kobs was calculated for sensorgrams generated at different vims concentrations by non­
linear least squares regression analysis, and a plot of kobs against the vims concentration 
gives a straight line with slope ka. As seen in Figure 20c, Gly225Asp vims binds to fetuin 
about 2-fold faster than X31 vims. In theory, the intercept on the ordinate gives the value 
for kd. Tn practice, however, measurements of the dissociation rate constant by this method 
are not reliable, since kd is usually small in relation to ka[V], and slight errors of the slope 
have large effects on the measured intercept. The dissociation rate was therefore 
determined in separate experiments.
3.2.6 Calculation of Dissociation Kinetics
Dissociation of vims from fetuin is observed upon replacement of sample injection by 
buffer. Assuming negligible re-association of released vims (due to effective removal from 
the flow cell by the buffer flow), the decrease of signal can be described by the equation:
R(t) = R0e-kd(‘-‘o) (2)
with Ro = the response at an arbitrary starting time to and kd = dissociation rate constant, kd 
is then calculated by non-linear least squares regression analysis.
Dissociation of vims from fetuin was observed for 45 min. The dissociation rate 
constant could be determined in a single experiment because it is concentration- 
independent. As shown in Figure 21, dissociation was very slow for both viruses but was 
significantly faster for the Gly225Asp vims. The affinity was then expressed as Kd = kd/ka. 
The rate constants and affinities are summarised in Table 1.
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Figure 21 Calculation of dissociation rate constants (kd) for the interaction of X31 
and Gly225Asp with fetuin After vims injection at a concentration of 0.14 nM for 25 
min, dissociation of vims from fetuin was observed for 45 min. The kd was calculated from 
the single-exponential decay equation as described in 3.2.6 Calculation of Dissociation 
Kinetics, p. 106. The dissociation curves were normalised by setting the total reaction 
amplitude to 1. The total reaction amplitude is the signal at the point where buffer flow 
starts minus the baseline signal immediately prior to vims injection.
Virus ka (M-V1) k„ (s'1) Kd (M)
X31 2.3+/- 0.15 xlO7 5.4 +/- 2.5 x 10'6 2.4+/-1.1 x 1013
Gly225Asp 3.8+/-0.2 x 107 2.9 +/- 0.5 x 10'5 7.6+ /-1.4 x 10'13
Table 1 Summary of the kinetic rate constants and affinities for the interaction of 
X31 and Gly225Asp with fetuin The ka and kd were calculated from the association and 
dissociation curves shown in Figures 20 and 21 and the affinity expressed as Kd = kd/ ka. 
The higher KD value of Gly225Asp compared to X31 means that the virus’ affinity for 
fetuin is lower than that of X31.
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3.2.7 Reproducibility of Results
In order to establish the accuracy of the results and the stability of fetuin on the sensor 
chip, the association experiment was repeated with a different X31 virus batch. As can be 
seen in Figure 22, the calculated association rates are practically identical and deviations 
between the two experiments are negligible.
3.2.8 Deviations from Monophasic Association and Dissociation Kinetics
Simple homogeneous interaction kinetics are described by single exponential functions 
(see equations 1 and 2). However, non-linear regression analysis of the virus-fetuin 
interaction revealed that the association and dissociation curves were not in fact 
monophasic, particularly at the higher virus concentrations used (see Figure 23). The 
curves were therefore analysed using two-exponential functions,
R(t) -  A / l  -  e~koM‘)  +  A2(  1 -  e~k°bsl‘).
However, the majority of the total amplitude (=  A\ +  A2) was associated with just one 
of the observed rates, which was used to calculate the kinetic rate constants. In the case of 
the association kinetics the kobs for this major component varied linearly with virus 
concentration, confirming the validity of this approach.
3.2.9 Mass Transport Limitations
Before interaction with immobilised ligand can occur, the analyte in the flow cell needs to 
be transported from bulk solution to the surface of the sensor chip. This is described by the 
rate of mass transport (km), and the equation of complex formation is therefore written as:
ka = 2.27 x 10 M s'
£1
ka = 2.38 x 10 M s
0.30.15 
[Virus] nM
0.2 0.250.05
Figure 22 Reproducibility of SPR results
The association rate constant (ka) was calculated for the virus-fetuin interaction using two 
different batches of X31 virus, kobs was determined from association curves with four 
different concentration of virus as described in 3.2.5 Calculation of Association Kinetics, 
p. 104. Plots of kobs against virus concentrations are shown in black and in red for the two 
different batches of virus, with the slope of this curve = ka.
109
3.2E+04
3.0E+04 -
^  2.8E+04 -I 
Z>
75  2.6E+04 ^
c  
D )
in
2.4E+04 H
2.2E+04
2.0E+04
0 500 1000
Time (s)
1500
Figure 23 Fit of experimental association curve to a single- and a two-exponential 
curve A typical sensorgram for the interaction of virus with fetuin (black) was analysed 
using one- (blue curve) and two- (red curve) exponential functions. The residuals 
(multiplied by 3 and offset from zero) are indicated at the bottom and show that the single 
experimental curve is inadequate. The interaction is shown for X31 virus.
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with analyte A, ligand B and km = rate for mass transport to and from the surface (the rate 
is the same in both directions). Mass transport is affected by flow cell dimensions and flow 
rate and also depends on the diffusion properties of the analyte.
The equations described above assume that the observed rate of binding reflects the 
interaction kinetics between analyte and ligand. This is the case if the rate of mass 
transport is much faster than ka and kd. If, however, this rate is considerably slower than 
the kinetic rates, the reaction is limited by mass transport, introducing artefacts 
predominantly at the beginning of association and the end of dissociation curves. An 
increase in flow rate and reduction of surface binding capacity (low concentration of 
immobilised ligand) reduce these limitations. In order to assess whether the heterogeneous 
kinetics are a result of mass transport limitations, the initial association rate constant was 
measured at different flow rates. A substantial increase (> 15%) of this rate serves as an 
indication for this effect. However, as seen in Figure 24, the virus-fetuin interaction is not 
markedly limited by mass transport.
3.2.10 BHA-Rosettes-Fetuin Interaction Studies by SPR
In order to investigate the effect of number of HA molecules per particle and particle size 
on the interaction kinetics, SPR experiments were also performed with BHA-rosettes 
prepared from X31 virus. Rosettes have been shown to contain an average of 6-10 BHA 
trimers and display multivalent binding characteristics based on their ability to agglutinate 
RBC (Skeheletal., 1982).
Rosettes were prepared by low pH-treatment of BHA (see 2.2.6 Preparation o f
low-pH-induced BHA Rosettes, p. 84) and injected over the fetuin-coated sensor surface at
different concentrations for 7 min. Dissociation of rosettes from fetuin was measured for
10 min (see Figure 25). However, inspection of the curves shows that the association and
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Figure 24 Mass transport test
An increased initial rate (RUs per second) for the complex formation as a result of faster 
flow rates indicates that the kinetics of the interaction is limited by mass transport. The 
initial rate was determined for the association curve of X31 virus injected over fetuin at 
different flow rates. Virus at 0.26 nM was injected over the sensor surface for 1 min. No 
substantial increase in the initial rate was observed.
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Figure 25 Association and dissociation curves for the interaction of BHA-rosettes 
with fetuin Rosettes were injected over the sensor surface at five different concentrations 
for 7 min generating association curves. Upon replacement of sample with buffer, 
dissociation was observed for 10 min. The association and dissociation phases both contain 
at least three major kinetic processes.
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dissociation phases consist of at least three exponential components, and each of these 
components makes a substantial contribution to the total reaction amplitude. This makes 
kinetic analysis to obtain binding constants impossible, since it is not known which 
association rate constant to associate with which dissociation rate constant. Inspection of 
the curves obtained for a range of rosette concentrations suggests that the affinity is 
approximately micromolar, so five or six orders of magnitude weaker than for virus. In 
regard to these limitations, all subsequent receptor-binding studies were performed with 
virus as substrate.
3.2.11 Linkage Specificity Studies of Influenza Virus by SPR
Due to the presence of both a(2,3)- and a(2,6)-linked Neu5Ac in fetuin, the affinity data 
described above does not discriminate between these two components. In order to study 
the linkage preference (specificity) of influenza virus, rate constants and affinities were 
determined for derivatised fetuin containing Neu5Ac either in the a(2,3)- or the a(2,6)- 
linkage (referred to as a(2,3)-fetuin and a(2,6)-fetuin).
3.2.11.1 Preparation of Derivatised Fetuin
a(2,3)- and a(2,6)-fetuin were prepared by incubation of asialofetuin with CMP-Neu5Ac
and linkage-specific sialyltransferases as described in 2.2.16 Preparation o f a(2,3)- and
a(2,6)-Fetuin as Substrates for Binding Experiments, p. 89. These enzymes covalently bind
sialic acid either to Galp(l,4)GlcNAc in the a(2,6)-linkage or to Galp(l,4/3)GlcNAc in the
a(2,3)-linkage and are specific for N-linked oligosaccharides (Williams et al., 1995). In
order to incorporate the same amount of Neu5Ac in either linkage, conditions for
saturation of asialofetuin at a specific enzyme concentration were established. Quantitation
of transferred Neu5Ac was performed by including a trace amount of 14C-labelled CMP-
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Neu5Ac in the reaction mixture. The results of these experiments are shown in Figure 26. 
Sialylation of fetuin appears to be complete after incubation for 4 hours, as determined in a 
timecourse experiment (Figure 26a). Then the experiment was performed using varying 
Neu5Ac concentrations. As can be seen, incubation with 765 nmoles of Neu5Ac leads to 
saturation of asialofetuin for sialylation in both linkages (Figure 26b). However, 
incorporation of a(2,6)-linked Neu5Ac was determined to be lower than for a(2,3)-linked 
Neu5Ac. Therefore, the amount of Neu5Ac was reduced to 153 nmoles for sialylation in 
the a(2,3)-linkage for preparation of derivatised fetuins for use in SPR assays. Under these 
conditions, a very similar amount of incorporated Neu5Ac was observed for incubation 
with both a(2,3)-and a(2,6)-specific transferases (73 and 71 nmoles, respectively).
3.2.11.2 Affinity of Influenza Virus for a(2,3)- and a(2,6)- Fetuin
Derivatised fetuin containing Neu5Ac in the a(2,3)- or a(2,6)-linkage was immobilised on
the sensor surface as described in 2.2.17 Surface Plasmon Resonance Binding
Experiments, p. 90. This led to saturation of the sensor surface, producing a stable signal of
~ 2,000 RUs, which corresponds to a density of fetuin on the sensor surface of ~ 2 ng/mm
(Stenberg et al., 1991). Then the interaction of X31 and Gly225Asp virus with the
derivatised fetuins was monitored as described above (see Figure 27 for the sensorgrams).
As a control, the single-site mutant Leu226Gln was included in the analysis. As described
in 1.7.4.2 Correlation between Receptor-Linkage Specificity and Host o f Origin, p .39,
residue 226 has been shown to be the major determinant in linkage specificity for the H3
subtype. Figure 28 shows the calculated association rate constant data and Figure 29 the
dissociation curves and rate constants. The kinetic data and the affinities of these viruses
for a(2,3)- and a(2,6)-fetuin are summarised in Table 2. The specificity index (SI = Kd
(a2,3)/Kd (a2,6)) was introduced in order to express the linkage preference (specificity) of
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Figure 26 Preparation of fetuin with Neu5Ac either in the a(2,3)- or the a(2,6)-linkage
Neu5Ac was transferred to terminal Gal of asialofetuin by use of linkage-specific 
sialyltransferases as described in 2.2.16 Preparation of a(2,3)~ and a(2,6)-Fetuin as 
Substrates for Binding Experiments, p. 89. Incorporation of Neu5Ac was quantitated by 
adding trace amounts of 1 C-labelled Neu5Ac and measuring radioactivity of resialylated 
fetuins. Curves in blue show sialylation with a(2,3)-sialyltransferase and curves in red 
sialylation with a(2,6)-sialyltransferase a) Timecourse for incubation of asialofetuin with 
400 nMoles of Neu5Ac to determine the endpoint of the sialylation reaction, b) Saturation 
of asialofetuin with Neu5Ac in the different linkages. Asialofetuin was incubated with 
different amounts of Neu5Ac for 4 hours and the experiments were performed in 
duplicates, c) Results of sialylation experiment of Figure b), showing that more Neu5Ac is 
incorporated in the a(2,3)- than the a(2,6)-linkage.
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Figure 27 Overlay of association and dissociation curves for the interaction of X31 
(a), Gly225Asp (b) and Leu226Gln (c) with resialylated fetuins Viruses were injected 
over the sensor surface containing a(2,6)-fetuin (red) and a(2,3)-fetuin (blue) for 25 min 
and dissociation was observed for 45 min. The arrow in b) shows a drop of the signal due 
to buffer refill of the BIAcore pump.
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Figure 28 Calculation of association rate constants (ka) for the interaction of X31 (a), 
Gly225Asp (b) and Leu226Gln (c) with a(2,6)-fetuin and a(2,3)-fetuin The viruses 
were injected over the sensor surface containing a(2,6)-fetuin (red) and a ( 2 ,3 ) - f e t u in  (blue) 
for 25 min at four different concentrations. The observed rate constant (k0bS) was 
determined for each of the association curves as described in 3.2.5 Calculation of 
Association Kinetics, p. 104. A plot of k0bS against virus concentration generates a straight 
line with slope ka.
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Dissociation Curves for X31, Gly225Asp and Leu226Gln viruses from
(2,3)- and (2,6)-fetuin
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X31 9.0 +/- 3.0 x 10'6 1.1 +/- 0.4 x 10-6
Gly225Asp 2.5 +/- 0.7 x 10‘4 2.0 +/-0.6 x 10'5
Leu226Gln 2.1 +/- 0.6 x 10-6 1.6 +/- 0.4 x 10 s
Figure 29 Calculation of dissociation rate constants (kd) for the interaction of X31, 
Gly225Asp and Leu226Gln with a(2,6)- and a(2,3)-fetuin a) After virus injection for 25 
min, dissociation of virus from a(2,6)- and a(2,3)-fetuin was observed for 45 min for one 
virus concentration (see Figure 27). The dissociation curves were normalised by setting the 
total reaction amplitude to 1 (see Figure 21 legend) b) The kd was calculated from a single­
exponential decay equation as described in 3.2.6 Calculation of Dissociation Kinetics,
p. 106.
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the virus in quantitative terms. As can be seen in Table 2, the tested viruses differed 
greatly in their specificity. Whereas X31 virus displays an 8-fold higher affinity for 
Neu5Ac in the a(2,6)-linkage compared to a(2,3), the Leu226Gln mutant binds Neu5Ac in 
this linkage about 10-fold more weakly than a(2,3)-linked Neu5Ac. The change in 
specificity results from a ~ 15-fold decrease in affinity for a(2,6)-fetuin and a ~ 6-fold 
increase in affinity for a(2,3)-fetuin compared to X31. This shift in specificity is in 
agreement with the reported preference of these viruses to agglutinate derivatised RBC 
(Rogers et al., 1983a). On the other hand, the mutation Gly225Asp appears to lead to a ~ 
200-fold reduction of affinity for the a(2,3)-linkage and to a ~ 10-fold decreased binding 
strength for the a(2,6)-linkage compared to X31, resulting in a highly a(2,6)-specific virus.
3.2.12 Importance of Quality of Virus Sample Preparation for SPR Experiments
Only pure virus samples consisting of intact virus particles were used in SPR studies. 
Therefore, every virus was inspected by electron microscopy prior to use. The effect of 
broken virus particles in a virus sample on affinity measurements was studied by collecting 
association rate constant data for a(2,6)-fetuin with a batch of intact virus and a batch 
containing ~ 50% broken particles. Figure 30a shows the electron microscopy pictures and 
Figure 30b the association kinetics. The apparent ka for the broken particle batch is about 
2-fold lower than for the intact particle batch. The reason for this difference is that as a 
result of the disruption, the measured NP concentration does not directly correlate with the 
number of virus particles. The kd would not be affected by disrupted particles, since it is by 
definition concentration independent. The use of an intact virus batch therefore reduces 
errors in the calculation of virus concentration and hence in determination of the 
association rate constant.
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Figure 30 Effect of quality of virus particles on calculation of association rate 
constants a) Negative-stain electron microscopy pictures of two different batches of 
Wyoming/3/03. Left = intact virus particles, right = intact and disrupted particles. 
Disruption occurred during the purification procedure due to instability of the virus 
particles b) Calculation of association rate constants (ka) for the interaction of intact and 
broken virus particles with a(2,6)-fetuin. The viruses were injected over the sensor surface 
containing a(2,6)-fetuin for 25 min at four different concentrations. The observed rate 
constant (kobs) was determined for each of the association curves as described in 3.2.5 
Calculation o f Association Kinetics, p. 104. A plot of kobs against virus concentration 
generates a straight line with slope ka.
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3.3 Discussion
3.3.1 Affinity of Influenza Virus for Fetuin
A novel receptor-binding assay for influenza virus and bovine fetuin using SPR has been 
established. The interaction with the receptor analogue is specific for Neu5Ac, since no 
binding to asialofetuin was detected. The generated association and dissociation curves 
allowed for quantitative analysis of kinetic rates from which the Kd could be calculated. 
The experiments were shown to be highly reproducible with different batches of the same 
virus, with only minor differences in the association rate constant obtained from 
independent experiments. This finding reflects the high resistance of fetuin on the sensor 
chip with regard to regeneration buffers, efficient activity of the NA inhibitor, insignificant 
errors in the determination of the virus concentration and fidelity of the BIAcore machine 
performance. A general disadvantage compared to other receptor-binding assays is the 
duration of the experiments, since the dataset for every virus is collected separately. 
Association curves are required to be generated at 4 different virus concentrations in order 
to calculate an accurate ka and a separate experiment has to be performed to determine the 
kd.
The affinity for the receptor analogue was determined to be very high for a 
receptor-ligand interaction, with a Kd of ~ 10"13 M (see Table 1). The observation that the 
virus concentration required to produce ~ 50% saturation of the chip is in this
g
concentration range is consistent with a K d  of this magnitude. High affinities ( K d  = 10" -
10'12 M) have been shown to be a typical feature for the binding of complete virions to cell
surfaces (Herrmann et al., 1995). This tight binding is in contrast to the weak interaction of
BHA trimers or virus with monovalent receptor analogues, with a Kd of ~ 10' M as
determined by NMR. This difference derives from the fact that the interaction of virus with
fetuin in the SPR experiments is multivalent. In the simplest case, the equilibrium
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dissociation constant for a multivalent interaction is equal to the Kd for the monovalent 
interaction raised to the power of n, where n is the valency. The data therefore indicate the 
simultaneous binding of virus to ~ 4 Neu5Ac moieties in the SPR assay.
The affinity of X31 virus for fetuin as determined by SPR ( K d  ~ 10'13 M) is 
significantly higher than the affinity measured in the routinely used solid phase assay (K d  
~ 10'8 M) (Gambaryan and Matrosovich, 1992). This discrepancy might reflect the 
differences in the way these assays are performed. In the solid phase assay the binding 
strength is determined by measuring the bound fetuin concentration at equilibrium 
conditions, whereas in the SPR assay, it is calculated from the kinetic constants. However, 
calculation of the Kd should be the same when determined with either method. 
Unfortunately, it was impossible to derive a Kd from sensorgram amplitudes because 
steady-state was not reached on the time scale of these experiments. The main difference 
between the two assays is the concentration factor in the equations for affinity 
determination, unbound fetuin in the solid phase study versus unbound virus in the SPR. 
The much higher affinity determined in the SPR assay is more likely due to the fact that 
fetuin is immobilised on the sensor surface. As a result, one virus can bind to more than 
one fetuin molecule, therefore increasing the valency of the interaction. The high local 
concentration of receptors reflects the conditions of binding of virus to the membrane of a 
host cell. In contrast, monomeric fetuin is added to immobilised virus in the solid phase 
virus. Furthermore, the solid-phase assay is complicated by the fact that the virus, which is 
probed by HRP-labelled fetuin, is immobilised on fetuin-coated wells. This could 
potentially remove virus from the wells during the experiment and therefore lead to an 
observed reduction in affinity. Additionally, the presence of the HRP-label might interfere 
with potential binding sites on the receptor analogue.
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3.3.2 Kinetic Rates of the Influenza Virus-Fetuin Interaction
In contrast to other reported assays, SPR is the first to gain insight into kinetic rates of the 
influenza-receptor interaction. The complex formation between virus and fetuin is fast,
7  1 1  *with a ka of ~ 10 M' s ' . In contrast, the dissociation rate is extremely slow, resulting m 
the tight binding of virus to fetuin. A kd of ~ 10"6 s'1 indicates that it takes 3 x 106 seconds 
(approximately 35 days) for 95% of the bound virus to dissociate. An accurate calculation 
of the kd, however, requires substantial dissociation from the sensor surface. Since it is not 
feasible to monitor dissociation for that long, the majority of the curve needs to be 
extrapolated. As a consequence, the confidence of the calculated value of kd is not as high 
as for ka. Nevertheless, even in the worst cases (low kd values), the dissociation rate 
constant is unlikely to be wrong by more than a factor of 2-3 and this would not affect the 
major conclusions of this study.
Analysis of the receptor-binding data revealed heterogeneity in the association and
dissociation curves, indicating the occurrence of multiple kinetic processes. Deviations
from homogeneous interaction kinetics can be caused by heterogeneous populations of
analyte or ligand, or by interference with impurities. A commonly encountered problem of
SPR studies is the introduction of heterogeneity by the limited rate of mass transport of
analyte to the sensor surface. However, the studies performed in order to assess this
possibility exclude mass transport limitation as the cause for the observed heterogeneity in
the binding curves. The deviation from monophasic interaction kinetics is more likely to
be a result of overcrowding effects of virus at the sensor surface. This has been shown to
be a common phenomenon for small immobilised ligands and large analytes at high
analyte concentration conditions (Biacore, 2003). These steric crowding effects can be
resolved by reducing the density of fetuin on the chip or the concentration of virus. This,
however, would lead to a decrease in the observed signal, and therefore limit the detection
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range. The component accounting for the majority of the reaction curves was used in the 
analysis. The validity of this approach was confirmed by the finding that this component 
varied linearly with virus concentration.
3.3.3 Sensitivity of the SPR Experiments
In order to address whether relatively small differences in affinity can be detected by SPR, 
the affinity of the single-site mutant Gly225Asp for fetuin was determined and compared 
to X31 virus. In a binding assay of HA-expressing cells the HA of X31 virus has been 
shown to bind to RBC about 2-fold more strongly compared to the Gly225Asp mutant 
(Martin et al., 1998). The obtained SPR data reveal a very similar difference in affinity of 
these viruses for fetuin, with X31 virus displaying a ~ 3-fold higher binding strength 
compared to Gly225Asp virus. The kinetic rate constants reveal that the single-site mutant 
associates slightly faster with fetuin than X31 virus, giving the impression of a higher 
affinity. However, this is compensated for by a ~ 5-fold decrease in the dissociation rate 
constant, resulting in reduced binding strength compared to X31 virus.
3.3.4 The Rosette-Fetuin Interaction
Receptor-binding studies were also performed with BHA-rosettes as ligand, in order to
determine the effect of valency and particle size on kinetic rate constants and affinity.
Previously, a similar assay using SPR has been established to study this interaction, which
determined kinetic rate constants of ka = 2 x 103 M'V1 and kd = 2 x KF4 s'1, resulting in a
Kd of ~ 10'7 M (Takemoto et al., 1996). It was therefore of interest to show how the
calculated data compare with the reported kinetic rate constants. However, due to the much
higher heterogeneity detected in the association and dissociation curves compared to the
virus-fetuin interaction, kinetic analysis of the rosette-fetuin interaction was not possible.
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Nevertheless, the fact that high rosette concentrations were required to obtain sensorgrams 
over the same time ranges as those observed at low virus concentrations does indeed 
suggest that the association rate constant is much lower for rosettes.
Since mass transport limitations could be ruled out as a factor for the heterogeneity 
observed in the virus-fetuin interaction, such limitations are not expected to occur when 
rosettes are used as analyte instead of virus. The reason for this is that transport of analyte 
to the sensor surface is only affected by the amount of ligand immobilised and the flow 
rate, both of which are the same in the two experiments. Overcrowding effects at high 
analyte concentrations are also not likely to occur, due to the smaller size of rosettes 
compared to virus. Instead, the deviation from single-exponential functions might be a 
result of the presence of distinct populations of rosettes with regard to the number of HA 
molecules per particle. This is in agreement with the reported estimate of 6-10 trimers per 
rosette (Skehel et al., 1982). Since separation of these different populations would be 
difficult, due to their similarity in size, rosettes are considered unsuitable for affinity 
measurements by SPR.
3.3.5 Specificity Studies by SPR
An important factor in the evolution of influenza virus in different hosts is thought to be
the ability of the virus to distinguish between sialic acid in the a(2,3)- and a(2,6)-linkages.
It is therefore of interest to compare the affinities of virus for the receptor determinant in
both linkages. The SPR assay described above does not distinguish between the two, due
to the presence of both linkages on fetuin. In order to determine the affinity of influenza
virus for a(2,3)- and a(2,6)-linked Neu5Ac separately, SPR studies were performed with
asialofetuin reconstituted with Neu5Ac in the respective linkages by linkage-specific
transferases. When Neu5Ac was provided in excess for both sialylation reactions, more
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was transferred to oligosaccharides in the a(2,3)- than the a(2,6)-linkage. This might 
reflect the difference in specificities of the enzymes for the linkage between Gal and 
GlcNAc. The a(2,6)-transferase recognises only the p(l,4)-linkage between the two,
whereas the a(2,3)-transferase recognises both the (3(1,4)- and the p(l,3)-linkage (Williams
1
et al., 1995). Since some N-linked fetuin oligosaccharides have been shown to contain the 
p(l,3)-linkage, the Gal of these would only be sialylated with Neu5Ac in the a(2,3)- and 
not the a(2,6)-linkage (Takasaki and Kobata, 1986) (see Figure 17b). Therefore, in order to 
obtain the same degree of sialylation for incubation with both transferases, the amount of 
Neu5Ac was reduced for the generation of a(2,3)-fetuin. The same degree of incorporation 
ensures a constant valency for both a(2,3)- and a(2,6)-fetuin, which would be important 
for direct comparison of affinities for these receptor analogues.
The SPR assay has been shown to detect up to a 1,000-fold difference in affinities 
of viruses for the reconstituted fetuins. The ~ 8-fold higher affinity of X31 virus for a(2,6)- 
fetuin over a(2,3)-fetuin is in agreement with the reported linkage preference of this virus 
determined by various assays. There are, however, differences in the degree of detected 
binding of X31 virus to a(2,3)-linked Neu5Ac. Whereas haemagglutination assays using 
de- and resialylated RBC did not detect binding of X31 virus to a(2,3)-linked Neu5Ac 
(e.g. Rogers and Paulson, 1983; Daniels et al., 1987), the ability of this virus to recognise 
this linkage has been shown by haemagglutination assays with paragloboside-reconstituted 
and derivatised glycoprotein-reconstituted RBC (Suzuki et al., 1986; Suzuki et al., 1987), 
virus-induced haemolysis of paragloboside-coated RBC (Nobusawa et al., 1991), TLC 
with paraglobosides (Ryan-Poirier et al., 1998; Masuda et al., 1999), solid-phase assays 
(Gambaryan and Matrosovich, 1992; Matrosovich et al., 2000) and NMR experiments 
(Sauter et al., 1989; Hanson et al., 1992). In addition, the structure of X31 HA bound to a
receptor analogue containing a(2,3)-linked NeuAc has been solved, providing a structural
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basis for the recognition of this linkage (Eisen et al., 1997). The solid phase assays also 
confirm the enhancement of affinity by multivalency. Compared to the mM affinity of 
virus for monovalent oligosaccharides, confirming the NMR results, a 1,000-fold increased 
binding strength was observed upon anchoring multiple copies of the same receptor 
analogues to a polymeric carrier (Gambaryan and Matrosovich, 1992; Matrosovich et al., 
1997). Whereas all the studies reported an a(2,6)-linkage preference for X31, the 
difference in relative affinity between a(2,3)- and a(2,6)-linked sialic acid differed from 
1.5- to 5-fold as determined in assays calculating a Kd. This contrasts with the ~ 8-fold 
difference observed in the SPR study reported here.
In contrast to X31 virus, the Leu226Gln virus has been shown to switch to
preferential a(2,3)-linkage recognition. Again, this finding confirms the linkage preference
observed in haemagglutination assays using de- and resialylated RBC (Rogers et al.,
1983a; Daniels et al., 1987), solid phase assays (Matrosovich et al., 1993; Matrosovich et
al., 1997) and NMR experiments (Sauter et al., 1989). There is, however, an essential
difference in how the reported preference for the a(2,3)-linkage is achieved. Whereas
Daniels et al. (1987) report the a(2,3)-linkage specificity to be a result of an increase of
binding capacity for this linkage, the SPR experiments suggest that the 10-fold higher
affinity of Leu226Gln for the a(2,3)-linkage is caused by both an increase in affinity for
the a(2,3)-linkage (6-fold) and a decrease in affinity for the a(2,6)-linkage (15-fold)
compared to X31. The reduced binding strength for a(2,6)-linked Neu5Ac as a result of the
Leu226Gln mutation is supported by the nature of the selection process, inhibition of
growth by a receptor analogue containing sialic acid mainly the a(2,6)-linkage (Rogers et
al., 1983b). As reported above for X31 virus and a(2,3)-linked Neu5Ac, no binding of
Leu226Gln virus to the unfavourable a(2,6)-linkage was detected by haemagglutination
assays, unless the RBC were resialylated to contain a substantially higher amount of
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a(2,6)-linked Neu5Ac (Daniels et al., 1987). Similarly to X31, the quantitative assays 
differed in the relative affinities for the two linkages, ranging from 2-fold to greater than 3- 
fold, which contrasts the 10-fold difference reported here. A summary of the linkage 
preference data for X31 and Leu226Gln virus reported in the literature is given in 
Appendix 3, p.257.
In contrast to the shift of preferential linkage-recognition from a(2,6) to a(2,3) of 
the Leu226Gln mutant, the mutation Gly225Asp appears to result in a substantial decrease 
in affinity for the a(2,3)-linkage (~ 200-fold compared to X31 virus). This leads to a much 
higher a(2,6)-linkage preference compared to X31 virus (as described by the specificity 
index), despite the concomitant decrease in affinity for the a(2,6)- linkage. Although a 
decrease in affinity for both linkages has been observed before for a virus containing the 
Gly225Asp together with a Glyl35Arg mutation (Laeeq et al., 1997), residue 225 has not 
been directly implicated in linkage recognition for the H3 subtype. However, a correlation 
of natural variants containing the same substitution and a(2,3)-linkage preference is 
described in Chapter 4.
General difficulties in affinity data comparison between the described assays are 
the differences of the substrates used with regard to their monosaccharide composition and 
linkage between these, valency and receptor density. Although the overall linkage 
preferences are consistent irrespective of the assay used, the factors described above 
influence both the calculation of absolute and relative affinities. Furthermore, it is 
unknown how well these experiments resemble the in vivo virus-receptor interaction at the 
cell surface. Difficulties in the understanding of this process are the lack of information on 
receptor density, distance from the cell surface, accessibility, valency and the identity of 
utilised receptors.
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4 Changes in Receptor-Binding Properties of H3 and HI 
Subtype Viruses in Relation to Antigenic Drift
4.1 Introduction
4.1.1 Identification of Antigenic Drift Variants
HA is subject to antigenic drift through human immune surveillance, leading to the 
emergence of antigenic variants with epidemic potential (see 1.7.5 Antigenic Variation, 
p. 52). In order to update the vaccine composition for novel variants the global influenza 
surveillance network routinely monitors the antigenic, genetic and epidemiological 
properties of circulating viruses. Ferrets are naturally susceptible to human influenza 
viruses and provide a suitable animal model for the study of immunity in humans due to 
their similarities in regard of disease symptoms (Smith et al., 1933) and elicited immune 
response. Their post-infection antibodies are subtype-specific (WHO, 1980) and have been 
shown to detect antigenic variation within the same subtype (e.g. Hirst, 1943b; Pereira et 
al., 1964; Both et al., 1983b; Raymond et al., 1986). The most widely used method for 
measuring the interaction of virus with antibody is the HI assay (Hirst, 1942b; WHO, 
2005c). This technique is based on the interference of bound antibody with the interaction 
of the virus with receptors on RBC. The advantage of this competition-based assay in the 
detection of antigenic variants is that only the viruses resistant against potentially 
neutralising antibodies are detected. However, the involvement of receptor-binding 
properties in HI assays also presents difficulties in the analysis of results. The failure of 
certain viruses to react with antibodies as judged by an HI test might not necessarily reflect 
differences in antigenicity but be the result of altered receptor-binding properties (e.g. 
Daniels et al., 1987). A further drawback of the HI test is its reported limitation to the
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detection of only major drift variants (Smith, 2003). Efforts are currently being made to 
improve the sensitivity of reliable measurements by the introduction of mathematical 
methods for the analysis of results (Smith et al., 2004).
Antigenic differences are also readily detected in virus neutralisation tests (Smith et 
al., 1933; WHO, 2005b). However, these experiments are too labour-intense for routine 
use and, as for the HI test, the same problems with receptor-binding properties may be 
encountered. In contrast, immunodiffusion (Schild, 1970; Schild et al., 1972; Hombeck, 
2001), complement fixation (CF) (Lief and Henle, 1959) and ELISA assays are not 
affected by receptor-binding properties of the viruses used. Although these methods do not 
discriminate between neutralising and non-neutralising antibodies, they can assist in the 
analysis of the results obtained in HI tests.
4.1.2 Molecular Mechanism for Antigenic Drift
The ultimate goal of antigenic and genetic studies of HA is to understand the underlying
patterns of HA evolution during replication in humans so as to be able to predict the next
antigenic variant with epidemic potential. Therefore, great efforts are being made to detect
HA residues under positive selection and to predict the fitness of a potential new variant by
mathematical and computational methods (Bush et al., 1999a; Lee and Chen, 2004; Smith
et al., 2004). However, the molecular mechanism of the appearance of antigenic drift
strains is not completely understood. Therefore, the timing and speed, as well as the nature
of antigenic variation have remained unpredictable. Several mechanisms for the escape
from neutralisation by human polyclonal antibodies have been proposed. Studies with
mice have shown that neutralising antibodies generated as a result of intranasal infection
are directed only against a limited number of antigenic sites (Smith et al., 1991; Patera et
al., 1995). Serological studies have also indicated a similar restricted antibody-repertoire in
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humans (Natali et al., 1981), rabbits and ferrets (Laver et al., 1981; Cleveland et al., 1997). 
Therefore, inhibition of binding by the predominant antibodies by substitutions at 
immunodominant epitopes might be sufficient for evasion of immune recognition. 
However, it has been shown that the specificity of produced antibodies varies between 
individuals (Wang et al., 1986; Nakajima et al., 2000). This suggests that sequential 
epitope changes in HA are necessary for a virus to be able to re-infect members of a 
population so as to evade herd immunity. The observation that drift variants of 
epidemiological importance usually contain > 4 amino acid changes located in > 2 of the 
antigenic sites (Wilson and Cox, 1990) supports this mechanism. Furthermore, changes in 
residues other than those targeted by antibodies might play a role in immune-evasion. 
Namely, since antibodies compete with cells for binding to virus, changes in the 
interaction with cellular receptors have been proposed to present an alternative mechanism 
for antibody-escape. Evidence for this is provided by the selection of receptor-binding 
variants (adsorptive mutants) by monoclonal and polyclonal antibodies (see 1.7.6 
Interrelationship between Antigenic Variation and Receptor-Binding Properties, p. 58). 
Furthermore, viruses with substitutions in the RBS are frequently isolated, many of which 
become fixed in the evolutionary line (e.g. Nobusawa et al., 2000; Medeiros et al., 2001). 
In addition, genetic studies have shown that a number of residues identified to be under 
positive selection in H3 HA are in the RBS (residues 135, 138, 190, 194 and 226) (Bush et 
al., 1999b), and are therefore likely to affect receptor-recognition.
The reason for the selection of adsorptive mutants is not clear. It has been
suggested that antigenic changes might be limited by the need to maintain the structure of
HA (Both et al., 1983b). Direct evidence for structural constraints is supported by a study
showing that a limited number of mutations in immunodominant sites provide constraints
for further antigenic change and the respective antibodies select for receptor-binding
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variants instead (Temoltzin-Palacios and Thomas, 1994). Alternatively, it has been 
suggested that sub-neutralising levels of antibodies (Fazekas de St. Groth, 1977; Yewdell 
et al., 1986; Temoltzin-Palacios and Thomas, 1994) or antibodies of reduced affinity 
(Laeeq et al., 1997) play a role in this process.
In summary, the implication of changes in receptor-binding specificity/affinity in 
immune surveillance highlights the importance of monitoring these properties, in addition 
to antigenicity, for circulating viruses. The following study compares the receptor-binding 
properties of a panel of viruses of the HI and H3 subtypes in relation to antigenic drift. 
These should lead to a further understanding of the interrelationship between these two 
properties and complement the available surveillance data.
4.1.3 Host Cell-Mediated Variation
Characterisation of antigenic and receptor-binding properties of circulating viruses
involves the propagation of the original clinical specimen in laboratory host cell systems.
However, initial adaptation to certain host cells, most importantly to growth in the
allantoic cavity of eggs (egg-adaptation), has been shown to select for variants with
distinct receptor-binding and/or antigenic properties. This phenomenon is known as host
cell-mediated variation and was first noted by Bumet and Bull (Burnet and Bull, 1943),
who showed that viruses repeatedly cultivated in eggs differed from the original isolate in
their agglutination capacities of chicken RBC. Further evidence for egg-mediated variation
was provided by studies with influenza B virus showing that viruses with altered antigenic
properties can be selected upon propagation in eggs compared with the same isolate grown
in MDCK cells (Schild et al., 1983). Sequence analysis revealed that the antigenic change
was associated with the loss of a specific glycosylation site at the distal tip of HA
(Robertson et al., 1985). In contrast to eggs, mammalian tissue culture cell lines, such as
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the routinely used MDCK and Vero cells, appear to select for variant viruses far less 
frequently (Katz and Webster, 1992; Govorkova et al., 1996). Sequencing of individual 
PCR-amplified clones has shown that virus derived from MDCK cells is representative of 
virus present in the clinical isolate, whereas egg-adapted virus can contain several different 
variants (Robertson et al., 1990; Robertson et al., 1991). Exceptions to this are baby 
hamster kidney (BHK) cells, which, like eggs, often select for receptor-binding variants 
(Govorkova et al., 1999).
Since propagation of MDCK-isolates in eggs often leads to the selection of variants 
but not the other way around, it was suggested that eggs provide the more restrictive 
system for virus replication. Upon initial egg-adaptation, influenza virus usually grows to 
high titres in the allantoic cavity. It has long been recognised that initial passage in the 
amnion prior to propagation in the allantoic cavity leads to higher efficiency of virus 
isolation (Hoyle, 1968b). However, despite the observed unrestricted growth in this host 
cell system, repeated cultivation in the amnion also leads to the selection of variants 
(Robertson et al., 1993; Ito et al., 1997b). The reason for this has been suggested to be 
exposure of the amniotic virus to the allantois through a hole between the two 
compartments caused by inoculation needles.
Pairwise sequence comparison of MDCK- and egg-grown viruses has identified the
changes at a number of residues implicated in egg-adaptation. Table 3 shows amino acid
substitutions most frequently associated with this process for HI and H3 subtype viruses
(see legend for references). A number of identified changes are located in antigenically
important areas, explaining why host cell-mediated variants often display altered antigenic
properties (Schild et al., 1983; Oxford et al., 1987). However, the majority of the
implicated substitutions were found to cluster around the RBS, which suggested their
selection on the basis of altered receptor-recognition. Indeed, it was noted that egg-adapted
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viruses displayed an increased affinity for cells of chorio-allantoic membranes (CAM), the 
major site of replication in eggs, compared to MDCK cell-grown virus (Gambaryan et al., 
1999). Staining of cells with linkage-specific lectins indicated that, whereas chorio­
allantoic and BHK cells contain predominantly a(2,3)-linked sialic acid (Ito et al., 1997b; 
Govorkova et al., 1999), human tracheal cells express mainly a(2,6)-linked sialic acid 
(Baum and Paulson, 1990; Couceiro et al., 1993). Since increased binding of many egg- 
and BHK-adapted viruses to receptor analogues containing a(2,3)-linked Neu5Ac was 
observed compared to MDCK cell-grown virus, it was suggested that variants are selected 
because the affinity of the non-adapted human viruses for the a(2,3)-linkage is too low 
(Gambaryan et al., 1997; Ito et al., 1997b; Govorkova et al., 1999). In contrast, MDCK and 
amniotic cells contain similar amounts of a(2,3)- and a(2,6)-linked sialic acid (Govorkova 
et al., 1996; Ito et al., 1997b), explaining unrestricted growth of human viruses in these 
cells. However, VERO cells contain predominantly a(2,3)-linked sialic acid but, in 
contrast to eggs and BHK cells, appear not to select for variants (Govorkova et al., 1996). 
This indicates that either the number of a(2,6)-linked sialic acids on VERO cells is 
sufficient for infection or that additional host-cell factors, yet to be identified, might play a 
role in host-cell mediated variation.
Table 3 shows the single-site substitutions of egg-adapted variants for which the 
effect on receptor-binding properties has been directly tested by comparison with MDCK- 
grown counterparts (Gambaryan et al., 1999; Mochalova et al., 2003). Confirming earlier 
observations, many of the substitutions lead to an increased affinity for a(2,3)-linked sialic 
acid. Other substitutions, which introduce a positively charged amino acid in HAi, have 
been suggested to enhance affinity for negatively charged receptors on host cells by non­
specific ionic interactions, based on the interaction with dextran sulphate (Gambaryan et
al., 1999). Furthermore, carbohydrates at the membrane-distal part of HA have been
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shown to generally interfere with the interaction of HA with cellular receptors by steric 
hindrance (Deom et al., 1986; Gunther et al., 1993; Matrosovich et al., 1997; Ohuchi et al., 
1997; Abe et al., 2004). Therefore, substitutions leading to the loss of carbohydrate 
attachment sites also have the ability to increase receptor-affinity. It has been suggested, 
for example, that the loss of a carbohydrate at 163 as a result of egg-adaptation for HI 
viruses would lead to a decrease of steric hindrance with more distant parts of receptors 
containing a(2,3)-linked sialic acid (Gambaryan et al., 1999).
Host cell-mediated selection of variants needs to be taken into consideration when 
receptor-binding and antigenic properties of clinical isolates are studied. Importantly, since 
vaccine candidates are still propagated in eggs, it needs to be ensured that their antigenic 
properties reflect those of the viruses circulating in the human population. Therefore, the 
HA should be sequenced directly from a clinical sample prior to cultivation of the virus in 
the laboratory, so that the predominant virus in the sample can be determined (Robertson 
et al., 1990; Robertson et al., 1991). Furthermore, the parallel propagation in eggs and 
MDCK/VERO cells and the monitoring of sequence changes in HA can assist in the 
detection of host cell-mediated variation. However, it is often difficult to trace back egg- 
adaptation mutations, since many viruses are subjected to cultivation in eggs prior to 
sequencing and because information of the passage history of the viruses used is often 
incomplete.
All the viruses used in the following study were egg-adapted and were further
propagated in eggs due to the general high yield and ease of purification from this host cell
system. Furthermore, viruses isolated from eggs generally display a more homogeneous
spherical morphology (Burnet and Lind, 1957; Choppin et al., 1960) than those propagated
in mammalian tissue culture cells (L. Calder, NIMR, London, personal communication).
Since a virus population of different sized particles is likely to result in heterogeneous
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association and dissociation kinetics (see 3.3.4 The Rosette-Fetuin Interaction, p. 126), a 
homogeneous morphology of the virus sample was considered to be important for SPR 
studies. The sequence data of the original clinical isolates was either not readily available, 
or, in the case of viruses isolated before PCR techniques became available, non-existent. 
The exact passage history of these viruses in eggs is also unknown. Whereas the passage 
number in eggs was estimated to be in the range of 4-8 for viruses isolated since 1980 
(WIC, personal communication), information for the earlier viruses is missing. Therefore, 
although it was not possible to clearly identify egg-adaptation mutations, their presence 
was addressed by comparison of residues that had previously been associated with this 
process (see Table 3). The difficulty with this approach is, that in the course of HA 
evolution, substitutions at different residues can become selected by egg-adaptation. For 
example, it has been shown that cultivation of H3 isolates of 1994 in eggs often led to 
variants at residues 194 and 226, rather than at residues 156 and 186 of H3 isolates of 1988 
(Hardy et al., 1995), which complicates egg-adaptation analysis. Furthermore, a number of 
residues that have been implicated in egg-adaptation for the H3 subtype have also been 
suggested to be under positive selection in the human host, which indicates the possibility 
of selection by escape from immunity as well (Bush et al., 2000). Identification of genuine 
egg-adaptation mutations for the isolates used in this study was therefore not possible.
4.2 Receptor-Binding Properties of H3 Subtype Viruses
4.2.1 Antigenic and Phylogenetic Relationships
Antigenically distinct H3 viruses from 1994-2003 were tested for their receptor-binding
properties using SPR. The H3 subtype viruses emerged in humans in 1968, causing the
Hong Kong pandemic, and have continued to circulate until today. The viruses included in
the study were a selection of vaccine strains of 1994 (Johannesburg/33/94) until 1999
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(Panama/2007/99), and the novel antigenic variants that appeared in 2002 (Fujian-like 
viruses). Following their emergence, these latter viruses have gradually increased in 
prevalence compared to Panama/2007/99-like viruses and since 2004 have replaced this 
virus as the H3 vaccine component. Since the reference virus Fujian/411/02 grew very 
poorly in eggs, this virus was not included in the study. Table 4 shows the antigenic 
characteristics based on HI tests using post-infection ferret sera. Sydney/5/97 and 
Panama/2007/99 are antigenically closely related but different to Johannesburg/33/94. The 
remaining viruses are clearly distinguished from Panama/2007/99 by reactivity with ferret 
sera and are antigenically related (Fujian-like viruses). Although differences can be seen in 
reactivity with ferret sera for the Fujian-like viruses, they could not be clearly separated 
into different antigenic groups. Figure 31 shows the phylogenetic relationship of the 
viruses used in this study including a number of additional viruses isolated from 1992- 
2003. As can be seen, the emergence of the antigenic variants coincided with the 
appearance of phylogenetically distinguishable variants. Although not apparent from 
Figure 31 due to the limited number of isolates, H3 viruses have evolved as a single 
lineage since their introduction into the human population in 1968. Therefore, genetically 
distinct viruses evolve directly from the preceding circulating viruses (Hay et al., 2001). 
However, it has been shown that the rate of HA antigenic evolution does not necessarily 
reflect the rate of genetic evolution. Although the rate at which substitutions occurred 
between 1997-2002 was similar to that before 1997 and led to the emergence of 
phylogenetically distinct lineages, the resulting amino acid changes did not result in 
significant antigenic changes (Hay et al., 2001). This is reflected in only one change in the 
vaccine component for the H3 viruses from 1997-2001. In contrast, the antigenic drift rate 
was high from 1968-1997, accounting for 18 changes in the recommended vaccine 
composition.
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Figure 31 Phylogenetic comparison of H3 HA genes
The sequences of nucleotides 78-1061 encoding the HAi domain were compared using 
Phylogenetic Analysis Using Parsimony, version 4.0 (Swofford and Olsen, 1990). Due to 
the limited number of strains used in this study, three additional viruses were used to 
construct the tree (indicated in blue). The lengths of the horizontal lines are proportional to 
the number of nucleotide differences, as indicated by the bar. Vaccine strains are indicated 
in capital letters.
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4.2.2 Affinity and Specificity Studies by SPR
The affinity of the antigenically distinct viruses for a(2,6)- and a(2,3)-linked sialic acid 
receptor analogues was determined as described in Chapter 3, with the kinetic rate 
constants calculated from 2 independent experiments. The viruses that were used to 
establish the conditions of the SPR experiments (X31 and its single-site mutants 
Leu226Gln and Gly225Asp) were included in the receptor-binding studies as controls, 
with X31 also representing the first human H3 subtype virus isolated at the beginning of 
the 1968 Hong Kong pandemic (Aichi/2/68). Furthermore, Dk/Ukraine/1/63 was included 
to compare the receptor-binding properties of an avian virus to those of human viruses. A 
Dk/Ukraine/l/63-like virus is thought to be the progenitor from which the HA of the 
pandemic virus Aichi/2/68 was derived after reassortment with a human virus (Laver and 
Webster, 1973; Fang et al., 1981; Bean et al., 1992).
Table 5 shows the calculated rate constants and affinities of the H3 viruses for 
a(2,3)- and a(2,6)-fetuin and the specificity index. Since the binding strength of viruses for 
the receptor analogues varied up to ~ 3,000-fold, the affinity is displayed in log-scale in 
Figure 32 for ease of comparison. Most of the human viruses used in this study display a 
higher affinity for a(2,6)-fetuin compared to a(2,3)-fetuin, whereas the avian virus and the 
single-site mutant Leu226Gln preferentially recognise a(2,3)-fetuin. This finding is in 
agreement with the reported specificity of human and avian H3 subtype viruses (see
1.7.4.2 Correlation between Receptor-Linkage Specificity and Host o f  Origin, p.39).
However, two of the viruses, Johannesburg/33/94 and Panama/2007/99, appear not to
distinguish significantly between a(2,3)- and a(2,6)-fetuin, and these viruses are therefore
classified as “duaP’-linkage-specific. Generally, the viruses can be separated into two
groups with regard to recognition of the a(2,3)-linkage. Whereas X31 and the viruses
isolated from 1994-1999 reveal considerable binding strength for a(2,3)-fetuin compared
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Chapter 4 Receptor-Bindins Properties in Relation to Antisenic Drift
to a(2,6)-fetuin (only up to 8-fold affinity difference), all the Fujian-like viruses show a 
big decrease in affinity for the a(2,3)-linkage. For example, Chita/1/03 and 
Christchurch/28/03 bind a(2,3)-fetuin ~ 400-fold and ~ 650-fold more weakly than 
Sydney/5/97, respectively. Notably, the affinity of Wyoming/3/03, Kumamoto/102/02 and 
United Kingdom/1861/03 for the non-preferred receptor analogue is so low that it remains 
undetected by SPR. The weak binding strength for a(2,3)-fetuin also accounts for the big 
affinity difference between the two linkages (~ 200-fold for Chita/1/03, ~ 3,500-fold for 
Christchurch/28/03). The Fujian-like viruses therefore feature a large shift in specificity 
towards the a(2,6)-linkage. However, since the specificity index only describes a relative 
affinity, it would be wrong to conclude that these viruses bind a(2,6)-fetuin more strongly 
than the earlier viruses. Indeed, none of the Fujian-like viruses binds this linkage more 
strongly than the viruses of 1994-1999. Whereas Christchurch/28/03, United 
Kingdom/1861/03 and Chita/1/03 bind a(2,6)-fetuin with similar affinity to the early 
viruses, Kumamoto/102/02 and Wyoming/3/03 display a considerably reduced binding 
strength for this linkage.
Further differences in the recognition of a(2,3)- and a(2,6)-fetuin are revealed 
between the viruses. Whereas the earlier viruses do not differ greatly in affinity for the 
receptor analogues, the Fujian-like viruses show substantial variation in recognition of 
both a(2,3) -and a(2,6)-fetuin. It should be noted that the “dual”-linkage specificity of 
Johannesburg/33/94 is mainly a result of a decreased affinity of this virus for a(2,6)-fetuin 
compared to X31. In contrast, the lack of linkage-discrimination for Panama/2007/99 
appears to be due to an increased affinity for a(2,3)-fetuin compared to X31.
4.2.3 Location of Amino Acid Changes in HA
Since the mutation rate of the viral RNA polymerase is high (Parvin et al., 1986),
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propagation of influenza virus in host cells can lead to amino acid changes. In order to 
compare the HAi sequence for the viruses used in the SPR study, it was therefore 
necessary to sequence this region of the HA gene upon virus isolation from eggs (2.2.1.5 
DNA Sequencing, p. 77) (see Appendix 4 for sequence alignment, p.264). An alignment of 
HAi residues, at which the viruses used in this study differ, is shown in Table 6. The 
amino acids were classified according to their potential to affect receptor-binding 
properties based on their location in the HA structure (based on the X31 HA structure). 
Residues considered to potentially affect the interaction with cellular receptors are 1) 
located within 20 A of the RBS with side-chains pointing towards it, 2) located further 
away from the RBS but in a position to affect interaction with receptor analogues of 
neighbouring HA monomers and 3) residues which are part of a glycosylation sequon (see 
Appendix 5 for carbohydrate attachment sites, p.266). The remaining residues comprise 
amino acids located elsewhere in HA.
Figure 33 shows the location of these residues in the HA structure. As can be seen, 
the majority of the changes cluster around the RBS, supporting that this area is under 
positive selection by immune surveillance (Wiley et al., 1981; Cox and Bender, 1995; 
Fitch et al., 1997; Bush et al., 1999b). Importantly, a number of substitutions have 
occurred at residues that are part of the receptor-binding pocket itself, shaded in black in 
Table 6 and coloured in pink in Figure 33. The majority of the residues might be involved 
in antibody-recognition based on their surface-exposed side chains. Of these, the residues 
underlined have been directly implicated to be part of an epitope, because substitutions at 
these positions have previously been selected with mAb (Wiley et al., 1981; Underwood et 
al., 1987; Smith et al., 1991; Temoltzin-Palacios and Thomas, 1994; Patera et al., 1995).
Residue 226, considered a major determinant for linkage specificity, was shown to
change from Leu —► lie —► Val from 1992-1998 (Lindstrom et al., 1996; Mori et al., 1999).
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a)
Figure 33 Schematic diagram showing residues containing changes in HAi for H3 
viruses used in this study
a) HA monomer showing the location of all the changes. The different colours represent 
the classification of the residues. Circles in pink are residues located in the receptor- 
binding site (residues shaded in black in Table 6a). Circles in blue are residues located 
within 20 A of the receptor-binding site or residues that are in a position to affect 
interaction with receptor analogues bound to neighbouring monomers. Circles in cyan are 
carbohydrate attachment sites. Circles in yellow are residues located elsewhere in HAi.b) 
Close-up of the receptor-binding site and the residues at which changes are observed. 
Bound Neu5 Ac is coloured in green.
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Since these amino acids are non-polar, they all fulfil the criterion for binding to a(2,6)- 
linked Neu5Ac (see Figure 7, p.42). All the viruses used in this study contained either lie 
or Val, indicating that Val226 has not become fixed in HA evolution. The only exception 
to this is Johannesburg/33/94, which contains the avian-typical Gin at this position. As 
described below, this is likely to be the result of growth of this vims in eggs.
4.2.4 Assessment of Egg-Adaptation Mutations
As stated in 4.1.3 Host Cell-Mediated Variation, p. 134, the viruses used in this study
might contain egg-adaptation mutations, which are likely to affect receptor-binding
properties. Comparison of HAi residues that had previously been associated with egg-
adaptation (see Table 3) suggests that the following viruses might contain substitutions
implicated in this process: Chita/1/03 (Vall86, Ile248), Christchurch/28/03 (Aspl26,
Seri38, Aspl86,), Panama/2007/99 (Ilel94), Sydney/5/97 (Ilel94), Johannesburg/33/94
(Gln226), Kumamoto/102/02 (Vall86, Tyr219) and Wyoming/3/03 (Vall86, Tyr219).
These residues are shaded in yellow in Table 6. How these particular potential egg-
adaptation mutations would affect the interaction with a(2,3)- and a(2,6)-fetuin is
uncertain, since for none of these pairwise comparison of receptor-binding properties for
egg-adapted and MDCK-grown viruses has been performed (see Table 3). However, since
residue 226 has been shown to be a major determinant for linkage specificity for the H3
subtype (see 1.7.4.2 Correlation between Receptor-Linkage Specificity and Host o f  Origin,
p. 39), the amino acid at this residue is expected to influence receptor-binding properties.
An increase in affinity for the a(2,3)-linkage with or without concomitant decrease in
binding strength for the a(2,6)-linkage has been reported for egg-adapted variants
containing the Leu226Gln mutation, although they differed at additional residues as well
(Ito et al., 1997b). The “duaf’-specificity of Johannesburg/33/94 is therefore likely to be
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the result of a decreased affinity for the a(2,6)-linkage due to an egg-adaptation 
substitution at residue 226. Notably, many viruses isolated from 1992-1994 were shown to 
contain the avian-typical Gln226, which have also been suggested to be the result of egg- 
adaptation (Lindstrom et al., 1996). Differences at other residues associated with egg- 
adaptation (137, 145, 155, 156, 158, 159 and 186) have also been identified for the viruses 
used in this study. However, since changes at these residues have been shown to be 
characteristic for the emergence of antigenic/genetic variants in the course of HA evolution 
(WIC, London, in-house sequencing), these are less likely to be the result of host cell- 
mediated variation.
4.3 Receptor-Binding Properties of HI Subtype Viruses
4.3.1 Antigenic and Phylogenetic Relationships
The receptor-binding properties of a panel of HI subtype viruses were also investigated by
SPR. These viruses were introduced into the human population in 1918, causing the
Spanish pandemic, circulated until 1957 and were then replaced by the emerging H2
subtype viruses. However, they reappeared in 1977 and since then continue to co-circulate
with H3 subtype viruses. Therefore, viruses isolated from both epidemic periods were
tested by SPR, starting with one of the first human viruses isolated, A/Puerto Rico/8/34. In
addition to the human viruses, a virus of swine origin, Sw/Iowa/15/30, was included in the
study. This was the first H1N1 virus isolated from a mammal, which emerged in pigs
around the same time as in humans (1918). Human and Sw/Iowa/15/30-like viruses have
been shown to share a common avian-like ancestor but have evolved into distinct lineages,
human H1N1 and “classical” swine H1N1 viruses (Gorman et al., 1991). The pig isolate
was included in the study in order to determine to what extent the receptor-binding
properties have diverged upon evolution in the two different hosts. Furthermore, in
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contrast to all the other viruses being of the H1N1 subtype, the study also included an 
H1N2 virus. These viruses appeared in 2001 and arose by reassortment between co- 
circulating H3N2 and H1N1 viruses (WHO, 2002c; WHO, 2002b). It has been shown that 
the H1N2 viruses contain an HA closely related antigenically and genetically to 
contemporary A/New Caledonia/20/99 (HlNl)-like viruses, while the NA and the other 
six gene segments are closely related to A/Moscow/10/99 (H3N2)-like viruses (Gregory et 
al., 2002). Since their introduction the H1N2 viruses have continued to circulate as a 
separate genetic lineage in various parts of the world together with H1N1 and H3N2 
viruses.
The antigenic relationships of the viruses from both epidemic periods used in this
study are shown in Tables 7 and 8. All the viruses isolated from 1934-1957 represent
distinct antigenic variants as indicated by the lack of cross-reactivity with post-infection
ferret sera, except for Finland/9/57 and Denver/1/57, which are closely related. Although
isolated early in the second epidemic period, Brazil/11/78 was included in the HI tests with
viruses from the first period. Soon after the re-emergence of the H1N1 viruses in 1977, it
was noted that these viruses were related antigenically and genetically more closely to
viruses isolated in 1949-50 than to strains which circulated before or after that period
(Kendal et al., 1978; Nakajima et al., 1978). The data presented in Table 7 confirm the
antigenic relatedness between Brazil/11/78 and Fort Warren/1/50. The antigenic properties
of the viruses used in this study of 1977-2003 are shown in Table 8. Except for
Taiwan/1/86 and Bayem/7/95, displaying antigenic similarity, the viruses from 1977-1999
are antigenically distinct. However, the data also shows that all later viruses are New
Caledonia/20/99-like, including the H1N2 virus Egypt/96/02. This is in agreement with the
reported slow antigenic evolution between 1986-1995 and 1999-2003 (Hay et al., 2001).
Compared to the H3 viruses, antigenic evolution has been shown to be slower for HI
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viruses isolated from the second epidemic period. This is reflected by only 10 changes in 
the recommended vaccine composition from 1977-2001 compared to 19 for the H3 viruses 
from 1972-2001 (Hay et al., 2001).
The phylogenetic relationships between the viruses from both epidemic periods are 
shown in Figure 34. The close genetic relationship between Brazil/11/78 and Fort 
Warren/1/50 is in agreement with previous reports (Nakajima et al., 1978). This finding 
also shows that, in contrast to H3 viruses, which evolve as a single lineage, HI antigenic 
variants do not always evolve directly from the preceding circulating strains. Similar 
observations of divergent evolution can also be made for antigenic variants that emerged in 
1995 (represented by Beijing/262/95). The HA genes of antigenically distinct 
Beijing/262/95-like and Bayem/77/95-like viruses had already diverged in early 1990 into 
two distinct phylogenetic lineages. These viruses co-circulated until Bayem/262/95-like 
viruses were replaced in 2001 by New Caledonia/20/99-like viruses (Hay et al., 2001). 
Although the currently circulating viruses are all antigenically similar to New 
Caledonia/20/99, Figure 34 shows that they can be classified into 3 different phylogenetic 
lineages. H1N1 variant group 1 is represented by New Caledonia/20/99, Bucharest/955/03 
and Prague/9/03, whereas Madagascar/57794/00 and Chile/8885/02 are classified into 
H1N1 variant group 2. Finally, Egypt/96/02 is an example of the reassortant group H1N2 
(group 3), with its HA closely related to H1N1 variant group 2.
4.3.2 Affinity and Specificity Studies by SPR
The receptor-binding properties of these human HI viruses and the pig isolate,
Sw/Iowa/15/30, were tested by SPR as described for the H3 subtype viruses.
Dk/Alberta/35/76 was included in the assay as an example of a bird isolate. As for the H3
subtype, all the viruses were propagated in eggs for reasons stated earlier. The rate
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A/Prague/9/03
A/Bucharest/955/03
A/Egypt/96/02 H1N2
H1N1 (1)
L A/NEW CALEDONIA/20/99
A/Chile/8885/02
A/Madagascar/57794/00
H1N1 (2)
A/BEIJING/262/95
  A/BAYERN/7/95
— A/Taiwan/1/86
—  A/CHILE/1/83
— A/BRAZIL/11/78
— A/Fort Warren/1/50
—  A/Finland/9/57
— A/Denver/1/57
—  A/Fort Leonard Wood/1/52 
— A/Fort Monmouth/1/47 
--------------------------------  A/Puerto Rico/8/34
10
nucleotide substitutions per 100 residues
Figure 34 Phylogenetic comparison of HI HA genes
The sequences of nucleotides 74-995 encoding the HAi domain were compared using 
Phylogenetic Analysis Using Parsimony, version 4.0 (Swofford and Olsen, 1990). The 
lengths of the horizontal lines are proportional to the number of nucleotide differences, as 
indicated by the bar. Vaccine strains are indicated in capital letters. The two 
distinguishable phylogenetic lineages of viruses 1999-2003 are indicated in blue and the 
reassortant virus in red.
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constants and affinities for a(2,3)- and a(2,6)-fetuin are shown in Table 9 and the affinities 
displayed in log-scale in Figure 35. Dk/Alberta/35/76 is characterised by a clear a(2,3)- 
linkage specificity, similar to the H3 bird isolate Dk/Ukraine/1/63. However, in contrast to 
the avian H3 virus, the affinity of this virus for the non-preferred a(2,6)-linkage was so 
low that no binding to the respective receptor analogue was detected. The human viruses 
and the pig isolate can be grouped into 3 different classes with regard to their linkage 
specificity. Class 1 is characterised by the preferential recognition of a(2,3)-fetuin, 
represented mostly by strains from the first epidemic period (Puerto Rico/8/34, Fort 
Leonard Wood/52, Denver/1/57 and Finland/9/57). In contrast, only two of the post-1977 
viruses are classified as a(2,3)-linkage specific (Taiwan/1/86 and Bayem/7/95). Class 2 
viruses appear not to distinguish significantly between a(2,3)- and a(2,6)-fetuin and are 
therefore classified as “dual”-linkage specific. This class is represented by Fort 
Monmouth/1/47, Fort Warren/1/50, Brazil/11/78, Chile/1/83, Beijing/262/95 and the pig 
isolate Sw/Iowa/15/30. A third class of viruses preferentially recognise a(2,6)-fetuin. 
Whereas none of the viruses from the first epidemic era appears to be clearly a(2,6)- 
specific, all the viruses isolated since 1999 including the H1N2 virus Egypt/96/02 are 
classified into this group.
4.3.3 Location of Amino Acid Changes in HA
As described for the H3 viruses, the HI viruses were sequenced in order to reveal the
changes in HAi amino acid sequence (see Appendix 6 for alignments, p.267).
Classification of these according to their potential to affect receptor-binding properties was
based on the structure of Sw/Iowa/15/30 HA and is shown in Table 10. The same criterion
was used as for the H3 viruses, with residues likely to affect interaction with cellular
receptors being 1) located within 20 A of the RBS with side-chains pointing towards it, 2)
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located further away from the RBS but in a position to affect interaction with receptors of 
neighbouring HA monomers and 3) being part of glycosylation sequon (see Appendix 7 
for carbohydrate attachment sites, p.269). Figure 36 shows the location of these residues in 
the structure of HA. As observed for the H3 viruses, the majority of these residues have 
the potential to be involved in antibody-recognition, because of their surface-exposed side- 
chains. Of these, the residues underlined in Table 10a have been directly implicated to be 
part of an epitope, because substitutions at these positions have previously been selected 
with mAh (Caton et al., 1982; Nakajima et al., 1983; Yates et al., 1990). A number of 
substitutions also involve amino acids in the RBS, shaded in black in Table 10a and pink 
in Figure 36. Of these, residues 138, 186, 190, 194 and 225 have been suggested to be 
involved in defining receptor specificity for the HI subtype (Rogers and D'Souza, 1989; 
Matrosovich et al., 1997; Gambaryan et al., 1999; Mochalova et al., 2003).
4.3.4 Assessment of Egg-Adaptation Mutations
Evaluation of HAi amino acid sequence with regard to egg-adaptation mutations reveals
that many HI isolates of 1934-1999 contain amino acids previously associated with
cultivation in eggs (see Table 3): Puerto Rico/8/34 (Alal38, Lysl63, Lysl89,), Fort
Monmouth/1/47 (Lysl29, Alal38, Lysl63, Gly225), Fort Warren/1/50 (Lysl29, Alal38,
Gly225), Fort Leonard Wood/1/52 (Lysl29, Alal38, Alal63), Denver/1/57 and
Finland/9/57 (Alal38), Brazil/11/78 (Lysl29, Gly225), Chile/1/83 (Lysl29, Alal38,
Asn225), Taiwan/1/86 (Alal38, Gly225), Bayem/7/95 (Alal38, Gly225), Beijing/262/95
(Gly225). These residues are shaded in yellow in Table 10. Changes at other residues that
had previously been associated with propagation in eggs have been shown to be
characteristic for the emergence of antigenic/genetic variants in the course of HA evolution
(WIC, London, in-house sequencing). These are therefore less likely to be the result of
166
a)
Figure 36 Schematic diagram showing residues containing changes in HAi for HI 
viruses used in this study
a) HA monomer showing the location of all the changes. The different colours represent 
the classification of the residues. Circles in pink are residues located in the receptor- 
binding site (residues shaded in black in Table 10a). Circles in blue are residues located 
within 20 A of the receptor-binding site or residues that are in a position to affect 
interaction with receptor analogues bound to neighbouring monomers. Circles in cyan are 
carbohydrate attachment sites. Circles in yellow are residues located elsewhere in HAi.b) 
Close-up of the receptor-binding site and the residues at which changes are observed. 
Bound Neu5Ac is coloured in green.
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host cell-mediated variation.
Whereas the Asp225Gly change has been shown to lead to an increased binding of 
a(2,3)-linked Neu5Ac, the Asp225Asn substitution does not appear to affect the affinity 
for 3’SL and 6’SLN (Gambaryan et al., 1999; Mochalova et al., 2003) (see Table 3). 
However, although associated with cultivation in eggs, Gly225 might also be 
representative of the original clinical isolate. Evidence for this finding is provided by the 
observed heterogeneity at this residue for the 1918 viruses isolated from people who died 
in the Spanish pandemic. Of these, 3 contained Asp and 2 Gly (Reid et al., 2003). 
Furthermore, evidence has been provided that the Asp225Gly substitution is involved in 
escape from mAb (Caton et al., 1982; Yates et al., 1990).
A single substitution Aspl90Asn has been shown to lead to an increased affinity 
for the a(2,3)-linkage and a decreased affinity for the a(2,6)-linkage (Gambaryan et al., 
1999). However, all the viruses used in this study of 1999-2003 contain Asnl90 and are 
clearly a(2,6)-linkage specific (see Figure 35), which is in disagreement with the egg- 
adaptation studies. Furthermore, residue 190 is not likely to be associated with egg- 
adaptation for these isolates, since other viruses since 1999 were found to contain Asp 190 
or Asnl90, irrespective of whether they were isolated from eggs or MDCK cells (WIC, 
London, in-house sequencing). Substitutions at position 190 have also been selected by 
mAb, which suggests the involvement of this residue in escape from immune surveillance 
(Nakajima et al., 1983).
The loss of a carbohydrate attachment site at 163, caused by the mutation Asn —> 
Lys/Ser, is thought to lead to a loss of steric hindrance with more distal parts of receptors 
containing a(2,3)-linked sialic acid (Gambaryan et al., 1999). However, it appears that the 
a(2,3)-linkage recognition is not greatly affected by residue 163, since both Denver/1/57
and Finland/9/57 are clearly a(2,3)-specific and contain a glycosylation site at 163.
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As can be seen in Table 3, the effects on receptor-binding properties of the 
remaining potential egg-adaptation mutations for the viruses used in this study (at residues 
129,138 and 189) have not been tested.
4.4 Discussion
4.4.1 H3 Subtype Viruses
4.4.1.1 Isolates Differ in their Receptor-Binding Properties and Antigenicity
A number of viruses from 1994-2003 were probed for their interaction with receptor 
analogues containing either a(2,3)- or a(2,6)-linked sialic acid by SPR. The data described 
here shows that evolution of H3 subtype viruses is not only associated with antigenic 
variation (see Table 4) but also with changes in affinity/specificity for host cell receptors 
(see Table 5 and Figure 32). Notably, the Fujian-like viruses, which emerged in 2002 and 
are antigenically different from previously circulating Panama/2007/99-like viruses, 
display unique receptor-binding properties by having a large decrease in affinity for a(2,3)- 
fetuin. As a consequence, these viruses display a large shift in specificity for the a(2,6)- 
linkage compared to the other isolates. In addition, they also show considerable variation 
(up to 200-fold) in binding strength for a(2,6)-fetuin. The remaining viruses are 
characterised by less marked differences in affinity for both a(2,6)- and a(2,3)-fetuin 
(maximum of ~ 6-fold for a(2,6)-fetuin). This indicates that antigenic variation can be but 
is not necessarily accompanied by large changes in receptor-binding properties.
Comparison of the HAi amino acid sequence determined in this study reveals that 
many residues, at which substitutions are observed, are located in close vicinity of the 
RBS. Since many of the antigenic sites have been shown to cluster around the RBS (see
1.7.5.2.1 Antigenic Sites, p. 54), the detected changes are most likely involved in escape
from immune surveillance. The accumulation of changes close to the RBS indicates that
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this area is favoured by positive selection in the human population, as suggested 
previously (Wiley et al., 1981; Wilson and Cox, 1990; Bush et al., 1999b). Since the 
viruses used differ in a number of residues, it is not possible to clearly identify the 
involvement of each individual substitution in the observed changes in antigenicity and/or 
receptor-binding properties. Nevertheless, the locations of a number of substitutions 
coincide with changes previously selected by mAbs for X31 (underlined residues in Table
6), indicative of their involvement in escape from antibody-recognition (Wiley et al., 1981; 
Underwood et al., 1987; Smith et al., 1991; Temoltzin-Palacios and Thomas, 1994; Patera 
etal., 1995).
Notably, a number of the observed substitutions are located directly in the RBS, in
agreement with earlier reports (Cox and Bender, 1995; Nobusawa et al., 2000; Medeiros et
al., 2001). Changes located in the RBS are likely to modulate receptor-binding properties
either by directly affecting atomic contacts with cellular receptors or by causing small
differences in the structure of the RBS. Why substitutions in the RBS occur is not clear. A
number of studies indicate that adsorptive mutants arise when the antibody pressure is
provided at sub-neutralising conditions (Fazekas de St. Groth, 1977; Yewdell et al., 1986;
Temoltzin-Palacios and Thomas, 1994) or when the antibody is of low-affinity (Laeeq et
al., 1997). Since binding to antibodies is in competition with attachment of virus to cells,
modulation of HA affinity and/or specificity for cellular receptors might be sufficient to
escape neutralisation by antibodies. Interestingly, infection by a novel antigenic variant has
been reported to lead to the production of antibodies of reduced affinity, which is thought
to be due to concomitant immunity to earlier strains (Fazekas de St. Groth and Webster,
1966). Therefore, such an alternative mechanism to antigenic variation for escape from
neutralising antibodies might operate in the human host. Furthermore, it has been
suggested that changes in the RBS might be due to structural constraints in antigenic sites
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(Temoltzin-Palacios and Thomas, 1994). Alternatively, in addition to receptor-binding, 
residues in the RBS might also be directly involved in antigenic drift if their side-chains 
are surface-exposed. In order to clearly show the involvement of a particular residue in 
immune-evasion, selection of variants with a substitution at this residue would have to be 
selected with mAbs. Then, a decrease in affinity of this virus for the selecting mAb would 
have to be shown by ELISA, in order to directly demonstrate the role of this residue in 
antibody-recognition. If the antibody binds with similar affinity than to wild-type virus, the 
selected variant is more likely to be a receptor-binding mutant. Furthermore, since the 
viruses differ from each other by a number of residues, the possibility that certain 
substitutions occur in order to compensate for a structural change close to or in the RBS 
can not be excluded.
It has been generally believed that RBS residues need to be conserved in the 
process of antigenic drift in order to maintain receptor-binding function (Both et al., 
1983b; Weis et al., 1988; Bizebard et al., 1995). However, the fact that substitutions in the 
RBS do occur indicates that the plasticity of the RBS is greater than expected.
4.4.1.2 Decreased Affinity for a(2,3)-Fetuin of Fujian-like Viruses
All the viruses used in this study isolated since 2002 displayed a marked decrease in 
affinity for the a(2,3)-fetuin compared to the earlier viruses. The reduced binding strength 
for this receptor analogue correlated with poor growth of these viruses in eggs, which 
presented problems in their isolation. Since allantoic cells have been shown to contain 
more a(2,3)- than a(2,6)-linked sialic acid (Ito et al., 1997b), the low virus yield from eggs 
could be a result of the low affinity for the a(2,3)-linkage.
Sequence comparison revealed that the Fujian-like viruses are distinguished from
the other isolates by the same substitution as the single-site X31 mutant Gly225Asp. This
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virus, which was initially used to test the sensitivity of the SPR assay (see Chapter 3),
exhibited a similar reduction in binding strength for a(2,3)-fetuin compared to X31 as the
recent viruses. This finding strongly implies that Asp225 is responsible for the reduced
affinity for a(2,3)-fetuin. The structural basis for this interaction is not obvious. Although
this residue is located directly in the RBS, no direct contacts of this amino acid with the
glycosidic linkage or more distant moieties of receptor analogues have been revealed in
structural studies for H3 HA (see Figures 7 and 8, p.42-43). This suggests that the negative
effect of Asp225 on the interaction with a(2,3)-fetuin is of indirect character. Since these
viruses all contain a glycosylation site at residue 165, an oligosaccharide attached at this
position would be projected towards asialo-components of receptor analogues containing
a(2,3)-linked but not a(2,6)-linked sialic acid (see Figure 37). It might be speculated that
the Gly225Asp causes a rearrangement of the oligosaccharide so as to interfere with
binding to receptors containing a(2,3)-linked sialic acid. Furthermore, the Fujian-like
viruses all contain a concomitant change Trp222Arg compared to other isolates. The close
location of residues 222 and 225 would enable a salt-bridge between the two. The
observation that the Fujian-like viruses bind a(2,3)-fetuin more weakly compared to the
Gly225Asp mutant might be a result of further structural rearrangements caused by the two
substitutions. The ability of oligosaccharides at the membrane-distal part of HA to affect
receptor-binding properties has been shown in a number of studies (Deom et al., 1986;
Matrosovich et al., 1997; Ohuchi et al., 1997; Abe et al., 2004). The effect of a specific
carbohydrate on linkage-recognition has been reported previously for USSR/90/77 and
Tiibingen/12/85 (H1N1) (Gunther et al., 1993; Gambaryan et al., 1998). These studies
have shown that variant viruses containing an oligosaccharide attachment site at residue
131 were distinguished by those without this site by a reduced affinity for receptor
analogues containing a(2,6)-linked sialic acid. However, the contribution of other residues
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Avian receptor
Carbohydrate 
at Asnl65
Figure 37 Model for reduced affinity of Fujian-like H3 HA for a(2,3)-fetuin
Schematic diagram showing the close proximity of a carbohydrate at Asnl65 protruding 
from the monomer on the left (coloured in grey) to a a(2,3)-linked receptor analogue 
bound to the neighbouring monomer (coloured in blue). Residues 222 and 225 could 
potentially influence the position of the carbohydrate, thereby affecting its interference 
with distant parts of a(2,3)-linked receptor analogues (“avian” receptor, coloured in green).
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to the detected changes in receptor-binding properties for the Fujian-like viruses should 
not be excluded.
The implications of the reduced affinity for the a(2,3)-linkage with regard to 
infection of human host cells is not clear. It is generally believed that the ability to infect 
human cells of the respiratory tract correlates with the recognition of a(2,6)-linked sialic 
acid, and that the observed a(2,6)-linkage specificity of human influenza viruses is a result 
of the selection pressure exerted by these cells (see 1.7.4.4 Host Cell Factors Involved in 
Selection o f Linkage Specificity, p. 49). However, mucins, produced by human epithelial 
cells, are rich in a(2,3)-linked sialic acid (Breg et al., 1987; Baum and Paulson, 1990). 
Since mucoproteins and mucopolysaccharides have been shown to inhibit the virus’ ability 
to agglutinate RBC (Burnet, 1951), reduced binding to these has been suggested to play a 
role in the evolution of receptor specificity towards recognition of the a(2,6)-linkage. The 
reduced affinity for a(2,3)-linked Neu5Ac observed for the recent Fujian-like isolates 
might therefore facilitate the infection of human host cells. This raises the possibility that 
the substitutions leading to the reduced binding strength for a(2,3)-linked Neu5Ac were 
selected by host cell-specific factors other than antibodies and reflect further adaptation to 
infection of the human host. Alternatively, the amino acid differences of the Fujian-like 
viruses compared to the earlier strains might be the result of antigenic variation leading to 
a concomitant effect on receptor-binding properties.
The finding that the H3 virus isolates of 1968-1999 used in this study interacted
with a(2,3)-fetuin indicates that the acquirement of a(2,6)-linkage recognition for the
initial transfer from birds to humans was not coupled with a loss of binding to the a(2,3)-
linkage. Thus, the SPR data indicate that, although the possible 1968 pandemic precursor
(Dk/Ukraine/1/63) already recognised the human-specific a(2,6)-linkage, the first H3 virus
isolated during the pandemic (represented by X31) displayed an almost 100-fold higher
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affinity for a(2,6)-fetuin. In contrast, only about a 5-fold decrease in affinity for the avian- 
specific a(2,3)-linkage was observed for X31 compared to Dk/Ukraine/1/63.
4.4.1.3 Distinct Receptor-Binding Properties of Christchurch/28/03
The weak binding strength for a(2,3)-fetuin renders the Fujian-like viruses highly a(2,6)- 
specific, reflected in their specificity indices being > 200 (see Table 5). This could give the 
impression that these viruses display high affinity for a(2,6)-fetuin. However, the Fujian- 
like viruses were shown to vary greatly with regard to a(2,6)-fetuin affinity. Notably, these 
viruses bound a(2,6)-fetuin generally more weakly compared to the earlier isolates, e.g 
X31. The only exception to this is Christchurch/28/03, which bound this receptor analogue 
as strongly as X31. Christchurch/28/03-specific changes in close vicinity to the RBS with 
the potential to affect receptor-binding properties are at residues 126, 138, 186 and 190 
(see Table 6a). The loss of a glycosylation site at 126 is not likely to account for the 
increase in affinity for a(2,6)-fetuin compared to the other Fujian-like viruses, since 
Wyoming/3/03 is also not glycosylated at this site due to a change at position 128.
Residue Glul90 in H3 HA has been shown to directly contact the 9-OH moiety of
Neu5Ac via a hydrogen bond (see Figure 6, p.37) (Weis et al., 1988). All the viruses used
in this study contain Aspl90, except for Christchurch/28/03, which contains Vail90. It is
possible that Asp, despite its smaller size compared to Glu, might still form a hydrogen
bond to 9-OH via a water molecule. In contrast, Vail90 would not be able to make any
contacts to Neu5Ac, which would be expected to lead to a decrease in affinity. However, a
change from Glul90 to Ala, which would also not be able to contact the 9-OH, has been
reported to lead to a slight increase of affinity for human RBC (Martin et al., 1998). In
addition, a Glul90Asp change has been implicated in the inability of viruses isolated since
1992 to agglutinate chicken RBC (Nobusawa et al., 2000). Interestingly,
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Christchurch/28/03 contains Aspl86, in contrast to the other Fujian-like viruses containing 
Val or Gly at this position. Asp 186 might be close enough to 9-OH to form a hydrogen 
bond and could therefore potentially take over the role of Glul90. This might explain the 
general increase in affinity of Christchurch/28/03 for both a(2,3)- and a(2,6)-fetuins
compared to the other Fujian-like viruses. Finally, residue 138 points towards residue 226 
and could potentially affect its position, thereby affecting receptor-binding properties.
Interestingly, Christchurch/28/03 does not only differ from the other Fujian-like 
viruses by substitutions in HA but also in NA, which can be distinguished phylogenetically 
(WHO, 2004). Christchurch/28/03 contains a NA closely related to that of New 
York/55/01 (Panama/2007/99-like virus). It is therefore likely that Christchurch/28/03 
obtained its NA by reassortment. Since a functional balance between HA and NA has been 
suggested to be important for optimal virus replication (see 1.10 Functional Balance 
between HA and NA Activity, p. 66), investigation of a possible correlation of receptor- 
binding and enzyme activity properties would be of interest.
4.4.1.4 Role of Residue 226 in Defining Linkage Specificity
As described in 1.7.4.2 Correlation between Receptor-Linkage Specificity and Host o f
Origin, p .39, residue 226 was shown to be a major determinant for defining receptor
specificity for the H3 subtype. Human isolates contain Leu/Val/Ile and are a(2,6)-specific,
whereas avian isolates contain Gln226 and are a(2,3)-specific (Connor et al., 1994;
Lindstrom et al., 1996; Mori et al., 1999). However, Johannesburg/33/94 contained the
avian-typical Gln226. Although the Gln226 is likely to be the result of egg-adaptation and
therefore not representative of the original clinical isolate, the decreased a(2,6)-fetuin
affinity of Johannesburg/33/94 compared to X31, Sydney/5/95 and Panama/2007/99 shows
the involvement of residue 226 in modulating linkage recognition. However, Gln226 did
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not cause a switch in receptor specificity, as observed for the Leu226Gln substitution for 
X31 (Rogers et al., 1983a). Therefore, additional residues appear to be important in 
defining receptor specificity. For example, as described above, residues 222 and 225 rather 
than 226 are suggested to be implicated in the large shift in specificity for the Fujian-like 
viruses.
4.4.1.5 Comparison of SPR Data with Previously Reported Results
Little information on receptor-binding properties of the viruses used in this study is 
available in the literature, except for Dk/Ukraine/1/63 and X31. The affinity data of X31 
was already discussed in Chapter 3 and is in general agreement with results from other 
studies. The a(2,3)-linkage specificity of Dk/Ukraine/1/63 described here is also consistent 
with the linkage preference of this virus determined by various assays (see Appendix 3, 
p.257). However, as for X31, considerable variation can be observed when the relative 
affinity differences between the a(2,3)- and the a(2,6)-linkages are compared, ranging 
from less than 2-fold (Nobusawa et al., 1991) to 60-fold (Matrosovich et al., 1993; 
Matrosovich et al., 2000). The SPR results of this study are in agreement with the latter 
value (see Table 5). As discussed in Chapter 3, the variation in relative affinity is probably 
due to differences in the assays, such as the choice of receptor analogues and their valency. 
The only other virus for which receptor-binding data was available is Sydney/5/97. A 
haemagglutination assay with RBC reconstituted with Neu5Ac either in the a(2,3)- or 
a(2,6)-linkage suggests a(2,6)-linkage specificity for this virus, with HAUs differing 2- 
fold (Medeiros et al., 2001). The relative affinity difference for Sydney/5/97 was ~ 4.5- 
fold as determined by SPR, which is in good agreement with the haemagglutination assay.
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4.4.2 HI Subtype Viruses
4.4.2.1 Antigenically Distinct HI Isolates Display Differences in Receptor-Binding 
Properties
Receptor-binding properties in relation to antigenic drift were also studied for HI subtype 
viruses isolated between 1934 and 2003. This virus was introduced in 1918 and caused the 
biggest human pandemic reported in the 20 century (see 1.8.1 Origin o f Pandemic 
Influenza Viruses, p.61). After introduction of the H2 subtype in 1957 they were absent 
from the human population until 1977, when they suddenly reappeared. Since then they 
continue to circulate together with the H3 subtype, which replaced the H2 subtype in 1968. 
It was therefore of interest to investigate whether viruses from the first epidemic period 
differed from the isolates of the second era with regard to affinity and/or specificity for 
receptor analogues.
The SPR data reveal great variations in affinities for a(2,3)- and a(2,6)-fetuin for 
viruses of 1934-2003. Importantly, in contrast to the general a(2,6)-linkage preference of 
the human H3 viruses studied, a number of HI isolates display either clear a(2,3)-linkage 
specificity or do not significantly distinguish between a(2,3)- and a(2,6)-fetuin (“dual”- 
linkage specificity) (see Figure 35). Notably, the majority of the viruses from the first 
epidemic period were shown to be a(2,3)-specific, namely the earliest isolate 
Puerto/Rico/8/34 and the viruses of 1952-1957. The remaining viruses of this period, 
including the swine isolate, appear to be “dual”-linkage specific. The viruses of the second 
epidemic era of 1978-1999 era are also either a(2,3)- or “dual”-linkage specific. 
Interestingly, all the viruses since 1999 are clearly “human”-like, as they are characterised 
by a clear a(2,6)-linkage preference (see Figure 35). In addition, these viruses are all
l
antigenically closely related (see Table 8), which is in agreement with the reported slow
antigenic evolution of 1999-2003 (Hay et al., 2001). Therefore no significant changes in
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either antigenic or receptor-binding properties have occurred since 1999. Slow antigenic
evolution has also been reported between 1986-1995 (Hay et al., 2001), which is supported
\
by the antigenic similarity for Taiwan/1 /86 and Bayem/7/95 (see Table 8). Since these 
viruses also display similarities in their interaction with a(2,3)- and a(2,6)-fetuin, (see 
Figure 35), an interrelationship between antigenic and receptor-binding properties is 
suggested. However, as noted earlier for the H3 viruses, the extent to which changes in 
antigenicity correlate with changes in the interaction with receptor analogues appears to 
vary.
Very similar receptor-binding properties were observed for Denver/1/57 and 
Finland/9/57, which differed from each other by only one residue, and for 
Bucharest/955/03 and Prague/9/03, which displayed identical HAi amino acid sequences. 
This finding strongly indicates the robustness of the SPR assay.
4.4.2.2 Residues Implicated in the Observed Variation of Receptor-Binding 
Properties
As for the H3 viruses, the HI isolates differ at many residues close to the RBS (see Table
10 and Figure 36). This finding makes it difficult to assess the involvement of each residue
in defining antigenic and receptor-binding properties. Almost all of these could potentially
be involved in antigenic variation, because their side-chains are surface-exposed.
Substitutions at a number of these residues have been selected by mAb, which suggests
their direct involvement in escape from neutralising antibodies (Caton et al., 1982;
Nakajima et al., 1983; Yates et al., 1990). Notably, differences are observed at residues
located directly in the RBS. These appear to correlate with the observed variation in both
receptor-binding and antigenic properties for viruses of 1934-1999. A number of RBS
residues, at which differences are observed, have previously been suggested to play a role
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in defining receptor specificity, namely residues 138, 186, 190, 194 and 225 (Rogers and 
D'Souza, 1989; Matrosovich et al., 1997; Gambaryan et al., 1999; Mochalova et al., 2003). 
Residues 225 and 190 have also been reported to be associated with propagation of viruses 
in eggs (see Table 3). Studies of egg-adaptation mutations of HI viruses have also 
provided evidence for the involvement of residues 190 and 225 in modulation of receptor 
specificity (Gambaryan et al., 1999; Mochalova et al., 2003). In contrast, the viruses since 
1999 not only display similar receptor-binding and antigenic properties, but also identical 
RBS residues, apart from a few amino acids for Egypt/96/02 (see below).
The viruses used in this study contain Glu, Asp or Asn at position 190, with the
exception of Beijing/262/95, which contains Vall90. Glul90 is highly conserved for all
avian subtypes, whereas human isolates have been reported to generally contain Asp 190
(Matrosovich et al., 1997). Interestingly, all the human isolates containing the avian-
typical Glul90 displayed clear a(2,3)-linkage preference, whereas all the viruses
containing Asnl90 were clearly a(2,6)-specific (see Figure 35). This finding suggests a
role of this residue in defining linkage preference. The structure of Sw/Iowa/15/30 HA
complexed with a receptor analogue containing Neu5Ac in the a(2,6)-linkage reveals a
hydrogen bond between Aspl90 and GlcNAc-3 (see Figure 12, p.48). This additional
contact might stabilise the accommodation of a(2,6)-linked Neu5 Ac, leading to an increase
in affinity. On the other hand, Asp 190 does not appear to prevent binding of Neu5Ac in
the a(2,3)-linkage, based on the observation that the viruses used in this study with Asp 190
were either “dual”- or a(2,3)-linkage specific. Therefore, Asp 190 does not necessarily
confer a(2,6)-linkage specificity. It could be speculated that the a(2,3)-linkage specificity
of isolates containing Glul90 would be the result of the inability of this amino acid to
provide the additional contact to receptors containing a(2,6)-linked sialic acid observed for
Asp. How Vail90, as in the case for Beijing/262/95, would affect receptor-binding
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properties, is not clear. However, a more passive role is predicted, since Val is not able to 
provide contacts to any parts of sialic acid-containing receptors. The structural basis for 
the contribution of Asnl90 for the a(2,6)-linkage preference of the viruses of 1999-2003 is 
yet unknown. However, Asn is similar in size and polarity to Asp and might therefore also 
be able to form a stabilising hydrogen bond to GlcNAc-3 of receptors containing a(2,6)- 
linked sialic acid. The correlation of Asnl90 and a(2,6)-linkage specificity for the viruses 
used in this study is in disagreement with an earlier study, where an Asp 190Asn 
substitution led to an increase in affinity for the a(2,3)-linkage with a concomitant 
decrease in affinity for the a(2,6)-linkage, resulting in “dual”-linkage specificity 
(Gambaryan et al., 1999) (see Table 3).
Residue 225 was either Asp or Gly, with the exception of Chile/1/83 containing
Asn at this position. The involvement of residue 225 in linkage specificity is based on
studies showing that an Asp225Gly substitution can lead to an increase in affinity for the
a(2,3)-linkage without markedly affecting affinity for the a(2,6)-linkage for monovalent
receptors (Gambaryan et al., 1999). When a multivalent receptor analogue was used, the
increase in affinity for the a(2,3)-linkage was greater than 500-fold, leading to very similar
affinities for both the a(2,3)- and a(2,6)-linkage (Mochalova et al., 2003). In contrast, an
Asp225Asn did not greatly affect the recognition of either linkage. No strict correlation
could be observed for amino acid 225 and receptor-binding properties for the HI viruses in
this study. Whereas the “dual”- and a(2,3)-linkage specific viruses contained either Gly or
Asp at 225 (with the exception of Asn for Chile/1/83), all the a(2,6)-specific viruses
contained Asp225. X-ray studies of Puerto Rico/8/34 complexed with receptor analogues
have shown that Asp225 can be directly involved in the interaction with the a(2,6)-linkage
by forming a hydrogen bond to Gal-2. In contrast, due to the lack of a side-chain, Gly225
of Sw/Iowa/15/30 is unable to contact any parts of this receptor analogue (see Figures 11
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and 12, p.47-48).
Residue 138 has been suggested to play a role in linkage-recognition, based on the 
observation that many of the early HI isolates containing Alai 38 were “duaP’-linkage 
specific, whereas later isolates containing Seri 3 8 were a(2,6)-linkage specific (Rogers and 
D'Souza, 1989). Indeed, all the viruses used in this study with Alai 3 8 were either “dual”- 
or a(2,3)-specific, whereas all the 1999-2003 viruses contain Seri 3 8 and are a(2,6)- 
specific. However, Seri 3 8 is not strictly correlated with a(2,6)-linkage specificity, since 
Brazil/11/78 with Seri 3 8 is “duaP’-linkage specific. This suggests that linkage specificity 
is defined by a combination of amino acids at different residues. No structural evidence 
has as yet been provided for the contribution of residue 138 to modulation of receptor- 
binding properties.
Residue 194 has been suggested to be involved in receptor-recognition due to the 
fact that it is a highly conserved Leu in avian subtypes, whereas human HI isolates usually 
contain He at that position (Matrosovich et al., 1997). However, the majority of the viruses 
used in this study contain the avian-typical Leul94. Furthermore, since the viruses 
containing Leul94 were either a(2,3)-, “dual”- or a(2,6)-linkage specific, residue 194 is 
not likely to play an important role in defining linkage specificity. Similarly, residue 186 
has been implicated in modulation of receptor-binding properties because it was shown to 
be a highly conserved Pro in avian HI viruses, whereas most human isolates contained 
Seri 86 (Matrosovich et al., 1997). However, all the viruses used in this study of 1999- 
2003 contain the avian-typical Pro 186 and are a(2,6)-linkage specific, whereas Puerto 
Rico/8/34, which also contains Pro 186, is a(2,3)-specific. Residue 186 is therefore 
unlikely to be a major determinant for linkage specificity.
In summary, it appears that receptor specificity is defined not by single residues but
by a combination of different amino acids. The only exception to this was Glul90, which
182
Chapter 4 Receptor-Bindim Properties in Relation to Antisenic Drift
strictly correlated with a(2,3)-linkage specificity. In order to address the contribution of 
residues 138, 190, 194 and 225 to linkage-recognition on a structural basis, X-ray studies 
of HA in complex with receptor analogues would have to be performed for a number of 
HI viruses used in this study.
As described in 4.3.4 Assessment o f Egg-Adaptation Mutations, p. 166, it is not 
clear whether the a(2,3)- and “duaP’-linkage specificity of isolates from 1934-1999 are 
representative of the original clinical specimen or an artefact of extensive laboratory 
passage of these viruses in eggs. Notably, the 1918 pandemic virus was reported to be 
a(2,6)-specific (Kobasa et al., 2004), which is in contrast to the a(2,3)-linkage specificity 
of Puerto/Rico/8/34. As mentioned above, the a(2,3)-linkage preference of 
Puerto/Rico/8/34 might be due to an avian-typical Glul90, whereas the 1918 isolates were 
reported to contain the human-typical Asp 190 (Reid et al., 2003).
4.4.2.3 Distinct Receptor-Binding Properties of the H1N2 Reassortant Virus
Antigenic evolution has been reported to be generally slower and less marked for the HI
subtype than the H3 viruses since 1977, despite their similar rate of genetic evolution. This
observation is reflected in the fewer changes in the vaccine composition for HI viruses
(Hay et al., 2001). In addition, the emergence of antigenic variants has been observed to
correlate with the predominance in epidemics (Lin et al., 2004). The less frequent and
slower emergence of antigenic variants for the HI viruses is therefore also reflected in the
infrequent predominance over H3 and B viruses, with prevalence only observed in 1988-
1989 and 2000-2001. Following the 2000-2001 epidemic season, the H1N2 reassortant
viruses appeared. These contain an HA antigenically and genetically similar to New
Caledonia/20/99 and a NA and six internal genes closely related to contemporary H3N2
viruses (Gregory et al., 2002). It was suggested that HA amino acid changes accumulated
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between 1995-1999 might have facilitated the replacement of H3 by HI HA, in order to 
functionally match the N2 NA activity. The acquired a(2,6)-linkage preference of all the 
viruses since 1999, including the H1N2 reassortant Egypt/96/02, show that the 
accumulated changes indeed had a large effect on receptor-binding properties (see Fijgure 
35). Furthermore, it was observed that Egypt/96/02 differs from the other 1999-2003 
viruses by a 10-fold higher affinity for a(2,6)-fetuin and a 100-fold lower affinity for 
a(2,3)-fetuin. As a result, this virus displays a higher a(2,6)-linkage preference compared 
to the other viruses.
Amino acid sequence comparison revealed that Egypt/96/02 differs from the other 
1999-2003 isolates at residues 132, 193 and 218. Since Egypt/96/02 is antigenically 
closely related to the other recent isolates, these changes are most likely to account for the 
observed differences in receptor-binding properties. Seri93 in HI viruses has been shown 
to contact Gal-4 of a receptor analogue with a(2,6)-linked Neu5 Ac by forming a hydrogen- 
bond with the hydroxyl of its side-chain (Gamblin et al., 2004) (see Figure 12, p.48), 
which might result in an enhanced interaction with this receptor analogue. Egypt/96/02 
contains Thr at 193 which, unlike the other viruses containing Ala at this position, would 
be able to contact receptor analogues with a(2,6)-linked Neu5Ac in the same manner. In 
addition, changes at residue 193 were reported to modulate binding to derivatised RBC 
containing a(2,3)-linked Neu5Ac for H3 viruses (Daniels et al., 1987). The increased 
binding to a(2,6)-fetuin and the decreased a(2,3)-fetuin affinity for Egypt/96/02 might 
therefore be a result of Thr 193. Residue 218, which is in the trimer interface, has also been 
shown to modulate receptor-binding properties, namely the interaction with a(2,3)-linked 
Neu5Ac (Daniels et al., 1987). The structural basis for this finding is unknown. In contrast, 
due to its location at the edge of the RBS, residue 132 is less likely to influence 
interactions with receptors.
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The low affinity of the H1N2 reassortant virus for a(2,3)-fetuin was observed to be 
very similar to that of the recent H3 viruses (see Figures 32 and 35). These distinct 
receptor-binding properties correlate with the presence of a closely related N2. Since it has 
been suggested that HA receptor-binding and NA receptor-destroying functions need to be 
balanced for optimal virus replication (see 1.10 Functional Balance between HA and NA 
Activity, p. 66), the changes in receptor-binding properties of the H3 and H1N2 virus might 
interrelate with changes in NA activity and/or specificity. The substitutions in Egypt/96/02 
compared to the other H1N1 HAs might therefore have been necessary to functionally 
match N2 NA activity. A possible interrelationship between the observed receptor-binding 
properties of recent H3 viruses and H1N2 viruses would be addressed by studying the NA 
activity and specificity of theses viruses.
4.4.2.4 Comparison of SPR Data with Previously Reported Results
Receptor-binding data on the viruses used in this study was available for Puerto Rico/8/34,
Dk/Alberta/35/76, Sw/Iowa/15/30, Fort Monmouth/1/47, Fort Warren/1/50, Fort Leonard
Wood/1/52, Denver/1/57, Brazil/11/78, Chile/1/83 and Taiwan/1/86 (see Appendix 3,
p.257). A number of the results reported in the literature were conflicting, which makes
comparison with the SPR data difficult. For example, Puerto Rico/8/34 was determined to
be either a(2,3)-specific, “duaP’-specific or a(2,6)-specific, depending on the study. The
SPR data reported here are in support of this virus displaying a(2,3)-linkage preference.
The differences in results might be due to the presence of different variants of this virus,
which are thought to have arisen by independent laboratory passages from the original
source. For example, whereas some viruses contain an oligosaccharide at position 131
(Cambridge strain), the strain used in this study (Mount Sinai strain) is characterised by a
loss of the glycosylation site due to a deletion at residue 132 (Winter et al., 1981; Caton et
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al., 1982). Furthermore, variants of this virus containing either Asp 190 or Glul90 are 
available, which are likely to affect receptor specificity (see Influenza database, 
http://www.flu.lanl.govA). The lack of information on the identity of the Puerto Rico/8/34 
strain used in the reported assays does not allow the comparison of results. Furthermore, as 
discussed in Chapter 3, variations in relative affinities might also be due to differences in 
the assays, such as the choice of receptor analogues and the valency of these. Despite these 
difficulties in data comparison, the SPR data are in general agreement with previous 
results. In particular, the “dual”-specificity of the HI viruses of the first epidemic era has 
been reported before, as was the a(2,3)-linkage specificity of Denver/1/57 and Fort 
Leonard Wood/1/52 (Rogers and D'Souza, 1989; Matrosovich et al., 1993).
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5 Substitutions in Avian H3 HA Associated with Selection by 
Derivatised RBC containing a(2,6)-linked Neu5Ac
5.1 Introduction
The Hong Kong pandemic (H3N2) in 1968 was caused by a reassortant virus introducing a 
novel HA into the human population (see 1.8 Emergence and Evolution o f Human 
Influenza Viruses, p.61). Initially, either an equine or avian origin of HA was proposed 
based on antigenic analyses of isolates in comparison with strains recovered from horses 
and birds (Coleman et al., 1968; Tumova and Easterday, 1969; Zakstelskaja et al., 1969; 
Laver and Webster, 1973). Subsequent sequence and phylogenetic studies were in support 
of an avian origin of HA (Fang et al., 1981; Ward and Dopheide, 1981; Bean et al., 1992). 
Although the identity of the bird virus involved in the reassortment has not been identified, 
the progenitor virus was closely related to Dk/Ukraine/1/63. The earliest human H3 
pandemic isolate (Aichi/2/68) differs from Dk/Ukraine/1/63 by only 15 amino acids in 
HAi, of which 5 are located in the RBS (at positions 137, 193, 226, 227, 228) (Ha et al., 
2003). Despite the small number of changes the two viruses display receptor-linkage 
preference typical of their host of origin (avian HA = a(2,3), human HA = a(2,6)) (Rogers 
and Paulson, 1983; Matrosovich et al., 1993; Matrosovich et al., 2000). The substitution 
Gln226Leu has been implicated in facilitating species transfer of the H3 subtype from 
birds to humans by shifting receptor-linkage preference from a(2,3) to a(2,6) (Matrosovich 
et al., 2000). The evolution of the contrasting linkage specificity of avian and human 
viruses is thought to have occurred by selection pressure exerted by the respective linkage 
of receptors on human and avian target cells (see 1.7.4.4 Host Cell Factors Involved in 
Selection o f Linkage Specificity, p. 49). The main evidence for the involvement of residue
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226 in linkage discrimination was provided by selection of X31 (reassortant virus 
containing the HA of Aichi/2/68) variants by means of propagation in the presence of a 
source of a(2,6)-linked sialic acid (horse serum) (Rogers et al., 1983a). These variants 
displayed a shift in linkage specificity from a(2,6) to a(2,3), which was attributed to a 
single mutation Leu226Gln. A further indication for the involvement of residue 226 in 
receptor specificity is that Gln226 is highly conserved across all avian HA subtypes, 
whereas human H3 viruses never contain Gin but always a non-polar amino acid (Leu, Val 
or lie) (Nobusawa et al., 1991; Matrosovich et al., 1997; Medeiros et al., 2001).
Selection in the reverse direction has also been performed by means of adsorption 
to and elution from RBC with a(2,6)-linked Neu5Ac, generating a Dk/Ukraine/1/63 
variant displaying a(2,6)-linkage preference typical of human isolates (Rogers et al., 
1985). Although this variant was characterised by a substitution at residue 226 from Gin to 
Leu, this mutation reverted upon growth in eggs. In contrast, Aichi/2/68 HA and its single­
site mutant Leu226Gln maintained residue 226 upon propagation in eggs. Structural 
comparison of HA reveals that, although the Dk/Ukraine/1/63 and Leu226Gln RBS are 
similar, small conformational differences are apparent (Ha et al., 2003) (see Figure 38). 
Since these viruses differ only at residues 137, 193, 227 and 228 in or close to the RBS, 
these are most likely to account for the observed conformational changes. It is possible that 
the small structural differences in the RBS would contribute to the inability of 
Dk/Ukraine/1/63 to maintain the Gln226Leu mutation upon growth in eggs.
Residues 137 193 227 and 228 all have the ability to affect receptor-binding
properties. Human H3 viruses contain Ser228 in contrast to a conserved Gly228 for all
avian subtypes (Nobusawa et al., 1991; Matrosovich et al., 1997). In the HA-receptor
analogue complex, residue 228 interacts with the 9-OH moiety of Neu5Ac either directly
(Ser228) or indirectly via a water molecule to its main chain (Gly228) in human H3 and
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Figure 38 Superimposition of the receptor-binding sites of Dk/Ukraine/1/63 and 
Leu226Gln to show conformational differences Dk/Ukraine/1/63 HA residues are coloured 
in white and Leu226Gln in green. Side-chain and main-chain shifts are indicated by dashed 
arrows.
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avian H5 HA, respectively (Weis et al., 1988; Ha et al., 2001). Although no contacts of 
this residue to any asialo parts of the receptor analogues have been observed, amino acid 
228 has been implicated in affecting receptor specificity. A Ser228Gly mutation in the 
presence of Leu226 has been shown to lead to a slight increase in affinity for human RBC 
(Martin et al., 1998). Furthermore, the substitution Gly228Ser in the presence of Gln226 
has been shown to lead to a decreased affinity for the a(2,3)-linkage (Matrosovich et al., 
2000). This observation suggests that, while human H3 HA acquired the ability to 
recognise receptors containing a(2,6)-linked Neu5Ac by the Gln226Leu change, a 
concomitant Gly228Ser change would contribute to the a(2,6)-linkage specificity by 
reducing the affinity for the a(2,3)-linkage. This finding is in agreement with a human H3 
virus containing a Leu226Gln mutation, which displayed an enhanced affinity for horse 
RBC by an additional Ser228Gly mutation (Vines et al., 1998). Horse RBC have been 
shown to contain mainly sialic acid in the a(2,3)-linkage and are not agglutinated by 
human but by avian viruses (Ito et al., 1997a). Furthermore, the Ser228Gly mutation, in 
addition to the Leu226Gln mutation in a human H3 HA, has been shown to be important 
for virus replication in duck intestine (Vines et al., 1998).
The presence of Pro at 227 for Dk/Ukraine/1/63 is unusual, since human and avian
H3 HAs usually contain Ser at this position (Bean et al., 1992). Receptor-binding studies
of avian H3 viruses have suggested that the Ser227Pro change causes a decreased affinity
for the a(2,3)-linkage (Matrosovich et al., 2000). Residue 193 has also been shown to
affect receptor-binding properties, since substitutions at this residue affected binding to
Neu5Ac in both the a(2,3)- and a(2,6)-linkage (Daniels et al., 1987). Modulation of
receptor-binding properties has not been demonstrated for residue 137, but since this
residue is located directly in the RBS, it has the potential to affect interactions with sialic
acid. In summary, the studies described above all stress the importance of residues other
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than 226 in the modulation of receptor-binding properties.
The selection assay with Dk/Ukraine/1/63 performed by Rogers et al. (1985) was 
repeated with the aim to determine whether continued selection pressure to recognise 
a(2,6)-linked Neu5Ac would lead to additional changes in HA upon substitution of residue
226 from Gin to Leu. Selected variants would then be tested by SPR for changes in their 
receptor-binding properties. As well as Dk/Ukraine/1/63, viruses isolated from ducks in 
Hokkaido in the 1980s have been shown to be closely related to Aichi/2/68 (Kida et al., 
1987; Bean et al., 1992). This finding raises the possibility that the HA progenitor for the 
pandemic strain was Dk/Hokkaido-like. In contrast to Dk/Ukraine/1/63 with Pro227, these 
viruses contain Ser227 typical for avian and human H3 isolates. Dk/Hokkaido/33/80 was 
therefore included in the selection assay, in order to elucidate the importance of residue
227 for genetic stability of acquired a(2,6)-linkage preference.
5.2 Receptor-Binding Properties of Dk/Hokkaido/33/80, Dk/Ukraine/1/63 
and Aichi/2/68
Prior to selection of receptor-binding variants, the HAi amino acid sequence and receptor-
binding properties of Dk/Ukraine/1/63 and Dk/Hokkaido/33/80 were compared. Sequence
analysis revealed 13 differences between the two viruses (at residues 25, 63, 81, 102, 137,
145, 158, 160, 201, 227, 236, 303, 307), which, except for residue 303 and 307, have been
reported before (Kida et al., 1987) (see Appendix 8 for sequence alignment, p.270). The
difference at amino acid 81 leads to the loss of a glycosylation site for Dk/Hokkaido/33/80
compared to Dk/Ukraine/1/63 and Aichi/2/68. Since Dk/Hokkaido/33/80 contains the
same amino acids at positions 137 and 227 as Aichi/2/68, these two viruses differ only at
residues 193, 226 and 228 in the RBS. As mentioned previously, Dk/Ukraine/1/63 differs
also at residues 137 and 227 from Aichi/2/68.
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In order to determine whether the sequence differences between 
Dk/Hokkaido/33/80 and Dk/Ukraine/1/63 affect the interaction with receptor analogues, 
receptor-binding studies using SPR were performed for the two viruses. The kinetic rate 
constants and affinities for a(2,3)- and a(2,6)-fetuin were calculated as described in 
Chapter 3 and compared to those of X31 (containing the HA of Aichi/2/68) and its single­
site Leu226Gln mutant. As can be seen in Table 11, Dk/Ukraine/1/63 and 
Dk/Hokkaido/33/80 appear to display very similar receptor-binding properties. This is in 
agreement with receptor-binding data obtained by means of a solid phase assay 
(Matrosovich et al., 2000). While the avian viruses preferentially recognise the a(2,3)- 
linkage, binding to a(2,6)-fetuin was also detected. This result indicates the ability of the 
pandemic precursor HA to recognise the linkage typical of human isolates, which might 
have facilitated the transfer from birds to humans. In contrast, no or little interaction with 
the a(2,6)-linkage was detected in haemagglutination assays (e.g. Rogers and Paulson, 
1983; Connor et al., 1994) (see Appendix 3, p.257). Therefore, the sequence differences 
between the two viruses do not appear to affect their interaction with cellular receptors. 
The difference in specificity compared to Aichi/2/68 is mainly the result of a ~ 90-fold 
lower affinity for the a(2,6)-linkage, whereas the binding strength for the a(2,3)-linkage is 
only ~ 6 times higher. The affinities of Dk/Ukraine/1/63, Dk/Hokkaido/33/80 and 
Leu226Gln for a(2,3)-fetuin are very similar, whereas the avian viruses bind a(2,6)-fetuin 
5-6-fold more weakly than Leu226Gln. This indicates that the differences at positions 193 
and 228 between the avian viruses and the Leu226Gln mutant mainly have an effect on 
affinity for a(2,6)-fetuin.
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5.3 Setup of the Selection Assay
5.3.1 Selection Procedure Described by Rogers et al. (1985)
Dk/Ukraine/1/63 variants displaying receptor-binding properties typical of human viruses 
were previously selected by means of RBC derivatised to contain Neu5Ac in the a(2,6)- 
linkage (Rogers et al., 1985). Virus at titres of 64-128 HAUs was incubated with the 
human RBC (5% haematocrit) and incubated for 5 min at room temperature. Since 
Dk/Ukraine/1/63 preferentially recognises a(2,3)-linked Neu5Ac (see above), only variants 
with the ability to bind to Neu5Ac in the a(2,6)-linkage are expected to bind to these 
erythrocytes. Upon elution of bound virus from the RBC by incubation with Clostridium 
perfringens sialidase (250 mU/ml) for 3 hours at 37°C, the virus was propagated in MDCK 
cells to amplify variants. This selection procedure was performed four times followed by 
plaque purification of potential variants. A total number of 5 of 64 clones were found to be 
specific for the a(2,6)-linkage, as judged by adsorption to derivatised RBC and inhibition 
by horse serum, which contains mainly a(2,6)-linked sialic acid. HA sequence analysis 
revealed that all of the variants contained a single mutation Gln226Leu.
5.3.2 Modification of the Selection Procedure
5.3.2.1 Preparation of RBC to Contain Neu5Ac in the a(2,6)-Linkage
In the assay described above, human RBC were prepared to contain a(2,6)-linked Neu5Ac.
This was achieved by treatment of the cells with Vibrio cholerae sialidase to remove
terminal sialic acid moieties and subsequent resialylation with CMP-Neu5Ac by a(2,6)-
linkage specific sialyltransferases purified from rat liver. This enzyme specifically
transfers sialic acid to terminal Galp(l,4)GlcNAc moieties of N-linked glycoproteins. The
conditions for resialylation were adjusted to incorporate 35-40 nmoles of Neu5Ac per ml
of packed RBC, as judged by adding trace amounts of CMP-[14C]Neu5Ac and measuring
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radioactivity. This incorporation level has been shown to be optimal for detecting 
differences in linkage specificity of influenza viruses in haemagglutination assays (Paulson 
and Rogers, 1987). In contrast, a(2,3)-resialylated RBC contained higher amounts of 
Neu5Ac (90-125 nmol/ml packed RBC). The reason for the lower level of Neu5Ac in 
a(2,6)-reconstituted cells is that higher amounts can lead to recognition of these cells by 
viruses with a(2,3)-linkage preference, as shown by the Leu226Gln single-site mutant of 
X31 (Daniels et al., 1987).
Since high selection pressure was considered to be important for the selection of 
variants, conditions were determined to obtain the highest amount of a(2,6)-linked 
Neu5Ac on RBS where no binding of the avian viruses was observed. Due to ready 
availability, turkey RBC instead of human RBC were used for enzymatic treatment. In 
addition to the de- and resialylation procedure described above, the possibility to 
selectively remove sialic acid in the a(2,3)-linkage from RBC was also investigated. In 
contrast to Vibrio cholerae NA, which removes sialic acid in the a(2,3)-, a(2,6)- and 
a(2,8)-linkages (Drzeniek, 1967; Drzeniek and Gauhe, 1970; Schauer, 1982), influenza 
virus NA of earliest N2 subtype strains introduced into humans in 1957 exhibited clear 
a(2,3)-linkage preference (Baum and Paulson, 1991). For viruses isolated from 1957-1987, 
a gradual drift towards cleavage of the a(2,6)-linkage was observed, suggesting co­
evolution of HA and NA for preferential recognition of the same receptor determinant. 
Therefore, RBC were treated with viral sialidases isolated from JAP (Japan/305/57; H2N2) 
and X31 (Aichi/2/68; H3N2) by bromelain-treatment of virus particles (see 2.2.10 
Treatment o f Turkey RBC with Viral Neuraminidases, p.86). De- and resialylation and 
incubation with the viral sialidases were performed as described in 2.2.11 De- and 
Resialylation o f Turkey RBC, p.86. Whereas varying amounts of enzyme was used for the
resialylation experiment, time was varied for treatment with viral NAs. Then the ability of
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X31, its single-site Leu226Gln mutant and Dk/Hokkaido/33/80 to adsorb to the derivatised
RBC was tested in a direct binding assay using radioactively labelled viruses. Since
Dk/Ukraine/1/63 did not differ in its receptor-binding properties from Dk/Hokkaido/33/80
as determined by SPR, this virus was not included in the experiment. Labelling of the 
1viruses with I-Bolton Hunter reagent and the binding experiments were performed as 
described in 2.2.13 Labelling o f Virus with 125Iodine (Bolton-Hunter Reagent), p. 87, 
2.2.14 Binding Experiments o f 125Iodine-labelled Virus to Turkey RBC, p. 88. In summary, 
the viruses were incubated with the RBC and unbound virus was removed by washing the 
cells with buffer. Then the amount of virus bound to cells was determined by measuring 
radioactivity in the RBC sample and expressed as percentage compared to binding to 
untreated blood.
The results of the binding experiments are presented in Figures 39 and 40. The
resialylation experiments show that an increasing amount of a(2,6)-linked Neu5Ac leads to
recovery of binding of X31 from less than 1% for desialylated cells up to 80% for
resialylated cells without mediating recognition by Dk/Hokkaido/33/80 (Figure 39a).
However, increasing amounts of incorporated a(2,6)-linked Neu5Ac led to adsorption of
the cells by the a(2,3)-linkage specific Leu226Gln. This finding has been reported before
(Daniels et al., 1987) and is most likely the result of a higher affinity of Leu226Gln for
receptor analogues containing a(2,6)-linked Neu5Ac compared to Dk/Hokkaido/33/80 as
determined by SPR (see Table 11). Therefore, although incubation with the highest
amount of enzyme led to the largest ratio of binding of X31 compared to
Dk/Hokkaido/33/80 (32:1), binding of X31 to the resialylated blood was only 3-fold higher
compared to the Leu226Gln mutant. Since the binding ratio between X31 and
Dk/Hokkaido/33/80 was still high upon treatment of the blood with 2.5 mU enzyme (24:1),
sialylation under these conditions was considered appropriate for the selection of receptor-
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Figure 39 Binding of X31, Leu226GIn and Hokkaido/33/80 viruses to resialylated 
turkey RBC containing Neu5Ac in the a(2,6)- or a(2,3)-linkage
Sialic acid was removed from RBC by incubation with Vibrio cholera sialidase as 
described in 2.2.11 De- and Resialylation of Turkey RBC, p.86. Desialylated RBC were 
reconstituted with Neu5Ac in the a(2,6)-linkage (a) or in the a(2,3)-lirikage (b) by 
incubation with increasing amounts of linkage-specific sialyltransferases. Binding to the 
de- and resialylated RBC was assessed by adsorption of 125I-labelled viruses compared to 
untreated blood.
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Figure 40 Binding of X31, Leu226Gln and Hokkaido/33/80 viruses to RBC treated 
with X31 (a) or JAP (b) sialidases for different lengths of time
RBC were treated with viral sialidases as described in 2.2.10 Treatment of Turkey RBC
with Viral Neuraminidases, p.86, in order to remove sialic acid in the a(2,3)-lmkage.
1 •Binding to the sialidase-treated RBC was assessed by adsorption of I-labelled viruses 
compared to untreated blood.
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binding variants. As a control for the resialylation procedure, the effect of incubation of 
desialylated blood with a(2,3)-sialyltransferase on binding of the viruses was also tested. 
As expected, binding of a(2,3)-linkage specific Leu226Gln and Dk/Hokkaido/33/80 was 
recovered upon resialylation with a(2,3)-linked Neu5Ac, (Figure 39b), which is consistent 
with similar affinities for receptor analogues containing a(2,3)-linked Neu5Ac, as 
determined by SPR (see Table 11). RBC incubated with the highest amount of enzyme 
also led to recognition of these cells by X31. This is in agreement with the detected 
recognition of the a(2,3)-linkage by SPR.
Treatment of RBC with X31 and JAP NA leads to a greater reduction of binding of 
Dk/Hokkaido/33/80 and Leu226Gln compared to X31, confirming the a(2,3)-linkage 
preference of these sialidases (see Figures 40a and b). However, substantial decrease in 
binding could not be gained without a concomitant large reduction of binding by X31. The 
difference in binding ability of X31 virus compared to the a(2,3)-linkage specific viruses 
was higher for treatment with JAP compared to X31 NA, in agreement with earlier N2 
subtype strains exhibiting higher a(2,3)-linkage specificity compared to viruses isolated in 
later years (Baum and Paulson, 1991). The maximal ratio of 8:1 (X31:Dk/Hokkaido/33/80) 
for incubation with JAP NA, however, was 3 times smaller compared to that determined 
for the de- and resialylation experiments. Therefore, reconstitution of sialic acid depleted 
RBC by the use of a(2,6)-specific sialyltransferases was chosen for the preparation of RBC 
for the selection assay.
5.3.2.2 Selection Procedure
The selection procedure was slightly modified from that described by Rogers et al. (1985)
and is described in 2.2.12 Selection Experiments, p. 87. Blood no older than four days upon
collection from turkeys was de- and resialylated, tested for binding by labelled X31 and
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Dk/Hokkaido/33/80 virus and used within 24 hours. Main modifications included the use 
of different RBC suspensions. Previously, viruses were incubated with RBC at a final 
concentration of 5% (haematocrit), which the authors considered to represent conditions of 
large viral excess over cells. In order to increase the selection pressure further, the 
adsorption was performed at a final concentration of 1% (containing ~ 107 cells per ml). In 
a separate selection process, the viruses were adsorbed to RBC at 0.1, 0.01 and 0.001%, 
with the aim to reveal the number of cells that would limit the adsorption and hence 
provide maximal selection pressure. The virus obtained by incubation with the highest 
dilution of cells was used for the next round of selection. Upon incubation with virus, the 
blood was washed 6 times instead of 4 times in the presence of BSA in the buffer, in order 
to decrease non-specific binding of virus to the RBC. Furthermore, the resuspended cells 
were transferred to a new tube after every wash step, since a negative control consisting of 
virus added to a tube without blood revealed the ability of virus to stick to the plastic. The 
selection was performed 7 times compared to 4, in order to increase the probability of 
accumulation of variants. Whereas adsorption to the 1% RBC suspension readily yielded 
viruses for every round of selection, the 0.01% suspension represented the highest dilution 
of blood at which virus was obtained upon propagation in MDCK cells. After the last 
selection, the viruses selected with 1% and 0.01% RBC suspensions were plaqued on 
MDCK cells separately. Then 20 clones for every virus (10 for each selection pressure) 
were analysed for changes in HAi amino acid sequence compared to parental virus, which 
had been propagated the same number of times in MDCK cells. Sequence alignment 
revealed that none of the clones contained the Gln226Leu change selected previously. The 
only substitution detected was Arg201Gly for all of the Dk/Hokkaido/33/80 clones 
compared to parental virus. In contrast, no substitutions were observed for any of the 
Dk/Ukraine/1/63 viruses.
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5.4 Discussion
5.4.1 Inability to Select an Avian HA Containing a Gln226Leu Mutation
A Dk/Ukraine/1/63 variant displaying a shift towards receptor specificity typical of human 
isolates was previously selected (Rogers et al., 1985). Sequence analysis revealed a 
mutation Gln226Leu in HA. Since selection in the reverse direction had also been 
achieved (Rogers et al., 1983a), these results supported the importance of residue 226 for 
receptor specificity and interspecies transmission. However, in contrast to the single-site 
Leu226Gln mutant of X31, the mutation reverted back to wild-type upon propagation of 
the Dk/Ukraine/1/63 variant in eggs. Structural differences in the HAs of Dk/Ukraine/1/63 
compared to X31 were suggested to play a role in the genetic instability of the Gln226Leu 
mutation (Ha et al., 2003). Notably, Pro227 is unique for Dk/Ukraine/1/63, in contrast to 
other avian and human viruses containing Ser227. Therefore, the selection assay was 
repeated with an additional potential avian HA progenitor Dk/Hokkaido/33/80, which 
contains Ser227. Since other residues have been shown to be implicated in defining 
receptor specificity (see 5.1 Introduction, p. 187), continued selection pressure to recognise 
Neu5Ac in the a(2,6)-linkage would reveal the importance of other substitutions in this 
process. Upon selection, the genetic stability of the mutations would then be tested by 
propagation of these viruses in tissue culture cells and eggs. However, the selection assay 
described above did not yield any Gln226Leu variants for Dk/Ukraine/1/63 or 
Dk/Hokkaido/33/80. Whereas none of the analysed Dk/Ukraine/1/63 viruses contained any 
HA substitutions compared to parental virus, all of the Dk/Hokkaido/33/80 clones 
contained a mutation Arg201 Gly.
The SPR studies show that, while displaying preference for a(2,3)-fetuin, both
Dk/Ukraine/1/63 and Dk/Hokkaido/33/80 also have the ability to recognise Neu5Ac in the
a(2,6)-linkage (see Table 11). This observation suggests that the selection pressure needed
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to obtain a variant with increased affinity for the a(2,6)-linkage would be high. However, 
as judged by the results obtained in the adsorption assay, the applied selection pressure 
appeared to be high, since binding of Dk/Ukraine/1/63 to a(2,6)-resialylated cells was as 
low as for desialylated cells. The conditions for the adsorption experiments and the 
selection assay were similar with incubation with 1% RBC, since the same amounts of 
virus and RBC were used.
Although the binding ratio between X31 and Dk/Hokkaido/33/80 for a(2,6)- 
resialylated blood was high (~ 24:1), a Gln226Leu mutant was not even obtained under 
conditions considered to be the most stringent (100-fold reduction of the amount of RBC). 
It therefore appears that the binding strength of the avian viruses to bind to the derivatised 
blood, although remaining undetected by the adsorption assay, was high enough to recover 
wild-type virus.
It was assessed whether the failure to obtain the Gln226Leu variant was due to
differences in the experimental assays. Whereas the amount of added virus was similar for
both selection assays (64-256 HAUs), incubation with RBC was previously performed
with RBC at a final concentration of 5%, in contrast to the 1% and 0.01% used here. The
use of a 5% suspension and the degree of resialylation were based on a study showing that
incubation with X31 at a titre of 4 HAUs leads to maximal binding of 90% compared to
the amount bound to native cells (Rogers and Paulson, 1983). In contrast, binding of
Dk/Ukraine/1/63 was below 10%. However, the same study showed that when RBC were
used as a 1% suspension, the amount of X31 bound was still 70%. It therefore appears
unlikely that a concentration difference of RBC of only 5-fold would account for the
failure to select the Gln226Leu mutant. Furthermore, the binding ratios of X31 and
Dk/Ukraine/1/63 in the adsorption assay described above were similar to those determined
in this study. The main difference between the two selection assays was the origin of
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erythrocytes. Due to ready availability, turkey RBC instead of human RBC were used in 
this study. Since the a(2,6)-sialyltransferases in both studies display the same specificities 
(to transfer sialic acid to terminal Gal of N-linked glycoproteins in the a(2,6)-linkage), 
other factors such as differences in the density or composition of the glycoproteins on 
human and turkey RBC might affect the interaction with virus and hence the selection 
assay. However, since little information on the nature of glycoproteins on turkey RBC is 
available, the reasons for the inability to obtain the Gln226Leu mutant remain unknown.
5.4.2 Selection of an Arg201Gly Variant
The results of the selection assay indicate the difficulty to select for an avian HA
containing the Gln226Leu substitution. Whereas no HA variant was obtained for
Dk/Ukraine/1/63, one substitution, Arg201Gly, was detected in all of the 20 clones
analysed for Dk/Hokkaido/33/80. The effect of this mutation on receptor-binding
properties of this virus has not been determined yet. Residue 201 is located in the HA
trimer interface, which is not an obvious location to affect the interaction with cellular
receptors. However, it has been shown that an amino acid in the HA interface (218) can
influence receptor specificity (Daniels et al., 1987). A virus containing a Gly218Glu was
reported to acquire recognition of the a(2,3)-linkage, whereas a Gly218Asp change led to a
decrease in affinity for both a(2,3)- and a(2,6)-linked Neu5Ac. It was suggested that the
observed change in receptor recognition might have been caused by an altered quaternary
structure of HA. Arg201 resides in the opposite side of the RBS to 218 and forms a
hydrogen bond to the main-chain carbonyl-group of residue 217 in a neighbouring
monomer. Since residue 217 is located next to 218, the substitution at 201 might have an
effect on receptor-binding properties. The effect of Gly201 on the interaction with cellular
receptors could be assessed by determining the affinity of this variant for a(2,3)- and
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a(2,6)-fetuin by SPR.
5.4.3 Possibilities to Improve the Selection Assay Using Turkey RBC
A difficulty in the selection of a receptor-binding variant might be presented by the
specificity of the viral NA. As described in 1.10 Functional Balance between HA and NA
Activity, p. 66, the activities and specificities of HA and NA need to be carefully balanced
for optimal virus replication. Since the HA of Dk/Ukraine/1/63 and Dk/Hokkaido/33/80
was shown to preferentially bind a(2,3)-linked Neu5Ac, the NA is likely to display the
same specificity. A variant containing an HA with a(2,6)-linkage specificity but a NA with
a(2,3)-linkage specificity might be impaired for efficient replication in MDCK cells and
hence be selected against. A drift in NA for a(2,6)-linkage preference might facilitate the
selection of an HA variant. Selection pressure directed against NA would be provided by
propagation of the virus in cells containing mainly a(2,6)-linked sialic acid. Since human
host epithelial cells have been shown to contain mainly a(2,6)-linked sialic acid (Baum
and Paulson, 1990; Couceiro et al., 1993), these might have provided the additional
selection pressure for efficient selection of an a(2,6)-linkage specific HA variant for the
transmission of virus from birds to humans. The routinely used cell lines for propagation
of influenza viruses (MDCK and VERO) cells, however, contain both a(2,3)- and a(2,6)-
linked sialic acid and would therefore not exert any selection pressure (Govorkova et al.,
1996; Ito et al., 1997b). In addition, since human viruses are also exposed to mucins,
which contain mainly a(2,3)-linked sialic acid, a combined selection for recognition of
a(2,6)-linked sialic acid on host cells but against recognition of a(2,3)-linked sialic acid by
mucins might be important for facilitated selection (Breg et al., 1987; Baum and Paulson,
1990; Couceiro et al., 1993). Propagation of virus in MDCK cells in the presence of an
a(2,3)-linkage-containing inhibitor might increase the probability of obtaining an HA
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variant with increased affinity for a(2,6)-linked sialic acid and concomitant decrease in 
a(2,3)-linkage-recognition. Alternatively, the selection assay could be repeated with 
Dk/Ukraine/1/63 and Dk/Hokkaido/33/80 viruses containing an a(2,6)-linkage specific NA 
generated by reassortment with a human H3 isolate.
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6 General Discussion
6.1 Effectiveness of SPR Binding Assay to Study the Interaction of 
Influenza Virus with Receptor Analogues
A receptor-binding assay using the BIAcore has been set-up to study the interaction of 
influenza viruses with receptor analogues. This method makes use of the optical 
phenomenon of SPR, a technique widely used to study receptor-ligand specificity, affinity
j
and kinetic rate constants for many biomolecular interactions, including viral proteins and 
whole virus particles (e.g. Casasnovas and Springer, 1995; McDermott et al., 2000). This 
assay has previously been used to study the kinetics and affinity of BHA-rosettes derived 
from influenza virus for a sialic acid-containing receptor analogue, fetuin (Takemoto et al., 
1996). The data presented here show that SPR assays can be performed with whole virus 
particles. In addition, the method was further developed to directly compare the affinity of 
virus for fetuin containing Neu5Ac either in the human-specific (a(2,6)) or the avian- 
specific (a(2,3)) linkage, allowing for the study of linkage specificity. The Kd was 
determined from the kinetic rate constants, since steady-state conditions were not reached 
on the time-scale of the experiments. The SPR assay allowed for the detection of a broad 
range of affinity differences, from ~ 3-fold, indicative of high sensitivity, up to ~ 3,000- 
fold. Furthermore, the experiments were highly reproducible with different batches of 
virus.
The affinity of virus particles for fetuin and derivatised fetuin was revealed to be
13very high, e.g. the Kd of the interaction of the laboratory strain X31 for fetuin was ~ 10' 
M. This interaction is ten orders of magnitude tighter compared to that of BHA or virus 
and trisaccharides (Kd of ~ 10‘3 M) (Sauter et al., 1989; Hanson et al., 1992). This affinity 
difference is accounted for by the simultaneous binding of multiple HA trimers on the
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virus envelope to multiple Neu5Ac on fetuin (multivalency), leading to amplification of
the 1:1 (monovalency) binding affinity. The virus-fetuin affinity is also five orders of
magnitude higher compared to the BHA rosettes-fetuin affinity previously determined by
SPR (K d  ~ 10"7 M) (Takemoto et al., 1996). This increase in affinity might also be
explained by an increase in valency, since the virus envelope contains -  500 HA trimers
compared to -  6-10 per BHA rosette. The advantage of the high affinity of the virus-fetuin
interaction is that only small amounts of virus are needed (in the range of the Kd) for
reliable measurements. The highest amount of virus used in the SPR assay was 0.26 nM (~
15 pg/ml total viral protein), in contrast to BHA rosettes, which had previously been used
at a concentration of 120 nM (~ 200 pg/ml HA). Furthermore, clear determination of the
Kd for the BHA rosette-fetuin interaction proved unsuccessful in this study due to the high
heterogeneity observed in the reaction curves. This is likely to be the result of a
heterogeneous rosette population with regard to the number of BHA trimers per rosette and
disagrees with the reported suitability of rosettes for affinity measurements by SPR. Visual
inspection of the reaction curves of the BHA rosette-fetuin interaction studied by
Takemoto et al. (1996) also suggests heterogeneity. Since little information on the data
analysis is provided, it is not clear how this heterogeneity was taken into account in the
calculation of the Kd-
A number of receptor-binding assays are available to study the interaction of
influenza virus with receptor analogues. However, quantitative binding data has so far only
been obtained by NMR, fluorescence polarisation and solid-phase assays (Gambaryan and
Matrosovich, 1992; Hanson et al., 1992; Sauter et al., 1992; Weinhold and Knowles,
1992). Of these, the solid-phase assay has been used to routinely detect affinity and
specificity differences between influenza viruses. This method determines equilibrium
dissociation constants indirectly by measuring the amount of HRP-labelled fetuin bound to
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vims adsorbed to 96-well microtitre plates in the presence of different amounts of the 
receptor analogue of interest. The advantage of this assay is that many viruses can be 
tested simultaneously. In contrast, the SPR method is more time-consuming, since the 
dataset for every vims has to be collected separately, which takes about 3 hours. Therefore, 
BIAcore is not a suitable method for high-throughput analysis. However, programming of 
the injection commands allows the experiments to be performed automatically without the 
need for attendance. In addition, only small amounts of derivatised fetuin are required for 
coupling to the sensor chip (~ 2 pg). Since fetuin is very resistant with regard to removal 
of bound vims by regeneration buffers, it is possible to re-use the same sensor surface for 
many binding experiments (> 100 times). In contrast, determination of the Kd in solid 
phase assays requires higher amounts of receptor analogues, since they need to be used at 
range of concentrations and can not be re-used. Since concentrations of analytes range 
from mM (sialyllactose) to pM (sialyllactose attached to polyacrylic acid carriers), the 
higher consumption of receptor analogues renders the solid-phase assay less cost-effective. 
A further advantage of the established SPR assay is that absolute affinities can be 
compared for different vimses, due to the controlled concentrations of both ligand and 
analyte. In contrast, absolute affinity comparison is more difficult for solid-phase assays, 
Where vims is bound to 96-well microtitre plates either directly by physical adsorption or 
indirectly to fetuin-coated wells. The amount of adsorbed vims might therefore vary with 
the absolute affinity of the vimses, especially when these are adsorbed to fetuin-coated 
wells.
Furthermore, the SPR assay also gives information on the kinetic rate constants ka 
and kd for the virus-fetuin interaction, thereby providing insight into which rate is the 
major determinant for binding strength.
In conclusion, despite being time-consuming, the development of the SPR assay
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has generated an effective method to routinely study affinities of influenza virus for 
receptor analogues.
6.2 Changes in Receptor-Binding Properties in Relation to Antigenic 
Drift
The established SPR assay was used to study the receptor-binding properties of a panel of 
HI and H3 viruses. These were chosen on the basis of differences in their antigenicity, as 
determined by HI tests with post-infection ferret sera. Since HA undergoes continuous 
antigenic drift in order to evade pre-existing immunity in the human population, it was of 
interest to investigate whether changes in antigenicity would correlate with differences in 
their affinity for receptor analogues containing a(2,3)- or a(2,6)-linked Neu5Ac. An 
interrelationship between these two properties is thought to be due to the location of 
antigenic sites in close vicinity of the RBS (see 1.7.6 Interrelationship between Antigenic 
Variation and Receptor-Binding Properties, p.58). Furthermore, substitutions in antigenic 
sites further away from the RBS can affect the interaction with cellular receptors if they 
create or abolish carbohydrate attachment sites.
The data presented in this study show that evolution of HI and H3 viruses in the
human population is not only associated with antigenic variation but also with changes in
affinities for receptor analogues. Notably, the emergence of antigenic variants was
accompanied by distinct changes in receptor-binding properties for the H3 viruses since
2002 (Fujian-like viruses) and for the HI viruses since 1999 (New Caledonia-like viruses).
The Fujian-like viruses were characterised by a large decrease in affinity for a(2,3)-fetuin,
resulting in a large increase in a(2,6)-linkage preference. The New Caledonia-like viruses
also displayed clear a(2,6)-linkage specificity, in contrast to the remaining HI isolates,
which were either a(2,3)- or “dual”-linkage specific. The differences in both antigenic and
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receptor-binding properties were correlated with many amino acid substitutions close to or 
in the RBS. It has initially been thought that RBS residues would have to be conserved in 
the process of antigenic drift in order to preserve receptor-binding function (Both et al., 
1983b; Weis et al., 1988; Bizebard et al., 1995). However, the observed changes at RBS 
residues, in agreement with earlier studies (e.g. Lindstrom et al., 1996; Mori et al., 1999; 
Nobusawa et al., 2000), strongly indicate that the plasticity of the RBS to accommodate 
cellular receptors is higher than previously thought. It should be noted that antigenic 
changes did not always result in large differences in affinity for receptor analogues. For 
example, Johannesburg/33/94 and Sydney/5/94 (H3 viruses), and Brazil/11/78 and 
Chile/1/83 (HI viruses) were antigenically distinct but displayed similar receptor-binding 
properties. This finding suggests that residues that are involved in recognition by 
antibodies differ in their propensity to affect receptor-binding properties.
The changes at residues close to the RBS are likely to be involved in antigenic 
drift, based on the observation that many of these are located in previously defined 
antigenic sites and the surface-exposed nature of their side-chains.
The main driving force for HA evolution is likely to be escape from pre-existing
immunity, so as to maintain infectivity of the virus. Therefore, the substitutions in the RBS
could be a consequence of immune pressure as well. These could play a direct role in
escape from neutralising antibodies if they are part of an antibody-combining site. On the
other hand, their involvement could be of indirect character, either to compensate negative
effects on receptor function caused by a change in an antigenic site affecting the structure
of the RBS or by modulation of receptor-binding properties as an alternative mechanism
for antibody-escape. Since binding to antibody is in direct competition with attachment to
cells, it has been suggested that an increase in affinity for cellular receptors might be
sufficient to prevent neutralisation by antibodies. This hypothesis is based on the
210
Chapter 6 General Discussion
observation that adsorptive mutants are often selected with low-affinity antibodies or when 
antibodies are provided at sub-neutralising concentrations (Fazekas de St. Groth, 1977; 
Yewdell et al., 1986; Temoltzin-Palacios and Thomas, 1994; Laeeq et al., 1997). Since 
concomitant immunity to previous infection has been suggested to lead to the production 
of antibodies with reduced affinity (Fazekas de St. Groth and Webster, 1966), it is possible 
that such an alternative mechanism for immune-evasion operates in the human host.
Interestingly, the Fujian-like viruses were shown to generally display a lower 
affinity for a(2,6)-fetuin compared to earlier isolates, which would be expected to have a 
negative effect on binding to human receptors. It is intriguing to speculate that the large 
reduction in affinity for a(2,3)-linked Neu5Ac would facilitate access of these viruses to 
cells by preventing binding to inhibitory mucins, which contain mainly a(2,3)-linked sialic 
acid, in the respiratory tract, thereby compensating for the negative effect of reduced 
binding strength for human receptors.
6.3 Implication of Changes in Receptor-Binding Properties for Virus 
Infectivity
Changes in receptor-binding properties as a direct or indirect result of immune pressure are
expected to have implications for the fitness of influenza virus. Although escape from
immune surveillance is essential for re-infection of the human population, receptor-binding
function is also important for virus infectivity. Therefore, a certain balance between the
ability to escape from neutralising antibodies and the ability to bind to cells needs to be
maintained. An increase in affinity as an alternative mechanism to antigenic drift would
undoubtedly provide an evolutionary advantage for a virus and would therefore be
selected. However, since mutations are by definition not directed, many substitutions
might be detrimental instead of beneficial for virus fitness. It has therefore been proposed
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that the rapid rate of antigenic drift might eventually impair the virus’ ability to survive in 
the human host due to the accumulation of detrimental point mutations (Fitch et al., 1991), 
a concept referred to as Muller’s ratchet (Muller, 1932; Felsenstein, 1974). Since HA 
appears to be in evolutionary stasis in aquatic birds (Kida et al., 1987; Gorman et al., 
1990a; Gorman et al., 1990b; Bean et al., 1992), it has been suggested that replacement of 
a deleterious HA with an HA from the avian reservoir by reassortment would restore the 
fitness of influenza virus (Fitch et al., 1991). Such a mechanism would imply the necessity 
for the introduction of an avian HA for the maintenance of influenza virus in the human 
host. Although Muller’s ratchet is an intriguing explanation for the emergence of pandemic 
strains, evidence for such a mechanism has not been provided (Donis, 1991). 
Alternatively, it is conceivable that the number of progeny virus is simply high enough in 
order to select against variants with deleterious mutations in a “quasi-species” population 
(Fitch et al., 1991; Domingo et al., 2001). Four of the five tested recent Fujian-like viruses 
displayed a lower absolute affinity for both a(2,3)- and a(2,6)-fetuin compared to earlier 
viruses. However, receptor-binding data on many more isolates would be needed to 
determine whether a low affinity would be characteristic of current H3 viruses.
6.4 Significance of Receptor-Binding Data Derived from Egg-Adapted 
Viruses
The phenomenon of host cell-mediated variation has been shown to occur when clinical
isolates are propagated in the laboratory, especially in eggs (see 4.1.3 Host Cell-Mediated
Variation, p. 134). This process needs to be taken into account when receptor-binding
properties of viruses are studied, since they might not be representative of the original
clinical isolates. The viruses used in this study were all egg-adapted and their HAi
sequence of the original clinical isolate was not readily available. Therefore, it is not clear
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how well the determined antigenic and receptor-binding properties reflect the 
characteristics of naturally circulating viruses. However, it was the aim of this study to 
investigate if antigenically distinct viruses would also display differences in their receptor- 
binding properties, irrespective of whether they reflect those of the original isolate. 
Nevertheless, sequencing of HA directly from the clinical specimen before propagation in 
the laboratory and cultivation of virus in MDCK or VERO cells, where host cell-mediated 
variation is less likely to occur, would enable to correlate these data to field strains. This 
might lead to a better understanding of evolution of antigenic and receptor-binding 
properties in the human host.
6.5 Implications of Changes in Receptor-Binding Properties for 
Surveillance Studies
The decision for including a novel strain in the influenza vaccine formulation is based on
detection of antigenic variation based on HI tests using post-infection ferret sera. This
assay reflects the conditions in the human respiratory tract, since antibody and cells
compete for the binding to virus. However, a major drawback of this competition-based
method is that it is significantly affected by changes in receptor-binding properties of a
virus, which complicates the analysis of HI tests. For example, a virus with increased
affinity for cellular receptors requires a higher amount of antibody to inhibit binding to
RBC. As a result, such a virus might be classified as antigenically different, unless
antibodies are provided at higher concentrations, which also presents technical difficulties
in the process of antibody production. In contrast, binding to RBC of a virus with low
affinity for cellular receptors would be inhibited by very low concentrations of antibody.
An indication of low-affinity viruses is that they often give higher titres with heterologous
ferret serum than the virus probed with its homologous serum. Therefore, the amount of
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antibody needs to be adjusted depending on the receptor-binding properties of a particular 
strains, which makes quantitation of reactivity with antibodies more difficult. Furthermore, 
the HI test can be performed with RBC of different origins, human, guinea pig, chicken or 
turkey (WHO, 2005c). Little information on the carbohydrate composition is available for 
turkey RBC, whereas the remaining RBC have been shown to differ in the relative 
prevalence of sialic acid in the a(2,3)- versus the a(2,6)-linkage (Ito et al., 1997a; 
Medeiros et al., 2001). Changes in affinity for an individual virus for only one of these 
linkages might therefore affect the extent to which the HI is affected depending on the 
nature of RBC used. Although these problems can be resolved by the use of assays that are 
not affected by receptor-binding properties, such as immunodiffusion and ELISA, these 
methods are more labour-intense.
Efforts are currently being made to quantify the antigenic relationships between 
viruses based on HI tests by applying mathematical models for the analysis of the results 
(Smith et al., 2004). These allow for an increase in sensitivity of measurements of 
antigenic differences and might help in the comparison of HI data from different 
laboratories. Information on receptor-binding properties might provide valuable data to be 
included in such mathematical models for further improvement in the analysis of antigenic 
data, prediction of antigenic evolution and vaccine strain selection.
6.6 Future Experiments
6.6.1 Modification of the SPR Assay for the Use of Virus Propagated in Mammalian 
Tissue Culture Cells
The SPR assay was set-up with egg-adapted viruses. The rationale for the use of eggs was
that growth in this host cell system yields a homogeneous population with regard to shape
and size of virus particles. This was' considered important to avoid heterogeneity in the
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association and dissociation curves in SPR studies, which would complicate the analysis of 
kinetics data. In addition, once adapted, viruses usually grow to high titres in eggs. 
However, the Fujian-like H3 viruses grew poorly in this host cell system, probably due to 
their decrease in affinity for a(2,3)-linked sialic acid, the predominant linkage in cells of 
the allantoic cavity (Ito et al., 1997b). Since growth restriction increases the chance of host 
cell-mediated variation, it would be of advantage to propagate these viruses in mammalian 
tissue culture cells, such as MDCK or VERO cells. These have been shown to select for 
variants less frequently and the antigenic and receptor-binding properties of viruses 
cultivated in such cells would therefore more closely reflect those of the respective clinical 
isolates. In addition, eggs present additional drawbacks, such as the lack of year-round 
supplies of high quality eggs and the possible presence of pathogens. Therefore, it would 
be of interest to propagate viruses in mammalian tissue culture cells for both antigenic and 
SPR studies. The observation that tissue culture isolates are usually more heterogeneous in 
particle size and shape compared to egg-isolates could potentially complicate analysis of 
kinetics data. However, if necessary, the virus purification method could be adjusted for 
the separation of different sized particles, for example by collecting narrower bands in the 
density centrifugation.
6.6.2 Testing Additional Isolates to Confirm Distinct Receptor-Binding Properties of 
Recent H3 and HI Viruses
The SPR data suggest that the distinct receptor-binding properties of the Fujian-like 
viruses (large decrease in affinity for a(2,3)-fetuin) and New Caledonia-like viruses 
(a(2,6)-linkage specificity) would be characteristic of viruses circulating since 2002 and 
1999, respectively. In order to confirm this finding, additional isolates would have to be
tested, possibly grown in mammalian tissue culture cells (for reasons stated above).
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6.6.3 Use of Reverse Genetics for Generation of Mutant Influenza Viruses
The generation of influenza virus entirely from cDNA (reverse genetics) has become a 
powerful tool for the generation of mutant influenza viruses (Neumann et al., 1999; 
Hoffmann et al., 2000). This technique could be applied for the investigation of the 
subjects described below.
6.6.3.1 Assessment of the Structural Basis for Reduction in Affinity for a(2,3)-fetuin 
of Fujian-like Viruses
The data presented in this study suggests that the reduced affinity of Fujian-like viruses for 
a(2,3)-fetuin is a result of substitutions at HA residues 222 and 225. These might 
potentially relocate an oligosaccharide protruding from residue 165 that would interfere 
with distant parts of receptors containing a(2,3)-linked sialic acid. X-ray studies of HAs of 
these viruses and the single-site mutant Gly225Asp complexed with receptor analogues 
might provide a structural basis for this observation. Furthermore, the involvement of a 
carbohydrate moiety in steric hindrance would be addressed by structural and SPR studies 
with a single-site mutant that lacks this glycosylation site.
6.6.3.2 Assessment of the Structural Basis for Residues Involved in Linkage- 
Recognition for HI Isolates
The structures of Puerto Rico/8/34 and Sw/Iowa/15/30 HAs complexed with receptor
analogues have provided first insight into residues involved in linkage specificity for the
HI viruses (Gamblin et al., 2004). The SPR data presented in this study proposes that
linkage-recognition is defined by a combination of amino acids in the RBS. X-ray studies
with a number of viruses used in this study would address the roles of these residues in
linkage specificity. As for the H3 viruses, the importance of individual amino acids in
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distinguishing between receptor analogues containing Neu5Ac in the a(2,3)- or a(2,6)- 
linkage would be assessed by receptor-binding studies using single-site mutants.
6.6.3.3 Residues Responsible for Distinct Receptor-Binding Properties of H1N2 Virus
All the HI isolates of 1999-2003 (New Caledonia-like) have been shown to display very 
similar receptor-binding properties, with the exception of the H1N2 virus, which differed 
from the others by a 10-fold increase in affinity for a(2,6)-fetuin and a 100-fold decrease 
in affinity for a(2,3)-fetuin. Since Egypt/96/02 was the only reassortant virus available for 
this study, it is not known whether these receptor-binding properties are typical of H1N2 
viruses in general. Therefore, additional reassortant viruses would have to be tested for 
their affinity for a(2,3)- and a(2,6)-fetuin. In addition, since Egypt/96/02 differs from the 
remaining New Caledonia-like viruses only at residues 132, 193 and 218, it would be of 
interest to elucidate the roles of these in linkage-recognition by X-ray studies and by 
testing receptor-binding properties of single-site mutants.
6.6.4 Studies of NA Activity and Specificity
This study only addressed receptor-binding properties of influenza virus. Since evidence
for a functional interplay between HA and NA for optimal virus replication has been
provided by a number of studies (see 1.10 Functional Balance between HA and NA
Activity, p. 66), it would be of interest to complement the receptor-binding data with NA
activity and specificity data. Activity would be tested in a routinely performed
fluorometric assay using labelled sialic acid (muNANA assay) (Potier et al., 1979),
whereas specificity studies would require labelled receptor analogues containing a(2,6)- or
a(2,3)-linked Neu5Ac (e.g. Mochalova et al., 2005). NA studies would be of particular
importance for recent HI, H3 viruses and the H1N2 virus Egypt/96/02. Notably, the H1N2
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isolate displayed a similar low affinity for a(2,3)-fetuin as the recent H3 viruses. Since it 
has previously been suggested that substitutions in HI HA accumulated from 1995-1999 
might have facilitated the reassortment between H1N1 and H3N2 viruses, these studies 
would further elucidate the importance of a functional balance between HA and NA.
6.6.5 Investigation of Involvement of RBS Residues in Antigenic Variation
The performed studies did not assess whether the observed changes for HI and H3 isolates 
in the RBS could be directly involved in antigenic drift by blocking binding to antibodies, 
or whether they merely affected receptor-binding properties. ELISA studies with an 
extensive panel of mAb of known epitope specificity would address this question. 
Furthermore, variants could be selected with mAb generated against individual isolates. 
Substitutions at RBS residues that would lead to a large decrease in binding to the 
selecting mAb in ELISA tests would provide evidence for the involvement of these 
residues in antibody-binding.
6.6.6 Testing of Receptor-Binding Properties of the Selection Assay Variant
The attempt to repeat the selection of an avian H3 virus containing a Gln226Leu 
substitution (Rogers et al., 1985) did not prove successful. However, since an Arg201Gly 
variant was selected for Dk/Hokkaido/33/80 instead, it would be of interest to test the 
effect of this single-site substitution on linkage-recognition.
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8 Appendix
Amino acid | Three letter codej One letter codej
alanine 1 ala | A |
arginine | arg 1 R !
asparagine | asn N
aspartic acid | asp | D 1
asparagine or aspartic acid| asx | B
cysteine | cys | c  )
glutamic acid glu E 1
glutamine ( 9>n ( Q
glutamine or glutamic acid glx | Z
glycine | giy 1 G i
histidine j his | H I
isoleucine ile 1 |
leucine j leu | L I
lysine 1 lys K j
methionine | met j M |
phenylalanine | phe | F j
proline | pro | P 1
serine ser | s  i
threonine | thr | T !
tryptophan | try I w  j
tyrosine | tyr Y 1
valine | val | v  I
Appendix 1 Amino acids, one- and three-letter codes
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A homogeneous 1:1 interaction between analyte and ligand is described by the equation 
ka
A + B AB
kd
where A is the analyte, B the surface-bound ligand, ka the association rate constant and kd 
the dissociation rate constant. The rate of complex formation is written as
d[AB] _
d t
= ka[A \B ]-kd[AB\
The concentration of free ligand [B] is the difference between the total amount of ligand 
[B]o and the amount of complex
[B] = [B \ - [A B ]
Substitution in the rate equation for complex formation gives
^ = k u m , - U B \ ) - K [ A B \
d t
In terms of the SPR signal, this equation is written as
= k ac { R mwL- R ) - k dR
d t
RU -maxdR/dt
t
where dR/dt is the rate of change of the SPR signal, C the concentration of free analyte A, 
Rmax the maximum analyte binding capacity in RU and R the SPR signal in RU at time t. 
Since sample injection is continuous, the concentration of free analyte C equals the 
concentration of analyte in the sample.
The equation can be rearranged to
d R
~  = k aC R m,dX- ( k aC  + k d )R  Integration of this equation gives
d t
k aC  + k d
k aC R m
with kobs = kaC +k<i and R.„  ----------
eq k„ C  + k
d
Appendix 2 Derivation of association kinetics equation for SPR assays
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